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T regulatory (Treg) cells play a pivotal role in the maintenance of self-tolerance and 
immune homeostasis. Forkhead box P3 (Foxp3)+ Treg function is controlled by 
environmental cues of which cytokine-mediated signaling is a dominant component. 
Recently, Interleukin (IL)-4 has been shown to play an important role in determining the 
fate of Foxp3+ Tregs. In vivo, IL-4-mediated signaling via Interleukin-4 receptor alpha (IL-
4Rα) was convincingly shown to mediate Treg transdifferentiation into ex-Foxp3 Th2 or 
Th17 cells, suggesting a negative regulation of Foxp3+ Tregs by IL-4Rα-mediated 
signaling. Puzzlingly, however, IL-4-mediated signaling was also independently found to 
reinforce the Foxp3+ Tregs, counter-arguing for the positive regulation of Foxp3+ Tregs by 
IL-4Rα-mediated signaling. In the face of such a conundrum, the present work was set forth 
as an attempt to unambiguously and conclusively decipher the bases of the regulation of 
Foxp3+ Treg by IL-4Rα-mediated signaling using transgenic murine models. 
It was first noted that Foxp3+ Treg cells do express IL-4Rα under steady-state. Furthermore, 
in vitro, purified CD25+ Tregs were prompted to higher Foxp3 expression and increased 
survival upon stimulation with IL-4 arguing for a potentiating role of IL-4Rα mediated 
signaling on Foxp3+ Treg cells. To better address the need for the host Foxp3+ Treg cells 
to express IL-4Rα as observed, we generated Foxp3-specific IL-4Rα deficient mice where 
IL-4Rα is specifically deleted from Foxp3+ T cells in the whole organism. Even though 
naïve Foxp3cre IL-4Rα-/lox mice model at homeostasis did neither reveal any significant 
alteration of the cellular, tissular and phenotypic profile nor development of spontaneous 
inflammatory disorder when compared to wild-type mice, under S. mansoni infection 
impairment IL-4Rα-mediated signaling on Foxp3+ Tregs resulted in heightened activation 
marker expression and elevated T cell effector functions as indicated by increased 
cytokines production and greater T cell proliferation rate. This heightened immune 
responsiveness translated overall into an exacerbated parasitic egg-driven 
fibrogranulomatous inflammation in the liver and the gut of schistosomiasis-diseased 
Foxp3cre IL-4Rα-/lox mice. Furthermore, in another model of helminth infection with the 
parasitic nematode, Nippostrongylus brasiliensis, Foxp3cre IL-4Rα-/lox mice showed a 
higher level of mucus and exaggerated emphysematous pathology in the lungs. 
Interestingly, the impairment of IL-4Rα signaling within the Foxp3+ Treg population in 
Foxp3cre IL-4Rα-/lox mice led to a reduced recruitment of Foxp3+ Tregs and a diminished 
expression of Foxp3, and other associated Treg suppressive markers (i.e. IRF4 and Helios) 
during the course of these helminth infections. Taken together, our findings supported a 
role for IL-4Rα signaling in the positive regulation of Foxp3+ Tregs function and thus, the 
suppression of inflammatory responses during helminth infections.  
In conclusion, this work demonstrated a positive role for IL-4Rα mediated signaling in the 
biology of Foxp3+ Treg cells whereby the latter cells require IL-4Rα signaling to survive 
and maintain Foxp3 expression and suppressive functions so as to efficiently control tissue 
inflammatory responses during infection. The data presented do provide insights into the 
mechanisms of Foxp3+ Treg regulation that are highly relevant for the therapeutic control 
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Chapter 1: Background and Problematic 
1.1 The immune system 
The mammalian immune system has evolved to protect the host against the pathogenic 
environment as well as to remove and/or inhibit potentially pathogenic self-reactive 
immune cells (Murphy et al., 2008). The immune system carries out its function through 
complex interactions between different types of immune cells. These cells are derived from 
pluripotent stem cells, present in the bone marrow, known as hematopoietic stem cells 
(HSCs). Through a series of stochastic events as well as the support of cytokine signals, 
HSCs can be differentiated into two main progenitors: common myeloid progenitor (CMP) 
and common lymphoid progenitor (CLP) (Socolovsky et al., 1998; Blom and Spits, 2006; 
Robb, 2007; Murphy et al., 2008). While CMP can differentiate into basophils, eosinophils, 
neutrophils, mast cells, granulocytes, monocytes/macrophage, and dendritic cells, CLP 
differentiates into natural killer (NK) cells, innate lymphoid cells (ILCs), B cell, and T cells 
(Kondo et al., 1997; Akashi et al., 2000; Murphy et al., 2008; Serafini et al., 2015). Based 
on the specificity and the timing at which these cells are activated in response to the 
invading pathogen/antigen, the cells can be grouped into two main arms; innate immune 
arm, which is less specific and considered to be the first line of defense, and adaptive 
immune arm, that is characterized by high level of specificity and is always shaped by the 
early innate immune signals. Innate immunity includes ILCs, basophils, eosinophils, 
neutrophils, mast cells, granulocytes, monocytes /macrophage, NK cells, NKT cells, and 
gamma-delta T cells, while adaptive immunity includes B cells and T cells (Murphy et al., 
2008).  
 
1.2 The regulation of the adaptive immune system 
Adaptive immune response is one of the two main pillars of the immune system. Its 
broad diversity and specificity confer by somatic recombination of T cell receptor (TCR) 
and B cell receptor (BCR) enables the host protection from rapidly evolving pathogens. 
The ability of the adaptive immune system to distinguish between self and non-self is the 
key to prevent deleterious immune-damage to the host, autoimmune diseases, and to mount 
an effective immune response against invading pathogens, respectively (Sprent and Cho, 
2008). In fact, the immune response is orchestrated so as to “achieve the best possible 
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protection against pathogens and the altered/pathogenic self while causing the least possible 
amount of damage to the host”. Therefore, multiple check-points and different levels of 
cell-intrinsic and cell-extrinsic immune-regulations are in place. These immune-regulations 
can be summarized into 3 main levels; i) First Tier Control, ii) Second Tier Control, and 
iii) Third Tier Control. First Tier Control is aimed at the elimination of autoreactive 
immature lymphocytes in the primary lymphoid organs (the thymus for T cells and the bone 
marrow for B cells) through a process known as negative selection. In negative selection, 
immature lymphocytes whose receptors confer a strong affinity to self-molecules are 
programmed to either die by apoptosis or clonal deletion, to produce a new receptor through 
a process known as receptor editing, to be functionally inactive, anergic, to self-antigens, 
or to have the state of immunological ignorance (Starr et al., 2003) and hence, only 
functionally competent lymphocytes migrate from the primary lymphoid organs to the 
periphery. In the periphery, there is a Second Tier Control whereby T cells and B cells do 
require two distinct signals for their activation (Lenschow et al., 1996). For T cells,  the 
first signal originates from the engagement of TCR with the peptide-major 
histocompatibility complex (MHC) complex (Murphy et al., 2008) and the second signal 
depends on the interaction of T cell costimulatory receptor cluster of differentiation (CD)28 
with CD80 and CD86 which are expressed on the surface of activated antigen-presenting 
cells (APC) (Lenschow et al., 1996). Although these two tiers of controls are very powerful, 
they are insufficient to counter the threat of immune-mediated pathology. Third Tier 
Control is therefore in place, mediated by a specialized T cell subset, known as regulatory 
T (Treg) cells, that possess immune suppression capability to keep in check the activation 
and expansion of aberrant or over-reactive T cells (Sakaguchi et al., 2008; Josefowicz et 
al., 2012). 
 
1.3 T cell-mediated immune regulation 
Initial discovery of thymus-derived T cell subset that can dampen the immune response 
and prevent autoimmunity, Treg cells, has been made 40 years ago thanks to neonatal and 
adult thymectomy experiments (Nishizuka and Sakakura, 1969; Penhale et al., 1973; 
Sakaguchi et al., 1982; Penhale et al., 1990; Fowell and Mason, 1993; Bonomo et al., 1995; 
Asano et al., 1996) as well as transplantation tolerance studies of chicken-quail chimera 
(Ohki et al., 1987) and  mice chimera (Salaun et al., 1990). It has been shown by Nishizuka, 
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Sakaguchi, and others that neonatal thymectomy (NTx) of normal mice performed at a 
critical period (between 2 and 4 days after birth) leads to T cell-mediated inflammation of 
various organs and appearance of tissues specific auto-antibodies in the circulation 
(Nishizuka and Sakakura, 1969; Sakaguchi et al., 1982; Bonomo et al., 1995; Asano et al., 
1996). In support, adult thymectomy of normal rats followed by four rounds of sublethal 
X-irradiation results in auto-immune thyroiditis as well as type 1 diabetes (Penhale et al., 
1973; Penhale et al., 1990; Fowell and Mason, 1993). In all cases, development of T-cell 
mediated tissue damage was prevented upon reconstitution of depleted cells with normal T 
cells from adult syngenic animals. In the second set of experimentation, studies of chicken-
quail chimera and mice chimera demonstrated that grafted thymic epithelium cells are 
responsible for xenograft tolerance (Ohki et al., 1987; Salaun et al., 1990). In these set of 
experiments, induction of tolerance to allogeneic tissue graft was mainly mediated by 
thymus-derived T cell subset that was capable of suppressing alloreactive T cells. 
Altogether, results of these experiments indicated the presence of a specialized T cell subset 
with the ability to prevent and control auto-immunity (Shevach, 2000; Sakaguchi et al., 
2008; Benoist and Mathis, 2012; Josefowicz et al., 2012).  
To distinguish this specialized T cell subset with immunoregulatory features from 
other T cells, several attempts were made to identify a specific cell marker for Treg cells. 
Although using CD5high, CD45RClow, RT6.1high, or CD45RBlow markers had helped in the 
better understanding of Treg cell biology (Sakaguchi et al., 1985; Sugihara et al., 1988; 
McKeever et al., 1990; Powrie and Mason, 1990; Morrissey et al., 1993; Powrie et al., 
1993; Asano et al., 1996), the expression of these markers by other cells (Josefowicz et al., 
2012), did not dismiss the pressing need for a more definitive phenotypic marker that would 
specifically identify Treg cells. In 1995, Sakaguchi and colleagues identified the interleukin 
(IL)-2 receptor α chain (CD25) as a candidate marker for Treg cell subsets, particularly 
under steady-state condition (Sakaguchi et al., 1995). Adoptive transfer of CD4+ CD25+ T 
cell subset to NTx mice and other different auto-immune models resulted in inhibition of 
auto-immunity. Although using CD25 as a marker for Treg cells further advanced our 
understanding of Treg cell biology in vivo under steady-state, showing that Treg cells are 
differentiated in the thymus, and in vitro, to study their suppressive function ability, the 
utility of that marker in vivo under inflammatory condition for more mechanistic insights 
was limited due to the upregulation of CD25 expression in all activated T cells (reviewed 
in Shevach, 2000; Sakaguchi et al., 2008; Benoist and Mathis, 2012; Josefowicz et al., 
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2012). Intensive studies in the last decade have now identified the transcription factor 
forkhead box P3 (Foxp3) as a marker specific for Treg cells (Fontenot et al., 2003; Hori et 
al., 2003; Khattri et al., 2003).  
 
1.4 Foxp3 is the master regulator of Treg cells development and function 
Foxp3 is an X-linked suppressor gene that belongs to the forkhead/winged-helix family 
of transcription factors. Role of Foxp3 in Treg cells was appreciated after the identification 
and study of mutations in Scurfy mice and human IPEX (immune dysregulation, 
polyendocrinopathy, enteropathy, X-linked syndrome) patients (Chatila et al., 2000; 
Bennett et al., 2001; Brunkow et al., 2001; Wildin et al., 2001; Fontenot et al., 2003; 
Gambineri et al., 2003; Hori et al., 2003; Ochs et al., 2005). Scurfy is an X-linked recessive 
mutant that results from a loss-of-function mutation in foxp3 encoding gene. Scurfy mice 
are characterized by hyperactivation of CD4+ T cells and exacerbation of pro-inflammatory 
cytokines production (Brunkow et al., 2001). Similarly, human IPEX patients, the human 
counterpart of Scurfy mice, develop fatal autoimmunity in multiple endocrine organs, 
inflammatory bowel disease (IBD), diabetes, hemolytic anemia, and eczema due to 
multiple mutations in human foxp3 homolog (reviewed in Gambineri et al., 2003; Ochs et 
al., 2005). In most cases, loss-of-function mutations in foxp3 encoding gene affect 
hemizygous males but not heterozygous females due to random inactivation of the X-
chromosome (Godfrey et al., 1994). Random inactivation of the X-chromosome happens 
as a result of the maternally derived X or the paternally derived X-chromosome randomly 
inactivated in the mammalian females (Lyon, 1961; Lyon, 1972). Hence, T cells that 
express a wild-type foxp3 allele keep in check pathogenic Treg cells that express a mutant 
foxp3 allele (Fontenot et al., 2005b; Gavin et al., 2007). Nevertheless, skewed X 
inactivation, that could allow for the expression of foxp3 mutant allele, as well as leaky X 
inactivation at the foxp3 locus can lead to disease manifestation in heterozygous females 
(Wildin and Freitas, 2005; Medema and Burgering, 2007; Zuo et al., 2007). 
Similarities in autoimmune disease noticed in Scurfy mice and human IPEX patients 
prompted three different laboratories to investigate the possible role of Foxp3 in CD25+ 
CD4+ Treg cells development and function (Fontenot et al., 2003; Hori et al., 2003; Khattri 
et al., 2003). A culmination of these studies came in 2003 revealing that Foxp3 is highly 
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and stably expressed in peripheral CD25+ CD4+ T cells and thymus-derived CD25+ CD4+ 
CD8- T cells but not in activated CD4+ T cells (Fontenot et al., 2003; Hori et al., 2003; 
Khattri et al., 2003). Furthermore, retroviral transduction of ectopic Foxp3 expression in 
activated peripheral CD25- CD4+ T cells confers Treg-like suppressor function, dampening 
T cell proliferation in vitro and inhibiting the development of autoimmune disease in vivo, 
as well as cell surface phenotypic markers, i.e upregulation of CD25, glucocorticoid-
induced tumor necrosis factor (TNF) receptor family related gene/protein (GITR), and 
cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) expression on the surface of those 
cells (Fontenot et al., 2003; Hori et al., 2003). Also, expression of the foxp3 transgene in 
mice was shown to confer suppressor activity to CD25- CD4+ and CD8+ CD4- T cells 
(Khattri et al., 2003). Indeed, the importance of Foxp3 in the differentiation of Treg cells 
came from the analysis of CD25+ CD4+ T cells in the thymus and secondary lymphoid 
organs of mixed bone marrow chimera experiments whereby a mixture of bone marrow 
cells from wildtype and foxp3-deficient mice were transferred into T cell-deficient mice. 
Only foxp3-sufficient but not foxp3-deficient precursors were able to give rise to CD25+ 
CD4+ Treg cells (Fontenot et al., 2003). In as much as, Foxp3 is not only crucial for the 
development, differentiation, and function of Treg cell, it’s continuous expression in Treg 
cells is required to maintain the transcriptional and functional programs defining mature 
Treg cells (Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003; Wan and Flavell, 
2007; Williams and Rudensky, 2007). Cyclic recombinase (Cre)-induced ablation of the 
foxp3 allele in mature Treg cells results in loss of their developmentally established 
suppressive capacity potentials with subsequent re-programming towards effector T helper 
(Th) cells (Williams and Rudensky, 2007). Quite notably, Foxp3 expression level within 
the Foxp3+ Treg cells has also been considered to be a quality control indicator of Foxp3 
suppressive function (Wan and Flavell, 2007; Williams and Rudensky, 2007). Although 
the frequency of Foxp3+ Treg compartment could be possibly comparable, reduction in 
Foxp3 expression within Treg cells can cause immune diseases under steady-state and 
failure to control immune responses under inflammatory conditions (Wan and Flavell, 
2007; Kitoh et al., 2009; Wohlfert et al., 2011). Altogether, these studies clearly indicated 





1.5 Mechanisms of Treg-mediated suppression 
Treg cells are equipped with potent suppressive mechanisms to maintain immune-
homeostasis under steady-state and to protect the host from immune-mediated collateral 
damage under inflammatory conditions. Treg-mediated suppression can be categorized, 
based on the location of the molecule/weapon used for suppression, into two main modes 
of action; transmembrane molecules-mediated suppression and secreted molecules-
mediated suppression (Fig. 1) (Sakaguchi et al., 2008; Vignali et al., 2008; Campbell and 
Koch, 2011; Josefowicz et al., 2012).  
 
1.5.1 Immune suppression by transmembrane molecules 
Transmembrane molecule such as CD25, CTLA-4, lymphocyte-activation gene 3 
(LAG3), ectonucleoside triphosphate diphosphohydrolase-1 (CD39), and ecto-5’-
nucleotidase (CD73) are crucial mediators of Treg cells-mediated suppression (Reviewed 
in (Sakaguchi et al., 2008; Vignali et al., 2008; Campbell and Koch, 2011; Josefowicz et 
al., 2012)). Role of CD25 in the suppressor function of Treg cells had been a long-standing 
debate. While one school of thought was suggesting an indispensable role for CD25 in Treg 
cell suppressor function by depriving activated T cells from IL-2 that is required for their 
survival and hence, facilitates the death of activated T cells (Thornton et al., 2004; Barthlott 
et al., 2005; Pandiyan et al., 2007; Busse et al., 2010), another school of thought was 
suggesting a dispensable role of CD25 expression (Fontenot et al., 2005a; Tang et al., 
2008). In fact, using recently available genetic tools, Rudensky and colleagues were 
successful to unambiguously interrogate the role of IL-2R in Treg cells suppressive 
function (Chinen et al., 2016). Rudensky and colleagues showed that IL-2R is dispensable 
for the suppression of activated CD4+ T cells but indispensable for dampening CD8+ T cell 
responses (Chinen et al., 2016). 
In addition to the ability of Treg cells to directly control T cells function, Treg cells 
can indirectly control T cells via regulating the maturation, the activation, and/or the 
function of dendritic cells (DCs). CTLA-4, a homolog of CD28, is centrally implicated in 
Treg-mediated suppression of DCs. Constitutive expression of CLTA-4 on the surface of 
Treg cells empowers them with the ability to down-modulate the activity of DCs by 
reducing the expression of co-stimulatory ligands CD80 and CD86 on the surface of the 
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activated DCs (Wing et al., 2008). Furthermore, CTLA-4 can induce DCs to produce 
indolamine 2, 3-dioxygenase (IDO) that can catabolize the essential amino acid tryptophan 
to kynurenine which is toxic to T cells (Fallarino et al., 2003; Oldenhove et al., 2009). 
Selective deletion of CTLA-4 within Foxp3+ CD4+ Treg cells leads to aggressive 
lymphoproliferative autoimmune disorder (Wing et al., 2008). Similarly, Treg cells use 
another important molecule known as LAG3 to control T cell-mediated immune response 
through modulating DC maturation and function. LAG3 is a CD4 homolog that binds MHC 
class II molecules with high affinity. Interaction of MHC class II molecules, expressed on 
the surface of immature DCs, with LAG3 leads to inhibition of DCs maturation (Huang et 
al., 2004; Liang et al., 2008). Other transmembrane molecules that have been recently 
shown to play a role in Treg-mediated suppression are the two ectoenzymes; CD39 and 
CD73. CD39 and CD73 induce the generation of pericellular adenosine from the 
extracellular nucleotides. Pericellular adenosine can inhibit DCs function as well as T cell 
proliferation (Kobie et al., 2006; Borsellino et al., 2007; Deaglio et al., 2007). 
 
1.5.2 Immune suppression by secreted molecules 
In addition to the transmembrane molecules, Treg cells can also secrete functionally 
important proteins (such as IL-10, IL-35, transforming growth factor beta (TGF-β), cyclic 
adenosine mono-phosphate (cAMP), granzyme A, granzyme B, and perforin) that play an 
instrumental role in Treg-mediated suppression. IL-10 is an immunoregulatory cytokine 
that plays an essential role in the maintenance of immune-homeostasis and the prevention 
of excessive inflammation (Iyer and Cheng, 2012). Selective deletion of IL-10 in Foxp3+ 
Treg cells demonstrated that IL-10 production by Foxp3+ Treg cells is essential to keep in 
check the immune response at environmental interfaces such as colon and lungs (Rubtsov 
et al., 2008). Another immunoregulatory cytokine that has an important role in Treg-
mediated suppression is IL-35. Vignali and colleagues showed that deletion of IL-35 
specifically in Foxp3+ Treg cells has a negative impact on Treg cells suppressive capacity 
in vitro and inability to suppress the development of IBD in vivo, upon adoptive transfer 
into the lymphopenic host (Collison et al., 2007). In support, a recently published report 
highlighted the presence of a distinct effector IL-35-Treg cell subset that produces IL-35 
and localizes to the T cell zone of secondary lymphoid organs in order to target auto-
reactive T cells (Wei et al., 2017). Similar to IL-35, TGF-β production by Foxp3+ Treg cells 
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is required to inhibit IBD in particular as well as Th1 immune responses in general (Li et 
al., 2007). Treg cells can also generate second messenger cyclic adenosine monophosphate 
(cAMP) that traverses through gap junctions to self-reactive or activated T cells to inhibit 
their proliferation and IL-2 synthesis (Bopp et al., 2007). Moreover, Treg cells can directly 
kill the responder T cell or APCs in granzyme or perforin-dependent manner (Gondek et 
al., 2005; Zhao et al., 2006; Cao et al., 2007; Gondek et al., 2008; Velaga et al., 2015). How 
Treg cells orchestrate these different mechanisms and/or what determine which tool(s) will 
Treg use in lymphoid and non-lymphoid organs under steady-state and different sets of 
inflammatory conditions to maintain immune-homeostasis is still incompletely understood. 
 
 
Figure 1. Schematic representation of mechanisms of Treg cell-mediated suppression. 
Treg cell-mediated suppression mechanisms can be grouped under two main modes of 
action; i) transmembrane molecules-mediated suppression and ii) secreted molecules-
mediated suppression. The figure is adapted from (Vignali et al., 2008; Campbell and Koch, 
2011; Meng et al., 2016). 
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1.6 Treg-mediated control of distinct immune responses 
Adaptive immune responses are tailored to combat different types of pathogens. Based 
on the nature of the pathogen encountered and subsequently the cytokines available in the 
milieu, naïve CD4+ T cells will be shaped to differentiate into a functionally distinct subset 
of effector Th cells (Th1, Th2, Th9, or Th17; Rothenberg, 2014). The functional 
specialization of these Th cell subsets is due to the expression of key transcription factors, 
namely T-box transcription factor (T-bet) for Th1 (Szabo et al., 2000), GATA-binding 
protein 3 (GATA3) for Th2 (Sauer, 1998), PU.1 for Th9 (Chang et al., 2010), and retinoic 
acid receptor-related orphan receptor-γt (RORγt) for Th17 (Ivanov et al., 2006), which 
activate the expression of a distinct set of genes that control their phenotypic and functional 
characteristics (Zhu et al., 2010). Tight regulation of these polarized immune responses is 
crucial to prevent unwanted immune-mediated pathology and tissues destruction. Hence, 
several groups suggested that subsets of Foxp3+ Treg cells express canonical Th cell-
associated transcription factors to initiate modular programs of suppression tailored to 
inhibit the polarized Th1, Th2, and Th17 cell-driven immune responses (Campbell and 
Koch, 2011; Josefowicz et al., 2012). For instance, T-bet expression by a subset of Foxp3+ 
Treg cells was shown to be required to maintain Treg cell homeostasis and function under 
Th1 cell-mediated inflammation (Koch et al., 2009; Levine et al., 2017). T-bet expression 
in Foxp3+ Treg cells promotes the expression of CXC chemokine receptor 3 (CXCR3) that 
facilitates migration, proliferation, and accumulation of these specialized Treg cell subset 
at the sites of Th1 immune responses (Koch et al., 2009). Conditional deletion of Tbx21 
(gene-encoding T-bet) in Foxp3+ Treg cells results in failure in the regulation of Th1 cell-
mediated immune responses, but not Th2 or Th17 cell-mediated immune responses (Koch 
et al., 2009; Levine et al., 2017).  
Similarly, expression of interferon regulatory factor 4 (IRF4), a transcription factor 
involved in Th2 cell differentiation (Lohoff et al., 2002; Rengarajan et al., 2002), by a 
subset of Foxp3+ Treg cells empowers them with the molecular machinery required to 
control Th2 cell-mediated immune responses (Zheng et al., 2009). Selective ablation of irf4 
in Foxp3+ Treg cells results in selective dysregulation in the frequency and the number of 
IL-4- and IL-5- producing CD4+ T cells, dramatic elevation in IL-4-dependent 
immunoglobulin (Ig)G1 and IgE production, and ubiquitous plasma cells infiltration in the 
spleen (Zheng et al., 2009). Under the same logic, deletion of signal transducer and 
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activator of transcription 3 (stat3), a transcription factor crucial for the generation of Th17 
(Yang et al., 2007), specifically in Foxp3+ Treg cells leads to the development of fatal 
intestinal inflammation driven by uncontrolled Th17 immune responses (Chaudhry et al., 
2009). Furthermore, it has been shown that Foxp3+ Treg cells do require B-cell lymphoma 
6 (Bcl6) expression, a transcription factor directing T follicular helper cells (TFH) 
differentiation (Nurieva et al., 2009; Yu et al., 2009), to control germinal center reactions 
(Chung et al., 2011; Linterman et al., 2011).  
Treg cell subsets can also co-opt the expression of cell-/tissue-specific transcription 
factors in an attempt to endow themselves with particular molecular machinery to maintain 
homeostasis at a particular location/cell/or tissue-type. For instance, visceral adipose tissue-
resident Treg cells, VAT-Treg cells, needs the expression of peroxisome proliferator-
activated receptor gamma (PPARγ), a transcription factor necessary for adipocyte 
development and differentiation (Barak et al., 1999; Imai et al., 2004), to control obesity-
associated inflammation and maintain insulin sensitivity (Feuerer et al., 2009; Feuerer et 
al., 2010; Cipolletta et al., 2012). Hence, the ability of Treg cells to co-opt the expression 
of certain transcription factors is crucial to drive the development of phenotypically and 
functionally specialized Treg cell subsets that can control distinct classes of immune 
response. 
 
1.7 Cytokine-mediated regulation of Foxp3+ Treg cells  
The ability of Treg cells to sense changes in the micro-environment, the environmental 
cues, is crucial and mandatory for their development, differentiation, and expansion 
(Mellor and Munn, 2011). The most defining environmental cue in the context of the host 
immune system is cytokines. Binding of the cytokines, available in the milieu, to their 
specific receptors, trigger signaling pathways that promote cell development, 
differentiation, expansion, and/or cell death. Indeed, cytokines play an indispensable role 
in Treg cells development. It has been shown that in addition to TCR signals, development 
and differentiation of Treg cells in the thymus are critically dependent on the availability 
of IL-2 and, to lesser extent, IL-7 and IL-15, common gamma-chain (γc) receptor-
dependent cytokines (Burchill et al., 2007; Vang et al., 2008). Whereas deletion of IL-2 or 
CD25 in mice leads to a two-fold reduction in the proportion and the absolute number of 
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Foxp3+ Treg cells, deletion of either IL-7 or IL-15 does not disrupt Foxp3+ Treg cells 
generation (Vang et al., 2008; Josefowicz et al., 2012). Interestingly, however, mice with 
combined deletion of IL-2, IL-7, and IL-15 are completely devoid of Treg cells (Fontenot 
et al., 2005a; Burchill et al., 2007; Malek, 2008; Vang et al., 2008). IL-2 also plays an 
important role in controlling Treg cells development. Recently, Robey and colleagues 
(2015) demonstrated that Treg cells within the thymus environment inhibit de novo 
generation of thymus (t)-derived Treg (tTreg) cells by limiting the supply of the available 
IL-2 and hence, providing a negative feedback loop to maintain a balanced production of 
Treg cells in the thymus (Weist et al., 2015; Kitagawa and Sakaguchi, 2017). 
In addition to the γc receptor-dependent cytokines, TGF-β plays a critical role in the 
development of Treg cells in the thymus. It has been shown that thymocyte apoptosis drives 
the production of TGF-β intrathymically from thymic epithelial cells, macrophages, and 
DCs. This TGF-β induces Treg cells generation in the thymus via enhancing Foxp3 
expression (Konkel et al., 2014; Hoeppli et al., 2015). TGF-β can also induce the generation 
of the peripherally-induced Treg cell (pTreg) in the presence of strong TCR signals. 
Moreover, TGF-β signaling pathway is crucial for Treg cells to maintain their homeostasis, 
regulatory functions and Foxp3 expression (Chen et al., 2003; Zheng et al., 2004; Marie et 
al., 2005; Selvaraj and Geiger, 2007).  
The differentiation of Treg cells into specialized Treg cell subsets to control distinct 
immune responses is also regulated by cytokines. For instance, interferon gamma (IFN-γ)-
mediated activation of STAT1 via IFN-γ receptor (IFN-γR) expressed on the surface of 
Foxp3+ Treg cells drives the expression of T-bet by a subset of Treg cells (Koch et al., 
2009). T-bet expression, as discussed earlier, plays a key role in controlling the migration, 
homeostasis, and immunoregulatory functions of those Treg cells during Type1 
inflammatory responses (Koch et al., 2009). Similarly, it has been shown recently that IL-
33 signaling through IL-33 receptor (ST2) is necessary and sufficient for VAT-Treg cells 
development, proliferation, as well as maintenance of transcriptional signature. Mice 
lacking either IL-33 or ST2 are completely devoid of VAT-Treg cells (Vasanthakumar et 
al., 2015). Nevertheless, the modulation of phenotypic and functional characteristics of 
Treg cells mediated by many other cytokines are not yet clear. For instance, the effect of 
interleukin-4 (IL-4)/IL-4 receptor alpha (IL4Rα)-mediated signaling on Foxp3+ Treg cells 
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development, maintenance, and regulatory functions under steady-state and inflammatory 
conditions remain controversial. 
 
1.8 Interleukin-4 and Interleukin-4 receptor alpha-mediated signaling 
1.8.1 Interleukin-4 
IL-4 is an anti-inflammatory cytokine that plays a crucial role in the induction and 
maintenance of type 2 immune response (Seder and Paul, 1994). Murine il-4 encoding gene 
locates on chromosome 11, on close proximity to il-5, il-13, and granulocyte macrophage-
colony stimulating factor (GM-CSF) encoding genes, and consists of 4 exons and 3 introns 
spanning over 6 kb (Lee et al., 1986; Otsuka et al., 1987; Paul, 1991). Murine IL-4 is a 
glycosylated protein with a molecular weight of 14-19 kDa based on the cellular source 
producing it (Ohara et al., 1985; Grabstein et al., 1986; Paul, 1991). IL-4 is produced by 
several immune cells including ILC2 (Noval Rivas et al., 2016; Pelly et al., 2016), basophils 
(Min et al., 2004), eosinophils (Sabin et al., 1996), mast cells (Plaut et al., 1989), gamma-
delta T cells (Ferrick et al., 1995), NK1.1+ T cells (Yoshimoto and Paul, 1994), and 
conventional T cells (Launois et al., 1995; Noben-Trauth et al., 2000).  
IL-4 has pleiotropic actions on a variety of immune cells (Paul, 1991; Seder and Paul, 
1994). For instance, IL-4 plays a key role in the induction, the establishment, and the 
regulation of Th2 cells (Paul, 1991; Seder and Paul, 1994). IL-4-mediated signaling on B 
cells enhances their expression of MHC class II (Noelle et al., 1984), Fc epsilon receptor 
(CD23) (Defrance et al., 1987), and co-stimulatory molecules (CD80 and CD86) (Stack et 
al., 1994), as well as it induces their class switching in order to produce type 2 antibody 
isotypes (IgE and IgG1) (Vitetta et al., 1985; Coffman et al., 1986). Moreover, it has been 
suggested recently that IL-4-mediated signaling on B cells helps in directing Th cells 
differentiation towards Th2 cells under inflammatory conditions (Hurdayal et al., 2017). 
IL-4 can also induce the generation of alternatively activated macrophages (Stein et al., 
1992). In combination with TNF-α, IL-4 can alter the expression pattern of adhesion 
molecules in order to enhance endothelial cells adhesion and hence, facilitates the 
recruitment of T cells and eosinophils to the site of inflammation (Thornhill et al., 1991; 




1.8.2 Interleukin-4 receptor alpha 
IL-4 exerts its function(s) by binding to its specific receptors expressed on the surface 
of the target cells. There are two distinct heterodimeric IL-4R complexes (Fig. 2); Type I 
receptor complex (consists of IL-4R-alpha (IL-4Rα) and the γc chain) (Russell et al., 1993), 
and Type II receptor complex (consists of IL-4Rα and IL-13Rα1) (Obiri et al., 1995; Hilton 
et al., 1996). IL-4Rα is a common component in the two heterodimeric IL-4R complexes. 
Murine il-4rα encoding gene locates on chromosome 7 and consists of 12 exons of which 
9 exons are encoding for IL-4Rα chain. IL-4Rα chain has an approximate molecular weight 
of 140 kDa and belongs to hematopoietic receptor superfamily (Bazan, 1990; Nelms et al., 
1999). The structure of the receptor consists of three main parts; i) extracellular region that 
consists of a tandem of type III fibronectin domain as well as the WSXWS box that together 
form the classical “cytokine binding homology region” which binds to the IL-4, ii) 
transmembrane domain, and iii) a very long cytoplasmic tail, with more than 500 amino 
acid residues, that is constitutively associated with Janus kinase 1 (JAK1) which plays an 
indispensable role in the IL-4Rα-mediated signaling pathway (Fig. 2) (Mosley et al., 1989; 
Bazan, 1990).  
IL-4Rα is expressed on the surface of hematopoietic cells (such as T cells, B cells, 
mast cells, and macrophages) as well as non-hematopoietic cells (such as hepatocytes, 
keratinocytes, fibroblast, epithelial cells, endothelial cells, brain tissues, stromal cells, and 
smooth muscles) (Ohara et al., 1985; Lowenthal et al., 1988). IL-4Rα chain is usually 
expressed in a range from 100 to 5000 receptors per cell (Ohara et al., 1985). IL-4 binds 
with a very high affinity to IL-4Rα chain with a dissociation constant ranging from 20 to 
300 pM (Ohara et al., 1985; Park et al., 1987; Mosley et al., 1989). T cells do only express 
the Type I receptor complex (Graber et al., 1998), which will be our main focus. 
 
1.8.3 Interleukin-4 receptor alpha-mediated signaling pathway 
Binding of IL-4 to IL-4Rα chain induces its heterodimerization with the γc chain, 
which is usually coupled to JAK3 (Russell et al., 1993; Russell et al., 1994; Musso et al., 
1995). Conformational changes induced by the IL-4 binding result in tyrosine 
phosphorylation of JAK1 and JAK3 that in turn phosphorylate tyrosine residues on the 
cytoplasmic tail of IL-4Rα chain (Smerz-Bertling and Duschl, 1995). The phospho-tyrosine 
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residues in IL-4Rα chain create docking sites for the Src Homology 2 (SH2) domain of 
STAT6 as well as insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) which are 
subsequently phosphorylated by the JAKs (Darnell, 1997). Phosphorylated-STAT6 
disengages from the receptor and forms homodimers (Fig. 2). STAT6 homodimers 
translocate into the nucleus whereby they bind to specific DNA sequence(s) on the 
promoter elements to switch on the expression of IL-4 responsive genes (Nelms et al., 
1999). Tyrosine phosphorylation of IRS-1 and IRS-2 leads to activation of 
phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein (MAP) pathways 
which are of importance for cell cycle activation, cell survival, and proliferation (Fig. 2) 
(Wang et al., 1993; Sun et al., 1995; Izuhara et al., 1996; Wills-Karp and Finkelman, 2008).  
 
Figure 2. Schematic representation of the IL-4Rα signaling pathway. Two types of IL-
4R can mediate the signaling pathway of IL-4. While type I receptor consists of IL-4Rα 
and γc, type II receptor consists of IL-4Rα and IL-13Rα. Only type I receptor is expressed 
on T cells. Binding of IL-4 to its receptor results in receptor dimerization and subsequent 
activation of JAKs associated with cytoplasmic tails of the receptor. Tyrosine residues, on 
the IL-4Rα cytoplasmic tail, phosphorylated by activated JAKs act as docking sites for 
STAT6 and IRS. Phosphorylation of STAT6 results in its dimerization, translocation into 
the nucleus, and activation of Th2-responsive genes required for Th2 differentiation and 
proliferation. Phosphorylation of IRS activates its signaling pathway that is linked to cell 
activation, proliferation, and cell survival. The figure is adapted from (Wills-Karp and 




































1.9 Th2 disease models 
IL-4/IL-4Rα-mediated signaling has an indispensable role in conferring protection to 
the host against helminths infection. Indeed, abrogation of IL-4/IL-4Rα-mediated signaling 
results in host susceptibility to infection comes from seminal studies on the highly tractable 
murine models of experimental infection with the hookworm Nippostrongylus brasiliensis 
(N. brasiliensis) (Barner et al., 1998; Urban et al., 1998; Nono et al., 2017b), and the blood 
fluke Schistosoma mansoni (S. mansoni) (Jankovic et al., 1999; Fallon et al., 2000; Herbert 
et al., 2004; Nono et al., 2017a), principally. 
 
1.9.1 Schistosomiasis 
Schistosomiasis is also called bilharzia having been first described by Theodor Bilharz 
in 1851, in Cairo, Egypt.  Schistosomiasis is the second most socio-economically 
devastating parasitic disease in the world after malaria.  It is endemic in 74 African, Asian 
and Latin American countries and infects an estimated 240 million people with 280,000 
deaths annually in sub-Saharan Africa and approximately 800 million at risk of infection 
(Chitsulo et al., 2000; Colley et al., 2014; Inobaya et al., 2014; Skelly et al., 2014).  
Schistosomiasis is caused by several blood-dwelling trematode species (flukes) of the 
genus Schistosoma, including Schistosoma mansoni, S. japonicum, S. intercalatum and S. 
mekongi that cause hepatic-intestinal schistosomiasis and S. haematobium that induces 
urinary disease (Barsoum et al., 2013; Elbaz and Esmat, 2013). 
 
1.9.1.1 Schistosome life cycle 
Schistosoma eggs are introduced to freshwater environment through urine or feces of 
the infected host where they hatch and release the free-living and ciliated miracidium (Fig. 
3).  The ciliated miracidium swims towards their specific intermediate snail host, penetrates 
it, loses its cilia, develops into sporocyst and then undergoes asexual reproduction until it 
becomes cercariae. Upon exposure to light, hundreds of free swimming, fork-tailed 
cercariae break out of snail tissue into freshwater where they swim actively until they come 
into contact with the skin of human or animal, the definitive host. Cercariae invade the skin 
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via secretion of excretory-secretory products (ESP), including proteolytic enzymes and 
immunogenic glycans (Hokke and Yazdanbakhsh, 2005; Knudsen et al., 2005; Hansell et 
al., 2008), undergo massive biochemical changes followed by their maturation into 
schistosomula (Walker, 2006; Collins et al., 2011). Schistosomes differ in their migratory 
pattern through skin layers; S. mansoni and S. haematobium are slower in their migration 
rate when compared to S. japonicum. For S. japonicum schistosomula, only two hours after 
exposure are enough for them to be found in the dermis and even some are already in the 
blood vessels, while S. mansoni and S. haematobium somula take 48 hours to reach the 
dermis and 72 hours to be found in the dermal blood vessels (McKerrow and Salter, 2002; 
Curwen and Wilson, 2003; He et al., 2005; Walker, 2011; Gryseels, 2012). Once in the 
blood capillaries, schistosomules migrate towards right heart ventricles and then to the 
lungs. Depending on the species, they reside in the pulmonary capillaries from 3-16 days 
which is consistent with their size and host spectra (Rheinberg et al., 1998; He et al., 2005).  
Schistosomules then make their way to the liver where they start feeding on blood and 
growing by active cell division. They become mature 28-35 days post-infection and start 
pairing and laying of eggs. The paired adults then travel to the place where they will finally 
reside; S. mansoni and S. japonicum reside in the portal and mesenteric vessels while S. 
haematobium resides in the pelvic venous plexus and veins around the bladder (Fig. 3).  
Massive numbers of eggs are laid daily; 300 eggs for S. mansoni and S. haematobium and 
3000 eggs for S. japonicum. About half the number of eggs produced is excreted with the 
feces or urine while the rest of eggs are swept with the blood to the liver where they cause 





Figure 3. The Schistosome Life cycle. The figure is adapted from (Ross et al., 2002; 
Inobaya et al., 2014; Weerakoon et al., 2015). 
 
1.9.1.2 Immunobiology of schistosomiasis 
During Schistosoma journey from the invasion until the establishment of infection 
(Fig. 3), the host immune response progresses through 4 different immune phases; i) early 
pre-patent immune response phase, ii) late pre-patent immune response phase, iii) acute 
phase, and iv) chronic phase (Pearce and MacDonald, 2002; Abdel Aziz et al., 2016). Early 
pre-patent immune response phase is the first phase that starts from day 0 up to 3 weeks 
post-infection. Early pre-patent immune response phase is characterized by the production 
of type 1, type 2, and type 17 cytokines from epidermal, lymph node, and lung cells (Abdel 
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Aziz et al., 2016). Initiation of the three different arms of the immune response was 
suggested to be a possible evasion mechanism, in C57BL/6 mice, as these immunological 
signals can counteract and antagonize each other, helping in creating an immunological 
chaos and hence, the establishment of infection (Abdel Aziz et al., 2016). In support, during 
this period, humoral immune responses to parasite antigens remain negligible and 
preponderantly of IgM isotype well until patency (El Ridi et al., 2006a; El Ridi et al., 2006b; 
Tallima et al., 2009). Late pre-patent immune response phase takes place during 3-5 weeks 
post-infection whereby the host immune system skews towards type 1 immunity in 
response to migrating immature parasites (Pearce and MacDonald, 2002). Parasite 
maturation, copulation, and production of eggs (5-6 weeks post-infection) result in the 
initiation of the acute phase of schistosomiasis that usually peaks between 6 to 8 weeks 
post-infection. Schistosome egg antigens induce a drastic reduction in type 1 immune 
response in concurrence with a significant shift towards type 2 immune response (i.e. IL-4 
and IL-13) which drives fibro-granulomatous inflammation around the eggs trapped within 
the tissue. It has been demonstrated that hegemony of type 2 immune response during acute 
schistosomiasis plays an indispensable role in host protection and survival (Pearce and 
MacDonald, 2002). For instance, infection of IL-4 deficient (IL-4-/-) C57BL/6 mice with S. 
mansoni cercariae results in severe and rapid cachexia and eventually the mice succumbed 
pre-maturely to the infection when compared to their littermate controls (Bennett et al., 
1997). Similarly, IL-4Rα-/- mice are highly susceptible to S. mansoni infection. S. mansoni-
infected IL-4Rα-/- mice succumb to the infection by 8 weeks due to impaired ability of egg 
expulsion, abrogation of granuloma formation, and severe gut inflammation that results in 
leakage of lipopolysaccharides in the bloodstream causing septic shock (Herbert et al., 
2004). Interrogation of IL-4Rα-responsive cells that play a key role in conferring protection 
or susceptibility to S. mansoni infection has been feasible by using Cre-locus of X-over 
P1(loxP) technology. For example, it has been suggested that IL-4Rα-responsive 
macrophages (using LysMcre IL-4Rα-/lox) (Herbert et al., 2004), non CD4+ T cells (using 
iLCKcre IL-4Rα-/lox) (Dewals et al., 2009), and smooth muscle cells (using SM-MHCcre IL-
4Rα-/lox) (Marillier et al., 2010) are critical in conferring protection to the host against acute 
schistosomiasis. The contribution of IL-4Rα-responsive Foxp3+ Treg cells towards host 
susceptibility or protection during acute schistosomiasis is yet to be interrogated.  
Ten weeks post-infection, the host immune system starts to down-modulate the type 2 
immune response, probably by the induction of IL-10 production and expansion of Treg 
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cells (Bosshardt et al., 1997; Hoffmann et al., 2000; Fairfax et al., 2012), preparing the host 
for the final stage of infection which is chronic schistosomiasis. Chronic schistosomiasis 
(≥ 12 weeks post-infection) results in a clinically patent tissue fibroproliferative pathology 
during which granulomas-formed around the newly deposited eggs are smaller in size with 
a significantly higher collagen deposition and hence, higher level of fibrosis when 
compared to granulomas formed during the acute stage (Fallon, 2000; Pearce and 
MacDonald, 2002). The persistence of granulomatous inflammation and fibrosis during the 
chronic stage, in most cases, result in portal hypertension, ascites, hepatosplenomegaly, 
hypersplenism, varices, variceal bleeding and ultimately death (Burke et al., 2009; Elbaz 
and Esmat, 2013; Inobaya et al., 2014). 
 
1.9.1.3 Foxp3+ Treg cells in schistosomiasis 
Unlike other helminths that induce activation and expansion of Foxp3+ Treg cells 
during the first week of infection, i.e. filariasis (Gillan and Devaney, 2005; McSorley et al., 
2008; Taylor et al., 2009) and intestinal nematodes infection (Finney et al., 2007; 
Blankenhaus et al., 2011; Redpath et al., 2013), in order to dampen the host effector 
immune mechanisms and hence, facilitates the establishment of infection, Schistosoma-
infection does neither induce Foxp3+ Treg cells expansion nor activation during the early 
pre-patent immune response phase (0-3 weeks post-infection) (Redpath et al., 2015). It has 
been demonstrated by Maizels and colleagues (2015) that C57BL/6 mice infection with S. 
mansoni does not induce Foxp3+ Treg cells expansion in either skin-draining lymph nodes 
(LN), lungs, lung-draining LN, or spleen during the first 3 weeks of infection when 
compared to naïve mice (Redpath et al., 2015). Moreover, after infection, the expression 
levels of Foxp3+ Treg cells activation markers (CD25, Foxp3, and Helios) are similar to 
naïve mice (Redpath et al., 2015). In support, Singh and colleagues (2005) showed that 
Foxp3 expression of splenocytes 8 weeks post-infection is similar to that of naïve mice 
(Singh et al., 2005). Nevertheless, upregulation of Foxp3 expression in the spleen 16 weeks 
post-infection was reported (Singh et al., 2005). In contrast to the spleen, liver of S. 
mansoni-infected mice showed 10 and 30 fold increase in Foxp3 gene expression level 8 
and 16 weeks, respectively, post-infection (Singh et al., 2005), indicating that Foxp3+ Treg 
cells might play a key role in the regulation of fibrogranulomatous inflammation in the 
liver. In fact, it was demonstrated that during acute egg-induced schistosomiasis, Foxp3+ 
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Treg cells do not play a major role in the regulation of effector T cell clonal expansion but 
rather they do control egg-induced effector Th2 cytokine production in an IL-10 
independent manner (Baumgart et al., 2006). The precise mechanism(s) via which Foxp3+ 
Treg cells control fibrogranulomatous inflammation is yet to be interrogated. 
 
1.9.2 Nippostrongylus brasiliensis 
N. brasiliensis is one of the most important gastrointestinal nematodes which 
physiologically and biochemically resemble the human hookworms (e.g. Ancylostoma 
duodenale and Necator americanus) (Finkelman et al., 1997; Gause et al., 2003) that 
represent a major part of neglected tropical disease as they do affect more than one billion 
people worldwide and cause severe morbidity and mortality especially in school-aged 
children (Hotez et al., 2008; Bouchery et al., 2017). N. brasiliensis is naturally a nematode 
parasite of rats, but it has been adapted to infect mice in order to understand how the host 
immune system can control the infection with these parasites and hence, identifies the 
factors that play a key role in conferring protection to the host (Bouchery et al., 2017).  
 
1.9.2.1 Nippostrongylus brasiliensis life cycle 
In the murine model, N. brasiliensis infection starts with administering the third larval 
stage (L3) subcutaneously, mimicking the natural infection. During the first 24-48 hours, 
the larvae exit the blood vessels and then enter the lungs where they moult into the fourth 
larval stage (L4). The parasites then migrate from the lungs and breach the alveolar spaces 
whereby they are coughed up and swallowed into the intestine. In the gut, the L4 parasites 
start to develop to the final mature stage (L5) (5-6 days post-infection), copulate and start 
to release eggs from day 6. The released eggs hatch in the soil within 24 hours and give rise 
to L1 stage that undergoes further differentiation to moult into L3 stage, the infectious stage 
(Fig. 4). N. brasiliensis infection is a naturally acute infection as the host can expel the 
worms from the intestinal lumen in less than 2 weeks (Finkelman et al., 1997; Gause et al., 





Figure 4. Life cycle of Nippostrongylus brasiliensis.  
 
1.9.2.2 Immunobiology of Nippostrongylus brasiliensis 
Mice infection with N. brasiliensis triggers a highly polarized type 2 immune response 
that is characterized by elevated production of type 2 cytokines (e.g. IL-4, IL-5, and IL-13) 
(Barner et al., 1998; Urban et al., 1998), eosinophilia, mastocytosis, as well as significant 
increase in serum antigen-specific type 2 antibody isotypes (IgG1 and IgE) (Finkelman et 
al., 1997; Gause et al., 2003). Furthermore, N. brasiliensis infection induces goblet cells 
hyperplasia and mucus secretion which are required to prevent the worms from either 
adhering to the intestinal lamina propria or feeding properly, facilitating the expulsion of 
the worms from the lumen (Koninkx et al., 1988). IL-4 was suggested to have a redundant 
protective role against N. brasiliensis infection as IL-4-/- mice can expel N. brasiliensis in 
time frame similar to immunocompetent mice, whereas treatment of severe combined 
immunodeficient (SCID) mice with exogenous IL-4 was sufficient to confer protection 
44 
 
against that parasite (Urban et al., 1995; Lawrence et al., 1996). In contrast, IL-13-/-, IL-4-
/-/IL-13-/-, STAT6-/-, or IL-4Rα-/- mice fail to expel N. brasiliensis worms, pointing towards 
an instrumental role of IL-13 and IL-4Rα-mediated signaling in conferring protection to 
the host against N. brasiliensis infection (Finkelman et al., 1997; Barner et al., 1998). 
Conditional ablation of IL-4Rα from smooth muscle cells results in delayed goblet cells 
differentiation, reduced mucus production and hence, delayed worm expulsion (Horsnell et 
al., 2007; Zhao et al., 2008). The exact role of other IL-4Rα-responsive non-hematopoietic 
as well as IL-4Rα-responsive hematopoietic cells in mediating host protection or 
susceptibility against N. brasiliensis infection is yet to be interrogated.  
 
1.9.2.3 Foxp3+ Treg cells in N. brasiliensis infection 
It has been shown that CTLA-4, a transmembrane molecule implicated in Treg-
mediated suppression, plays an important role in limiting Th2 immune response during N. 
brasiliensis infection (McCoy et al., 1997). Blockade of CTLA-4 during N. brasiliensis 
infection results in heightened Th2 cytokine production that drives accelerated worm 
expulsion (McCoy et al., 1997). Interestingly, it was reported that N. brasiliensis infection 
induces an increase in Foxp3+ Treg infiltration into the lung (Liu et al., 2008). These Foxp3+ 
Treg cells produce a high level of IL-10 (Liu et al., 2008), that was demonstrated to play a 
crucial role in controlling lung inflammation and down-modulating IL-17 expression (Chen 
et al., 2012). Treg depletion by using anti-CD25 results in heightened IL-17 production that 
drives severe lung inflammation during N. brasiliensis infection (Liu et al., 2008). The 
kinetics of Foxp3+ Treg cells during N. brasiliensis infection as well as their regulatory role 





1.10 The controversial effect of IL-4Rα-mediated signaling on Foxp3+ Treg cells 
The role of IL-4Rα-mediated signaling on Foxp3+ Treg cells has been a long-standing 
debate. It has been shown that oral sensitization of il4raF709 mice, mice whose IL-4Rα chain 
has a single-amino-acid substitution of tyrosine (Y) to phenylalanine (F) at position 709 
that leads to abrogation of immunoreceptor tyrosine-based inhibitory motif (ITIM) function 
and hence, augmentation of IL-4Rα-STAT6 signaling pathway (Tachdjian et al., 2010), 
with ovalbumin (OVA) in combination with staphylococcal enterotoxin B (SEB) results in 
impaired generation of allergen-specific Treg cells (Noval Rivas et al., 2016).  In this study, 
it was demonstrated that selective augmentation of IL-4Rα-mediated signaling on Foxp3+ 
Treg cells induces the transdifferentiation of Foxp3+ Treg cells to Th2-like cells, termed 
ex-Foxp3 Th2 cells. In that case, ex-Foxp3 Th2 cells were producing IL-4 while 
maintaining Foxp3 expression (Noval Rivas et al., 2016; Noval Rivas and Chatila, 2016). 
Similarly, house dust mite sensitization of il4raR576 mice, mice with a single-amino-acid 
substitution of glutamine (Q) to arginine (R) at position 576 of the IL-4Rα chain, results in 
transdifferentiation of pTreg cells to Th17-like cells, termed ex-Foxp3 Th17 cells, in an IL-
4 dependent manner. Ex-Foxp3 Th17 cells started to produce IL-6 and IL-17 and to express 
RORγt, the canonical transcription factor of Th17 (Massoud et al., 2016). Using fate-
reporter system, Wilson and colleagues (2017) suggested that chronic helminth infection 
such as H. polygyrus induces transdifferentiation of a significant proportion of Foxp3+ Treg 
cells to become ex-Foxp3 Th2 cells in IL-4/IL-4Rα-dependent manner whereby Foxp3+ 
Treg cells start to lose Foxp3 expression and to produce type 2 cytokines (Pelly et al., 2017). 
A strong case was therefore made for the negative regulation of Foxp3+ Treg cells by IL-
4Rα-mediated signaling.  
Intriguingly, an independent report rather made mention of a supporting role of IL-
4Rα-mediated signaling on Foxp3+ Treg cells in vitro (Maerten et al., 2005). In that report, 
it was shown that CD4+ CD25+ Treg cells cultured in the presence of IL-4 have a better 
survival capacity and an enhanced Foxp3 expression (Maerten et al., 2005). This resulted 
into a higher potency of CD4+ CD25+ Treg cells to suppress CD4+ T cell proliferation and 
cytokines production, when compared to CD4+ CD25+ Treg cells cultured in medium 
without IL-4 (Maerten et al., 2005).  
Another study by Pillemer and colleagues (2009) reported on the controversial effect 
of IL-4/IL-4Rα-mediated signaling on Foxp3+ Treg cells (Pillemer et al., 2009). The latter 
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study demonstrated in vivo, under allergic inflammation, and in vitro, that even though IL-
4 maintains Foxp3 expression and enhances Treg proliferation, IL-4 signaling on Foxp3+ 
Treg cells abrogates their suppressive functional capacity (Pillemer et al., 2009).  
In conclusion, even though some studies are suggesting a positive influence of IL-4Rα-
mediated signaling on Foxp3+ Treg cells, these studies are conflicted with equally well-
conducted studies indicating that IL-4Rα-mediated signaling on Foxp3+ Treg cells might 
have a deleterious effect on the Treg cell functions, pointing overall a rather conflicting 
picture of the role of IL-4Rα signaling on Foxp3+ Treg cells (Fig. 5). 
 
Figure 5. The controversial effect of IL-4Rα-mediated signaling on Foxp3
+
 Treg cells. 
Schematic diagram showing the conundrum in the literature with regards to the role of IL-
4Rα-mediated signaling on Foxp3
+
 Treg cells. IL-4Rα signaling on Foxp3
+
 Treg cells could 
have a supportive role (i.e. enhances their survival and enforces Foxp3 expression) or a 
detrimental role (i.e. induces Treg cells reprogramming towards Th2 or Th17). The figure 






The present work was set forth as an attempt to unambiguously and conclusively decipher 
the bases of the regulation of Foxp3+ Treg by IL-4Rα-mediated signaling. To dissect this 
role of the IL-4Rα on Foxp3+ Treg cells, the present thesis sought to: 
- generate a transgenic mouse model whereby IL-4Rα is specifically removed from Foxp3+ 
Treg cells (Foxp3cre IL-4Rα-/lox mice). 
- characterize, under steady-state, the cellular, tissular, and phenotypic profile as well as 
the inflammatory disorders in naïve Foxp3cre IL-4Rα-/lox mice. 
- characterize the overall fitness of Foxp3+ Treg cells in diseased Foxp3cre IL-4Rα-/lox mice 
in controlling T cell proliferation, effector function, and tissue inflammation during 
infection  
In combination, these objectives should help understand how IL-4Rα controls the Foxp3+ 









Chapter 2:  





Chapter 2: Materials and Methods 
2.1 Mice generation and genotyping  
IL-4Rα-/-, IL-4Rα-/lox, and Foxp3cre IL-4Rα-/lox mice on BALB/c background were 
generated by using the Cre-loxP technology. Cre-loxP system is a site-specific 
recombination system that can be used to alter the genetic makeup of the host by mediating 
genetic deletion, insertion, inversion, and/or translocation (Sauer, 1987; Sauer and 
Henderson, 1988). The Cre-loxP system consists of two main components; the Cre-
recombinase enzyme and it's recognition sequence which is known as loxP sites. Cre-
recombinase enzyme is a bacteriophage P1 integrase protein with an approximate 
molecular weight of 38-kDa and two main domains; the amino-terminal domain (consists 
of five α-helices connected via short loops) and the carboxy-terminal domain (contains nine 
α-helices and small beta-sheet strand) (Abremski and Hoess, 1984; Guo et al., 1997; Guo 
et al., 1999). loxP site is 34-bp consensus sequence that consists of two sets of palindromic 
13-bp sequence (ATAACTTCGTATA) with nonpalindromic 8-bp (GCATACAT or 
ATGTATGC) spacer in between (Abremski and Hoess, 1984; Nagy, 2000). Cre enzyme 
binds cooperatively to the loxP sites with sub-nanomolar affinity in order to catalyze the 
recombination reaction between the two sites and hence, deletion of a region of interest.  
In brief, IL-4Rα-/- BALB/c mice were generated by constructing a gene-targeting 
vector containing an EcoRI-flanked fragment of the il4ra derived from BALB/c genomic 
clone spanning IL-4Rα exons 4–12 (Fig. 8) (Wrighton et al., 1992; Mohrs et al., 1999). 
LoxP sites flanking selection cassette (neomycin and the herpes simplex virus (HSV) 
thymidine kinase (tk)) at 5’ of exon 7 as well as LoxP site at 5’ of exon 10 were introduced 
(Fig. 8). The linear targeting construct was electroporated into BALB/c embryonic stem 
(ES) cells and the Geneticin (G418)-resistant ES cell colonies were isolated 9 days after 
the addition of selection medium. Clones with proper integration of the targeting vector 
were electroporated with a plasmid expressing the Cre-recombinase for the two-steps 
strategy (Mohrs et al., 1999). Two-steps strategy is a technique whereby Cre-recombinase 
enzyme used first to remove the selection cassette and then the intervening sequences 
between exon 6 and exon 10. Clones with a deletion of exons 7–9 were injected into 
C57BL/6 blastocysts. Chimeric male offspring were mated to BALB/c females, and 
progeny with the mutated allele were intercrossed to obtain mice homozygous for the gene 
disruption on BALB/c background. Mice were genotyped by doing PCR of tissue biopsies 
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(Mohrs et al., 1999). IL-4Rαlox/lox BALB/c mice were generated following the same exact 
strategy described for IL-4Rα-/- BALB/c mice generation except for inducing Cre-
recombinase expression in a transient manner. Transient Cre-recombinase expression 
resulted in the deletion of the selection cassette and retention of the LoxP sites at 5’ of exon 
7 and exon 10, generating IL-4Rαlox/lox BALB/c mice (Fig. 9). IL-4Rαlox/lox BALB/c mice 
were intercrossed with IL-4Rα-/- BALB/c mice to generate IL-4Rα-/lox BALB/c mice 
(Herbert et al., 2004). 
Generation of Foxp3cre IL-4Rα-/lox mice required the intercrossing between three 
different mice strains; i) Foxp3-IRES-Cre BALB/c mice, ii) IL-4Rα-/- BALB/c mice and 
iii) IL-4Rαlox/lox BALB/c mice. Foxp3-IRES-Cre BALB/c mice were generated by 
following the standard gene-targeting strategy procedure (Fig. 6) whereby the gene-
targeting vector was constructed to introduce ires-cre coding genes downstream foxp3 gene 
stop codon (Fig. 10) (Wing et al., 2008). IRES is an internal ribosomal entry site that allows 
for the expression of several genes under the control of the same promoter through the 
generation of dicistronic fusion mRNA (Jang et al., 1988; Pelletier and Sonenberg, 1988; 
Mountford and Smith, 1995). Therefore, Cre-recombinase enzyme will be expressed under 
the control of foxp3 gene promoter in Foxp3-IRES-Cre BALB/c mice. Transgenic Foxp3-
IRES-Cre BALB/c mice were intercrossed for two generation with IL-4Rα-/- BALB/c mice 
(Mohrs et al., 1999). These mice were further intercrossed with homozygous IL-4Rαlox/lox 
BALB/c mice (Herbert et al., 2004) to generate hemizygous Foxp3cre IL-4Rα-/lox BALB/c 
mice (Fig. 11, A-B and Flowcharts 1-2). Hemizygous littermates (IL-4Rα-/lox) were used as 








Mice were genotyped by extracting genomic DNA from the tail as previously 
described (Mohrs et al., 1999; Herbert et al., 2004). In brief, mouse tail was incubated 
overnight with 500 µl of lysis buffer (50 mM Tris-HCl (pH 8), 100 mM EDTA, 100 mM 
NaCl, and 1% (w/v) SDS) at 56oC. The sample was spun down at 8000 x g for 10 mins at 
room temperature (RT) and the supernatant was transferred into a new tube. Equal volume 
of isopropanol was added to the supernatant, mixed gently by inversion, and then spun 
down at 8000 x g for 10 mins at RT. The supernatant was decanted and the pellet was 
washed twice with 70% ethanol. The tube was opened to allow for ethanol evaporation and 
the pellet was then resuspended in nuclease-free water. End-product polymerase chain 
reaction (PCR) was used for mice genotyping by using the following primer pairs: 
Table 2.1. Primers sequence used for genotyping of Foxp3cre IL-4 Rα-/lox mice  
Gene target Primer sequence 
WT IL-4Rα-Forward 5’ TGACCTACAAGGAACCCAGGC 3’ 
WT IL-4Rα-Reverse 5’ CTCGGCGCACTGACCCATCT 3’ 
Deleted IL-4Rα-Forward 5’ GGCTGCTGACCTGGAATAACC 3’ 
Deleted IL-4Rα-Reverse 5’ CCTTTGAGAACTGCGGGCT 3’ 
LoxP-Forward 5’ GGCTGCTGACCTGGAATAACC 3’ 
LoxP -Reverse 5’ GTTTCCTCCTACCGCTGATT 3’ 
Cre-Forward 5’ CTGCTTCCTTCACGACATTCAAC 3’ 
Cre-Reverse 5’ TTCGCAAGAAGAGGAGCCAACG 3’ 
PCR conditions were 94oC for 2 min, 94oC for 30 seconds, 57oC for 30 seconds, and 72oC 
for 1 min for 40 cycles in T100™ Thermal Cycler (Bio-Rad, Hercules, California). PCR-
products were then separated on a 1.5% agarose gel and stained with ethidium bromide. 
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2.2 Ethics statement 
All mice were maintained in specific-pathogen-free barrier conditions in individually 
ventilated cages at the University of Cape Town biosafety level 2 animal facility. 
Experimental mice were sex and age-matched and used between 6-8 weeks of age. This 
study was performed in strict accordance with the recommendations of the South African 
national guidelines and University of Cape Town practice for laboratory animal procedures. 
All mouse experiments were conducted according to protocols approved by the Animal 
Research Ethics Committee of the Faculty of Health Science, University of Cape Town 
(ethics protocols number 014/003, 016/027, 016/024, and 017/002). All efforts were made 
to minimize animals suffering.  
Prior to percutaneous infection with S. mansoni cercariae, animals were anaesthetized 
by intraperitoneal injection of a cocktail of Ketamine (100 mg/kg) and Xylazine (10 mg/kg) 
and monitored for 5 mins prior to confirming anaesthesia has been induced. Anaesthesia 
was confirmed by the absence of pedal reflex (toe pinch) and eyeblink reflex amid a regular 
respiratory rate. The anaesthesia duration was of a maximum of 30 min. During the 
anaesthesia phase, animals were exposed to an infra-red lamp (Philips, Amsterdam, 
Netherlands) to help them maintain their core body temperature. This procedure was 
performed and dully cared for by trained and authorized researchers. Post-infection, 
animals were monitored until regaining of consciousness and moistened food was added to 
the cage bedding. Upon reaching the study experimental endpoint and/or the protocol-
defined humane endpoint, animals were euthanized via exposure to an excess of Halothane 
(4% in air) for 5 min. The fatal anaesthesia was confirmed by a total absence of pedal reflex 
(toe pinch) and eyeblink reflex as well as the total absence of a respiratory rate. Death was 
confirmed either by neck dislocation or exsanguination by cardiac puncture.  
For survival study, the humane endpoint was determined by measuring the mice body 
weight and evaluating their physical performance. Mice that lost 20% of their initial body 
weight and/or showed aggravated weakness i.e. a grip scale of 3+ and/or persistent bloody 
diarrhoea (> 48 hr) apparent on the animal fur or combinatively, that displayed the 
simultaneous occurrence of 2 out of the 3 following symptoms i.e. “10-19 % weight loss”, 
“grip scale of +2” or “bloody diarrhoea for 24-48 hr”, were euthanized immediately as 
described before. The mice were then completely exsanguinated by cardiac puncture 
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followed by cervical dislocation. This set of procedures were carried out by researchers 
trained and South African Veterinary Council (SAVC) authorized. 
 
2.3 Mice infection 
2.3.1 Schistosoma mansoni 
2.3.1.1 Life cycle maintenance 
Biomphalaria glabrata snails (NMRI strain, NR-21962, provided by Biomedical 
Research Institute, Rockville, MD) were used as an intermediate host for the maintenance 
of Schistosoma mansoni (NMRI strain) life cycle as previously described (Tucker et al., 
2013).  In brief, B. glabrata snails were kept in clean tanks containing conditioned water 
(4.48 mM CaCl2.2H2O, 9.97 mM MgSO4, 0.23 mM K2SO4, 4.99 mM NaHCO3, and 0.5 ml 
of 0.03% FeCl3.6H2O (Merck, Kenilworth, New Jersey)), aerated for 1 to 2 days before 
usage. The tanks were maintained at 24oC with regulated light/dark cycle. For snails’ 
infection, livers of 8 weeks S. mansoni infected mice were collected in saline (0.9% NaCl, 
Merck), chopped into small pieces, and homogenized at a maximum speed for 30 seconds. 
Eggs were then isolated by passing the liver homogenate thorough series of decreasing size 
sieves. The filtrate was diluted 40-times in conditioned water and then placed in volumetric 
flask partially covered with tin foil. The un-foiled area of the flask was exposed to an infra-
red light for 20 min, for concentrating the photo-tactic miracidia at the neck region of the 
flask. Juvenile snails placed in conditioned water were individually infected overnight with 
5-8 miracidia before placing them back into their respective tank.  
Shedding of the cercariae from the infected B. glabrata snails were done 5-8 weeks 
post-infection whereby the infected snails were kept in dark for 48 hr, placed in 100 ml 
beaker containing conditioned water (at a density of one snail per 2 ml water), and then 
exposed to strong light for 30 min. Cercariae yield was then determined by using iodine 
(Merck), to kill and stain the cercariae, and dissecting microscope (SMZ800N Stereo 





2.3.1.2 Mice infection and egg count 
Mice were shaved ventrally and anaesthetized via intraperitoneal injection of 10 mg/kg 
Xylazine and 100 mg/kg Ketamine cocktail, as mentioned above. Mice were infected 
percutaneously via the abdomen, using stainless-steel rings, with 80 or 100 viable cercariae 
of NMRI strain of S. mansoni obtained from the infected Biomphalaria glabrata snails as 
described. For egg load in the infected animals, liver and ileum were digested in 5 ml of 
5% KOH (Merck) overnight at 37oC and the eggs were counted at 40× magnification as 
described previously (Cheever, 1970).  
 
2.3.2 Nippostrongylus brasiliensis 
2.3.2.1 Life cycle maintenance 
Nippostrongylus brasiliensis life cycle was maintained by passage through Wistar rats 
as previously described (Camberis et al., 2003). In brief, rats were anaesthetized by 
exposure to Isoflurane for 3-5 min and then subcutaneously injected with 5000 L3 
larvae/500 µl phosphate buffered saline (PBS, 136.9 mM NaCl, 2.68 mM KCl, 10.14 mM 
Na2HPO4, 1.76 mM KH2PO4, all from Merck)/rat by using a 18-G needle (Braun, 
Melsungen, Germany). From day 5 post-infection, rats were kept in wire-bottomed cages 
with a try beneath covered with a well-dampened paper for faeces collection. Rats’ faecal 
pellets were collected on day 6, 7, and 8 whereby the faecal pellets were softened by 
incubating them for an hour with 5 µg/ml fungizone. The paste was then prepared, by 
mixing the soften pellets with activated charcoal (Sigma-Aldrich, St. Louis, Missouri, 
catalogue no. 242241), distributed on moistened filter paper placed in sterile Petri-dishes, 
and finally incubated in dark at 26oC in order to facilitate egg hatching and development of 
L3 larvae. After 7-days, L3 larvae were harvested to be used for future infections. 
 
2.3.2.2 Mice infection and worm count 
L3 larvae were washed off the filter paper in saline (0.9% NaCl), counted under a 
dissecting microscope, and resuspended at a concentration of 2500 L3 larvae/ml. Mice were 
injected subcutaneously with 500 N. brasiliensis L3 larvae in 200 µl 0.9% NaCl using a 
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21-G needle. Mice were euthanized 9 days post-infection, worms were counted and tissue 
samples were collected for further analyses. 
For worm count, the small intestine was removed from the infected animals, opened 
longitudinally to expose the lumen, cut into small pieces, and then incubated in saline in 
shaking incubator at 37oC for 4 hr. After the incubation period, the gut suspension was 
poured out into a large graded Petri-dish and the total number of adult 
worms/intestine/mouse was determined by using a dissecting microscope (SMZ800N 
Stereo Microscope). 
 
2.3.2.3 Nippostrongylus brasiliensis antigens preparation 
L3 larvae were sediment by centrifugation at 315 x g (Heraeus™ Megafuge™ 40, 
Thermo Scientific, Waltham, Massachusetts) for 10 min at RT, resuspended in 2 ml PBS, 
and then homogenized at maximum speed for 30 seconds. The homogenate was filtered 
through 0.45 µm filter, and the protein content was measured by using Pierce BCA Protein 
Assay Kit (Thermo Fisher Scientific, catalogue no. 23225) as per manufacturer's 
instruction. 
 
2.4 Cells isolation 
2.4.1 Thymus, mesenteric lymph nodes, and hepatic lymph nodes 
Thymus, mesenteric lymph nodes (MLN), and hepatic lymph node (hLN) were 
collected in 1 ml of filter-sterilized Iscove’s Modified Dulbecco’s Medium (IMDM) 
(Gibco, Waltham, Massachusetts) supplemented with 10% inactivated fetal bovine serum 
(iFBS, Gibco), and 100 U/ml penicillin-streptomycin (Gibco). Single-cell suspensions were 
achieved by mechanical squeezing, using plunger top part of 2 ml sterile syringe, through 
70 µM cell strainer (Falcon, Corning, MA), followed by sieving through 40 µM cell strainer 
(Falcon), to get rid of any cell clumps and/or debris. The cell suspension was spun down at 
315 x g for 10 min at 4oC. The supernatant was decanted and the cell pellet was resuspended 
in 5 ml IMDM medium for checking cell viability and cell count by using trypan blue 
(Lonza, Walkersville, Maryland). After the cell number had been estimated, the cells were 
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sediment by centrifugation at 315 x g for 10 min at 4oC and then resuspended at a 
concentration of 10 million cells/ml. 
 
2.4.2 Spleen 
Spleen was collected in 1 ml of filter-sterilized IMDM Medium. Single-cell suspension 
was obtained by mechanical squeezing, using plunger top part of sterile syringe, through 
100 µM cell strainer (Falcon), followed by sieving through 70 µM cell strainer, and then 
centrifugation at 315 x g for 10 min at 4oC. To get rid of red blood cells, the cell pellet was 
incubated for 10 min at RT with 5 ml of pre-warmed red blood cells (RBCs) lysis buffer 
(156 mM NH4Cl, 0.127 mM EDTA, and 11.9 mM NaHCO3, all from Merck). IMDM 
medium was then added up to 10 ml, to neutralize the effect of RBCs lysis buffer, and the 
cell suspension was spun down at 315 x g for 10 min at 4oC. The supernatant was decanted, 
the cell pellet was resuspended in 5 ml IMDM medium, and then sieved thorough 40 µM 
cell strainer. Trypan blue was used for checking cell viability and determining cell count. 
Then, the cells were sediment by centrifugation at 315 x g for 10 min at 4oC and finally 
resuspended at a concentration of 10 million cells/ml. 
 
2.4.3 Lung 
Lungs were chopped into 10 mm3 pieces and then incubated in shaking incubator for 
30 min at 37oC with digestion buffer (IMDM supplemented with 220 U/mg Collagenase I 
(Sigma, catalogue no. C9891), 13 U/mg DNase I (Sigma, catalogue no. DN25), and 5% 
iFBS). The resulting suspension was mechanically squeezed through 70 µM cell strainer, 
followed by sieving through 40 µM cell strainer. The cell suspension was spun down, 
treated with RBCs lysis buffer, and then resuspended in IMDM medium. Cell’s viability, 






2.4.4 Liver and small intestine 
Liver and gut lymphomyeloid cells were isolated following a modified version of the 
method of Gossen et al and Hardy et al (Goossens et al., 1990; Hardy et al., 1997). Briefly, 
luminal content of the small intestine was flushed out and then small intestine and liver 
tissues of individual animals were chopped, separately, into 10 mm3 pieces. Liver and small 
intestine samples were incubated in shaking incubator for 30-45 min at 37oC with either 
liver digestion buffer (IMDM medium supplemented with 110 U/mg Collagenase I, 110 
U/mg Collagenase II (Sigma, catalogue no. C6885), 13 U/mg DNase I, and 5% iFBS) or 
small intestine digestion buffer (IMDM medium supplemented with 220 U/mg Collagenase 
I, 13 U/mg DNase I, and 5% iFBS), respectively. The resulting suspension was 
mechanically squeezed through 100 µM sterile cell strainer, followed by sieving through 
70 µM sterile cell strainer and then centrifugation at 315 x g for 10 min at 4oC. Supernatant 
was discarded, the cells were resuspended in 3 ml PBS containing 3% iFBS and then mixed 
with 1.7 ml Percoll (Sigma, catalogue no. P1644), giving a final concentration of 36% 
isotonic Percoll. The suspension was mixed thoroughly and the separation was performed 
at 500 x g, without breaks, for 10 min at 4oC. Liver cells were treated with RBCs lysis 
buffer as described earlier. Cells were then washed, resuspended in IMDM medium, sieved 
through 40 µM cell strainer, counted by trypan blue staining, and finally resuspended at a 
concentration of 10 million cells/ml. 
 
2.5 Flow cytometry 
2.5.1 Antibodies 
Antibodies used for flow cytometry analyses were as follows: CD3ε (BD Biosciences, 
Franklin Lakes, New Jersey, clone: 500A2), CD4 (BD, clone: RM4-5), CD8α (BD, clone: 
53-6.7), CD25 (BD, clone: 7D4), CD19 (BD, clone: 1D3), Lineage (BD), CD124 (BD, 
clone: mIL4R-M1), Foxp3 (eBioscience, Waltham, Massachusetts, clone: FJK-16s), 
GATA3 (BD, clone: L50-823), T-bet (eBioscience, clone: eBio4B10), Bcl-6 (BD, clone: 
K112-91), RoRγt (BD, clone: Q31-378), Helios (BD, clone: 22F6), IRF4 (Biolegend, San 
Diego, California, clone: irf4.3e4), Ki67 (BD, clone: B56), IFN-γ (BD, clone: XMG1.2), 
IL-4 (BD, clone: 11B11), IL-10 (eBioscience, clone: JES5-16E3), IL-13 (eBioscience, 
clone: eBio13A), F4/80 (eBioscience, clone: BM8), Ly6G (eBioscience, clone: RB6-8C5), 
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CD11c (BD, clone: HL3), MHCII (eBioscience, clone: M5/114.15.2), SiglecF (BD, clone: 
E50-2440), T1/ST2 (BD, clone: DJ8), ICOS (BD, clone: MIH4), and CD11b (BD, clone: 
WT.5). 
For staining of cell surface markers, cells were plated, at a density of 1 x 106 cells, in 
96 well V-bottom plates (Thermo Fisher Scientific) and then sedimented by centrifugation 
at 315 x g for 10 min at 10oC.  Cells were stained with 50 µl antibody mix containing 2 % 
inactivated rat serum and 1 % unlabelled anti-CD32/CD16 antibody, to avoid non-specific 
binding, for 30 min at 4oC in dark. Unbound antibodies were washed off by centrifugation 
at 315 x g for 10 min at 10oC, and the cells were resuspended in FACS buffer (PBS 
containing 1% bovine serum albumin (BSA) (Roche, Switzerland) and 0.1% NaN3 
(Merck)) for acquisition. 
 
2.5.2 Intracellular cytokine staining 
For detection of intracellular cytokines, MLN or hLN cells were seeded at a density of 
2 x 106 cells/well in complete IMDM culture medium and stimulated with 50 ng/ml phorbol 
myristate acetate (PMA), 250 ng/ml ionomycin, and 200 µM monensin (all from Sigma) 
for 8-12 hr at 37oC in a humidified atmosphere containing 5% CO2. After the incubation 
period, cells were harvested, washed with FACS buffer, stained with extracellular markers 
for 30 min, and then fixed with 2% (w/v) paraformaldehyde for 1 hr at 4oC in dark. The 
cells were washed with ice-cold PBS and then permeabilized with 0.5% saponin buffer 
(PBS containing 1.58 mM saponin, 1 mM CaCl2, 1.034 MgSO4, 7.69 mM NaN3, 1 g/l BSA, 
10 mM HEPES, with pH adjusted to 7.4) for 1 hr at 4oC in dark. The cells were sediment 
by centrifugation at 315 x g for 10 min at 10oC and then stained for 1 hr with cytokines 
antibodies (IFN-γ, IL-4, IL-10, IL-13). Cells were washed with saponin buffer and then 
resuspended in FACS buffer for acquisition. 
 
2.5.3 Intranuclear staining 
For detection of transcription factors, BD Pharmingen™ Transcription Factor Buffer 
Set (BD Biosciences, catalogue no. 562574) was used as per manufacturer's instruction. 
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Briefly, single-cell suspensions (1 x 106 cells) were stained for cell surface markers for 30 
min, washed with 1x Perm/Wash buffer, and then incubated in 1x Fix/Perm buffer for 1 hr 
at 4oC in dark, for fixation and permeabilization. The cells were washed with 1x Perm/Wash 
buffer and then stained with transcription factors antibodies and proliferation markers for 
1 hr at 4oC in dark. Cells were washed with the 1x Perm/Wash buffer and then resuspended 
in FACS buffer. 
In all staining settings, staining specificity was verified by appropriate isotype-matched 
antibody controls. All the incubation periods were done at 4oC in dark. Acquisition was 
performed using BD LSRFortessa™ (BD Biosciences) and data were analysed using 
FlowJo software (Treestar, Ashland, Oregon). 
 
2.6 Real-time polymerase chain reaction 
2.6.1 Genotypic evaluation of efficiency and specificity of IL-4Rα deletion 
Genomic DNA was isolated, as described above,  from CD3+ CD4+ Foxp3-, CD3+ 
CD4+ Foxp3+ T cells and CD19+ B cells sorted using BD FACSAria™ III cell sorter (BD 
Biosciences). While cell purity was determined by flow cytometer and it was at least 99%, 
NanoDrop (ND-1000 Spectrophotometer, Thermo Fischer Scientific) was used for 
measuring DNA concentration and purity. Efficiency of il-4rα gene deletion was quantified 
by real-time PCR (qPCR) on LightCycler® 480 Instrument II (Roche) using the following 
primers; exon 5: forward 5' AACCTGGGAAGTTGTG 3' and reverse 5' 
CACAGTTCCATCTGGTAT 3', exon 8: forward 5' GTACAGCGCACATTGTTTTT 3' 
and reverse 5' CTCGGCACTGACCCATCT 3'. PCR conditions were 94oC for 2 min, 94oC 
for 20 seconds, 45oC for 30 seconds, and 72oC for 20 seconds for 55 cycles. 
 
2.6.2 Transcriptional evaluation of Foxp3 expression by qRT-PCR 
2.6.2.1 RNA extraction 
Liver tissues from Foxp3cre IL-4Rα-/lox mice and their littermate controls were collected 
in QIAzol Lysis Reagent (Qiagen, Hilden, Germany) and RNA was extracted by using 
RNeasy Mini Kit (Qiagen) following manufacturer’s instructions. In brief, Liver tissues 
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were homogenized in Qiazol on ice and then one-fifth volume of chloroform (Merck) was 
added to each sample. The homogenate and the chloroform were shaken vigorously, 
incubated at RT for 3 mins, shaken again, and then spun down by centrifugation at 8000 x 
g for 15 mins at 4oC. Afterwards, the tubes had three different layers, the upper aqueous 
layer was transferred into a new tube, an equal volume of 70% ethanol was added, and the 
tubes were shaken for mixing. The mixture, up to 700 µl, was then transferred into the 
RNeasy spin column placed in a 2 ml collection tubes, incubated for 1 min, and then spun 
down at 8000 x g for 15 seconds at 4oC. Flow-through was discarded, the RW1 buffer was 
added to the spin column, incubated for 1 min, and then spun down at 8000 x g for 15 
seconds at 4oC. To get rid of DNA contamination, samples were treated with DNase I for 
15 mins at RT and then washed with RW1 buffer. RBE buffer was added to the spin 
column, incubated for 1 min, and then spun down at 8000 x g for 15 seconds at 4oC. The 
previous step was repeated and then the spin column was placed into a new collection tube 
to get rid of any residual solution by centrifugation for 1 min at full speed. RNA was eluted 
in a new tube by using RNase-free water. RNA concentration was determined by using 
NanoDrop. 
 
2.6.2.2 Complementary DNA synthesis 
RNA was converted into a complementary DNA (cDNA) by using Transcriptor First 
Strand cDNA Synthesis Kit (Roche catalogue no. 04 379 012 001) following 
manufacturer’s instructions. Briefly, RNA, with a concentration of at least 0.5 µg/ml, was 
mixed with the primer mix (2.5 µM anchored-oligo(dT)18 primer, 60 µM random hexamer 
primer, and PCR-grade water up to 13 µl), incubated for 10 mins at 65oC in T100™ 
Thermal Cycler (Bio-Rad), and then chilled on ice immediately. The master mix 
(transcriptor reverse transcriptase reaction buffer containing 8 mM MgCl2, 20 U RNase 
inhibitor, 1 mM deoxy-nucleotide mix, and 10 U transcriptor reverse transcriptase) was 
added to the template-primer mix and then incubated in T100™ Thermal Cycler (with 
heated lid) for 10 mins at 25oC, 60 mins at 50oC, followed by 5 mins at 85oC. The tube was 
placed on ice for 5 mins to stop the reaction and then aliquots of cDNA were prepared for 




2.6.2.3 RT-PCR amplification 
Foxp3 and HPRT transcripts were quantified by qPCR on LightCycler® 480 
Instrument II (Roche) using primer pairs in Table 2.2. PCR conditions were 95oC for 5 min, 
95oC for 10 seconds, 62oC for 15 seconds, 72oC for 20 seconds, and 76oC for 5 seconds for 
45 cycles. Foxp3 expression was normalized to the expression level of HPRT. 
Table 2.2. Primers sequence for evaluation of Foxp3 expression   
Gene target Primer sequence 
Foxp3-Forward 5’ GTGCACGTACACACATGCAG 3’ 
Foxp3-Reverse 5’ TAGGCATGGATTGGGGCTTG 3’ 
HPRT-Forward 5’ GTT GGA TAT GCC CTT GAC 3’ 
HPRT-Reverse 5’ AGG ACT AGA ACA CCT GCT 3’ 
 
2.7 Cell culture 
2.7.1 Cytokine stimulation 
Spleen and MLN cells from naïve Foxp3cre IL-4Rα-/lox mice and their littermate 
controls were cultured at 5 x 106 cells/ml in Roswell Park Memorial Institute (RPMI) 
medium (Lonza) containing 10% iFBS and 100 U/ml penicillin-streptomycin (RPMI 
culture medium) with 0 or 1 ng/ml recombinant (r)IL-4 (BD Biosciences) for 40 hr at 37oC 
in a humidified atmosphere containing 5% CO2. After the incubation period, cells were 
harvested, washed in FACS buffer and then stained for IL-4Rα (BD, clone: mIL4R-M1) in 
the presence of inactivated rat serum and unlabelled anti-CD32/CD16 antibody (2.4G2). 
IL-4Rα expression was detected by flow cytometry (BD LSRFortessa). In other settings, 
sorted CD4+ CD25+ T cells from naïve Foxp3cre IL-4Rα-/lox mice and their littermate control 
were cultured at a density of 1 x 106 cells/ml in RPMI culture medium with 0 or 10 ng/ml 
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rIL-4 for 18 or 36 hr, at 37oC in a humidified atmosphere containing 5% CO2. Cell survival 
and Foxp3 expression were assessed by flow cytometry. 
 
2.7.2 Ex-vivo restimulation of MLN cells 
Single cell suspensions from MLN cells were prepared as described above. The cells 
were cultured at a density of 1 x 107 cells/ml in 96 well flat-bottom plates (Thermo Fisher 
Scientific) either coated with α-CD3 (20 µg/ml) or supplemented with soluble egg antigens 
(SEA, 20 µg/ml, Theodor Bilharz Research Institute, Giza, Egypt). Cells were incubated at 
37oC in a humidified atmosphere containing 5% CO2, supernatants were collected after 72-
96 hr, and cytokines were measured by enzyme-linked immunosorbent assay (ELISA) 
(Herbert et al., 2004). 
 
2.8 In vitro Treg assays 
2.8.1 CD4+ T cell enrichment 
From naïve mice, lymph nodes (LNs) and spleen were collected in sterile RPMI culture 
medium. Single cell suspension preparation and cells counts were done as described before. 
Cells were resuspended in Easy Sep buffer (PBS containing 2% iFBS, and 1 mM EDTA 
(Merck)) at a concentration of 1 x 108 cells/ml for CD4+ T cell enrichment by using 
EasySep™ Mouse T Cell Isolation Kit (Stemcell Technologies, Vancouver, Canada, 
Catalogue no.19852A) as per manufacturer's instruction. In brief, cells were mixed with rat 
serum (50 µl/ml of sample), transferred to polystyrene round-bottom tube (BD), mixed with 
antibody isolation cocktail (50 µl/ml of sample), and then incubated for 10 min at RT. 
RapidSpheres™ (75 µl/ml of sample) was added to the sample, mixed, incubated for 2.5 
min, and then the tube (without lid) was placed into the magnet for 2.5 min at RT. The 
magnet was picked up and in one continuous motion, the magnet and the tube were inverted 
to pour the enriched cell suspension into a new tube. Enriched CD4+ T cells were washed 





2.8.2 Cell sorting 
Enriched CD4+ T cells were surface stained with antibodies for CD4 and CD25, and 
7-aminoactinomycin D (7AAD, Sigma, catalogue no. SML1633) as mentioned above. 
Cells were then washed and resuspended in 3 ml FACS buffer for sorting CD4+ CD25- (for 
Treg conversion assay) and CD4+ CD25+ (to be cultured with 0 or 10 ng/ml rIL-4) cells 
using BD FACSAria™ III cell sorter (BD Biosciences). 
 
2.8.3 Treg conversion assay 
Sorted CD4+ CD25- cells (2.5 x 106 cells/ml) were cultured with plate-bound anti-CD3 
(10 µg/ml) in the presence of soluble anti-CD28 (2 µg/ml, eBioscience, clone: 37.51 ) and 
different concentration of transforming growth factor beta (TGF-β, BD Pharmingen) (0, 1, 
or 2, ng/ml) in 96 well, flat-bottomed plates in triplicates. After 3 days incubation at 37oC 
in a humidified atmosphere containing 5% CO2, the induced Treg (iTreg) cells were 
harvested, washed in FACS buffer, and then stained for analysing CD25 and Foxp3 
expression by flow cytometry. 
 
2.9 Serum analyses 
2.9.1 Serum collection and measurement of immunological parameters 
Cardiac puncture was used to collect blood in serum separator tubes (BD Biosciences). 
Blood in serum separator tubes was then spun down at 8000 x g for 10 min at 4°C to 
separate the serum. Aliquots of sera, 50 μl each, were stored at -80°C on an individual basis 
to measure liver enzymes, serum cytokines (IL-4 and TNF-α) and antibody isotypes titer. 
 
2.9.2 Liver enzymes 
Hepatocellular damage was assessed by measuring the serum level of aspartate 




2.10 Immunological analyses 
2.10.1 Cytokine measurement by sandwich ELISA 
The release of IFN-γ, IL-4, IL-5, IL-10, IL-13, and IL-17 (BD Pharmingen) was 
measured as follows. The Nunc™ MicroWell™ 96-Well Microplates (Thermo Fischer 
Scientific) were coated with 1 µg/ml capture antibody in coating buffer (PBS) and 
incubated overnight in a humidified chamber at 4°C. Plates were washed 3 times with 
washing buffer (13.4 mM KCL, 5.8 mM KH2PO4, 684.4 mM NaCl, and 0.25% Tween 20 
(all from Merck)), blocked with 200 µl of  2% (w/v) milk powder in PBS for 2 hr at 37°C, 
washed 3 times, and then the samples were loaded and incubated overnight at 4°C. The 
plates were washed 3 times, (0.5 µg/ml) biotin-labelled antibody was added, incubated for 
2 hr at 37°C, and then washed 3 times by washing buffer. Avidin-horseradish peroxidase 
or avidin-alkaline phosphatase (KPL, Gaithersburg, Maryland) was added and incubated 
for 1 hr at 37°C. Plates were washed 6 times, then developed by adding either TMB 
Microwell Peroxidase Substrate (KPL) or 1 mg/ml p-nitrophenyl phosphate disodium salt 
hexahydrate (Sigma, catalogue no. N2765), and finally The absorbance was read at 450 or 
405 nm, respectively, using VersaMax™ microplate spectrophotometer (Molecular 
Devices, Sunnyvale, California). 
 
2.10.2 Antibody isotype 
S. mansoni soluble egg antigens specific serum antibody isotypes and total IgE titer 
from naïve/infected mice were measured by coating The Nunc™ MicroWell™ 96-Well 
Microplates (Thermo Fisher Scientific) with either 20 µg/ml SEA or 1 µg/ml of IgE capture 
antibody, respectively. Plates were sealed and incubated overnight at 4°C and then washed 
3 times with washing buffer. Nonspecific sites were blocked with 200 µl of 2% (w/v) milk 
powder in PBS for 2 hr at 37°C, and then plates were washed 3 times. While sera were 
diluted 1:10, 1:100, 1:1000, and 1:1000 for detecting antibody isotypes (IgG1, IgG2a, and 
IgG2b) titers, 50 µl of undiluted sera was used to detect the total IgE. The serum samples 
were incubated overnight at 4°C. Alkaline phosphatase-labelled secondary antibody (0.5 
µg/ml) was added, incubated for 3 hr at 37°C, and then plates were washed 6 times. Plates 
were developed by the addition of 1 mg/ml p-nitrophenyl phosphate disodium salt 
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hexahydrate (Sigma). The absorbance was read at 405 nm using VersaMax™ microplate 
spectrophotometer (Molecular Devices). 
 
2.11 Histology 
2.11.1 S. mansoni infection 
Liver and gut tissues were fixed in 4% (v/v) formaldehyde in PBS, embedded in wax, 
processed, and 5–7 μm sections stained with hematoxylin and eosin (H & E). Micrographs 
of liver granuloma were captured using Nikon Eclipse 90i (Nikon). Granuloma diameter of 
20-50 granulomas per animal was determined using Nikon NIS-Elements imaging software 
(Nikon Corporation). For fibrosis assessment, tissue sections were stained with 
chromotrope 2R and analine blue solution (CAB) and counterstained with Wegert's 
hematoxylin for collagen staining. 
 
2.11.2 N. brasiliensis infection 
Lung tissues were fixed in 4% (v/v) formaldehyde in PBS, embedded in wax, 
processed, and 5 μm sections were stained with periodic acid-Schiff reagent (PAS) to 
visualize mucus-producing goblet cells (Johannes and Klessen, 1984). Micrographs of lung 
sections were captured using Nikon Eclipse 90i. 
 
2.12 Tissue homogenate for cytokine analyses 
From naïve and infected animals, tissues were collected and homogenized in protein 
extraction buffer (PBS (pH 7.1) containing 0.1% Tween 20 (Merck), and 1% protease 
inhibitor cocktail (Sigma-Aldrich, catalogue no. P8340)). Cytokines were measured in the 
protein extracts by sandwich ELISA as described previously. Cytokine values were 
normalized according to the protein content measured by Pierce BCA Protein Assay Kit 





2.13 Hydroxyproline quantifications 
Hydroxyproline content as a measure of collagen production was quantified using 
modified protocol (Bergman and Loxley, 1963). In brief, weighed liver samples were 
hydrolyzed overnight at 110oC in 6 M HCl (Sigma) and then filtered through Whatman® 
filter papers. Filtrate was neutralized with 1% phenolphthalein and titrated against 10 M 
NaOH (Merck). An aliquot was mixed with isopropanol (Merck) and added to a 
chloramine-T/citrate buffer solution (pH 6.0) (Sigma). Ehrlich's reagent solution (25 g p-
dimethyl-amino-benzaldehyde, 37.5 ml 60% perchloric acid (Merck)) was added and the 
absorbance was then measured at 570 nm using VersaMax™ microplate spectrophotometer 
(Molecular Devices). Hydroxyproline levels were calculated by using 4-hydroxy-L-proline 
(Calbiochem, San Diego, California) as a standard, and results were expressed as μg 
hydroxyproline per weight of liver tissue that contained 104 eggs. 
 
2.14 Statistics 
Statistical analysis was conducted using GraphPad Prism 4 software 
(http://www.prism-software.com). Data were calculated as mean ± SD. Statistical 
significance was determined using the unpaired Student's t-test or One-Way ANOVA with 
Bonferroni's post-test, defining differences to IL-4Rα-/lox mice (p>0.05; ns, *, p≤0.05; **, 









Chapter 3:  
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Chapter 3: The role of IL-4Rα-mediated signaling on Foxp3+ Treg cells under steady-
state 
3.1 Results 
3.1.1 Foxp3+ Treg cells express IL-4Rα under steady-state 
IL-4Rα-mediated signaling and associated factors critically mediating the function of 
Th2 cells were recently shown to play an important role in controlling Foxp3+ Treg cells 
function (Maerten et al., 2005; Pace et al., 2005; Pillemer et al., 2009; Kelada et al., 2013; 
Noval Rivas et al., 2015; Massoud et al., 2016; Pelly et al., 2017). However, whether IL-
4Rα-mediated signaling on Foxp3+ Treg cells promotes (Maerten et al., 2005; Kelada et 
al., 2013) or inhibits (Noval Rivas et al., 2015; Massoud et al., 2016; Pelly et al., 2017) 
their suppressive function(s) remains unclear. To address this, the surface protein 
expression pattern of IL-4Rα on Foxp3+ Treg cells was examined in spleen and MLN of 
naïve BALB/c mice. Interestingly, the present study found that CD4+ Foxp3+ Treg cells did 
express IL-4Rα under steady-state condition (Fig. 7, A-C). This result suggests that IL-
4Rα-mediated signaling might be needed by Foxp3+ Treg cells to maintain immune-




Treg cells express IL-4Rα under steady-state.  
(A) Gating strategy for identifying CD4+ Foxp3+ Treg cell population.  (B) Representative 
histograms of IL-4Rα expression by Foxp3+ Treg cells in spleen and MLN of IL-4Rα-/- 
(gray tinted) mice and naïve (solid line) IL-4Rα-/lox mice with the mean of Δ GMFI IL-4Rα 
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3.1.2 Generation and characterization of Foxp3cre IL-4Rα-/lox BALB/c mice 
3.1.2.1 Generation of Foxp3cre IL-4Rα-/lox BALB/c mice 
To better dissect the role of IL-4Rα-mediated signaling on Foxp3+ Treg cells, a murine 
model, termed Foxp3cre IL-4Rα-/lox, with a specific cyclic recombinase (Cre)-mediated 
deletion of the il-4rα gene in Foxp3-expressing cells was generated. IL-4Rα-/- BALB/c 
mice, IL-4Rαlox/lox BALB/c mice, and Foxp3-IRES-Cre BALB/c mice were required for the 
generation of Foxp3cre IL-4Rα-/lox mice. IL-4Rα-/- BALB/c mice were generated by gene-
targeting strategy using an isogenic target vector (derived from BALB/c genomic clone) 
and the two-steps Cre-mediated site-specific recombination strategy in BALB/c ES cells 
(Fig. 8, Mohrs et al., 1999). Cre-recombinase enzyme-enabled the removal of the selection 
cassette first and then the intervening sequences (exon 7-9) between the remaining two 
LoxP sites, generating a non-functional allele of il4ra gene in BALB/c ES cells (Fig. 8, 
Mohrs et al., 1999).  
 
 
Figure 8. Generation of IL-4Rα-/- BALB/c mice.  
Schematic representation of the targeted il4ra gene locus. Homologous recombination 
between the il4ra gene locus and the targeting vector, whereby LoxP sites flanking selection 
cassette at 5’ of exon 7 as well as LoxP site at 5’ of exon 10 were introduced, and the two-
steps Cre-mediated recombination had resulted in the deletion of exon 7-9 and the 
generation of non-functional allele of il4ra gene in BALB/c embryonic stem cells. Numbers 
indicate the position of exons of il4ra gene. B, BamHI; E, EcoRI; S, SmaI; Xh, XhoI. 
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For IL-4Rαlox/lox BALB/c mice generation, transient expression of Cre-recombinase 
enzyme in successfully targeted ES cells, using an isogenic target vector, resulted in 
deletion of the selection cassette and maintenance of LoxP sites at the 5’ of exon 7 and exon 
10, generating a floxed allele of il4ra gene in BALB/c ES cells (Fig. 9, Herbert et al., 2004). 
 
 
Figure 9. Generation of IL-4Rαlox/lox
 
BALB/c mice.  
Schematic representation of the targeted il4ra gene locus. Homologous recombination 
between the il4ra gene locus and the targeting vector, whereby LoxP sites flanking selection 
cassette at 5’ of exon 7 as well as LoxP site at 5’ of exon 10 were introduced, and transient 
Cre-mediated recombination had resulted in the generation of the conditional floxed (LoxP 
sites flanking exons 7 and 10) allele of il4ra gene in BALB/c embryonic stem cells. 
Numbers indicate the positions of exons of il4ra gene. B, BamHI; E, EcoRI; S, SmaI; Xh, 
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Standard gene-targeting strategy procedure and IRES technique were used for the 
selective expression of Cre-recombinase enzymes in Foxp3+ Treg cells in Foxp3-IRES-Cre 
BALB/c mice (Wing et al., 2008). The ires-cre construct was introduced downstream the 
foxp3 gene stop codon to enable the expression of Cre-recombinase enzyme under the 
control of foxp3 gene promoter (Fig. 10). 
 
Figure 10. Generation of Foxp3-IRES-Cre BALB/c mice.  
Schematic representation of the targeted foxp3 gene locus. Homologous recombination 
between the foxp3 gene locus and the targeting vector, whereby the ires and cre-coding 
genes were inserted downstream the foxp3 gene stop codon, had resulted in the generation 
of the foxp3-ires-cre construct in BALB/c embryonic stem cells. K, KpnI; Xb, XbaI. 
Adapted from (Wing et al., 2008). 
 
 
Foxp3cre IL-4Rα-/lox mice were generated by intercrossing BALB/c mice expressing 
Cre under the control of foxp3 gene promoter (Wing et al., 2008) with global knock-out 
(IL-4Rα-/-) BALB/c mice (Mohrs et al., 1999), for two generations, to generate a Foxp3cre 
IL-4Rα-/- BALB/c mice (Flow chart 1-2 and Fig. 11 A-B). These mice were further 
intercrossed with homozygous floxed IL-4Rα (IL-4Rαlox/lox) BALB/c mice (exon 7 to 9 
flanked by LoxP sites) (Herbert et al., 2004) to generate a Foxp3-specific IL-4Rα deficient 
mouse on BALB/c background (Foxp3cre IL-4Rα-/lox BALB/c mice, Flow chart 1-2 and Fig. 








Flowchart 1: Generation of Foxp3Cre-/+ IL-4Rα-/lox BALB/c mice using males Foxp3Cre-/+ mice to start the generation of males and females 
Foxp3Cre-/+ IL-4Rα-/lox mice and their littermate controls. The gene genotype is indicated above the drawn chromosome, while the number of 




Flowchart 2: Generation of Foxp3Cre-/+ IL-4Rα-/lox BALB/c mice using females Foxp3Cre-/+ mice to start the generation of males and 
females Foxp3Cre-/+ IL-4Rα-/lox mice and their littermate controls. The gene genotype is indicated above the drawn chromosome, while the 





Figure 11. Generation of Foxp3Cre-/+ IL-4Rα-/lox BALB/c mice.  
(A) Mouse breeding strategy. IL-4Rα-/- BALB/c mice were intercrossed for two generations 
with transgenic BALB/c mice expressing Cre-recombinase under the control of foxp3 gene 
promoter. The Foxp3Cre-/+ IL-4Rα-/- progeny were further intercrossed with IL-4Rαlox/lox 
BALB/c mice to generate Foxp3Cre-/+ IL-4Rα-/lox mice and their littermate controls on 
BALB/c background. (B) Schematic diagram showing the structure of il4ra gene loci in 






3.1.2.2 Genotypic evaluation of IL-4Rα deletion on Foxp3+ Treg cells 
Foxp3cre IL-4Rα-/lox mice were identified by PCR genotyping (Fig. 12 A). The cellular 
specificity of Cre-mediated IL-4Rα deletion was assessed at the genomic level by 
performing quantitative real-time PCR. Genomic DNA was extracted from CD19+, CD4+ 
Foxp3-, and CD4+ Foxp3+ sorted cells from pooled spleen and MLN cells of naïve Foxp3cre 
IL-4Rα-/lox, their littermate control (IL-4Rα-/lox), and global knock-out (IL-4Rα-/-) mice (Fig. 
12 B), and il-4rα exon 8 (absent in IL-4Rα-deficient cells) was quantified by qPCR and 
normalized to il-4rα exon 5 (present in all cells). As expected, only CD4+ Foxp3+ T cells, 
but not CD19+ nor CD4+ Foxp3- cells, from Foxp3cre IL-4Rα-/lox mice had a lower 
exon8/exon5 ratio, when compared to their littermate control (Fig. 12 C). Together, these 
data indicate a knock down, rather than knock-out, of il-4rα specifically on CD4+ Foxp3+ 
Tregs in the Foxp3cre IL-4Rα-/lox mice. 
 
Figure 12. Genotypic characterization of Foxp3Cre-/+ IL-4Rα-/lox mice.  
 (A) Genotyping of Foxp3Cre-/+ IL-4Rα-/lox mice. DNA was extracted from the tail of naïve 
IL-4Rα-/lox, Foxp3cre IL-4Rα-/lox, and IL-4Rα-/- mice and PCR was performed. The Cre 
specific amplicon is 368 bp, loxP is 450 bp (floxed) or 356 bp (wild-type), the wild-type 
IL4-Rα amplicon is 600 bp and the deleted IL-4Rα amplicon is 471 bp. (B) Representative 
flow cytometric analysis of the CD19+, CD4+ Foxp3-, and CD4+ Foxp3+ cell populations 
before and after FACS sorting of fixed-permeabilized cells from spleen and MLN of naïve 
IL-4Rα-/lox, Foxp3cre IL-4Rα-/lox, and IL-4Rα-/- mice. (C) Efficiency of IL-4Rα deletion on 
sorted cells by quantitative real-time PCR. Genomic DNA was extracted from sorted 







































































































deficient cells) was quantified by qPCR and normalized to the quantity of exon 5 (present 
in all cells).  
Results are representative of three independent experiments with 6-8 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 
P < 0.0001 by one-way ANOVA with Bonferroni post-test analysis. 
 
3.1.2.3 Phenotypic evaluation of IL-4Rα deletion on Foxp3+ Treg cells 
Genotypic deletion of il-4rα within CD4+ Foxp3+ Treg cells in Foxp3cre IL-4Rα-/lox 
mice was further confirmed at the protein level by flow cytometry analysis of IL-4Rα 
surface expression on spleen and MLN cells of naïve Foxp3cre IL-4Rα-/lox, their littermate 
control, and global knock-out mice. CD19+ B cells and CD4+ Foxp3- T cells from Foxp3cre 
IL-4Rα-/lox mice and their littermate control had a comparable level of IL-4Rα expression 
in spleen (Fig. 13 A) and MLN (Fig. 13 B). In contrast, IL-4Rα was deleted specifically 
within CD4+ Foxp3+ Treg cell population in spleen (Fig. 13 A) and MLN (Fig. 13 B) of 
males and females Foxp3cre IL-4Rα-/lox mice, when compared to their littermate controls. 
il-4rα gene deletion within the CD4+ Foxp3+ Treg cell population was more efficient in 
males (efficiency of deletion=90.48 ± 5.45%, Fig. 13, C and D) when compared to females 
(efficiency of deletion=39.74 ± 5.776%, Fig. 13, C and D), enabling via the present model 
an assessment of the effect of partial (female) versus quasi-complete (male) impairment of 
IL-4Rα-mediated signaling on CD4+ Foxp3+ Treg cell in Foxp3cre IL-4Rα-/lox mice.  
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Figure 13. Phenotypic characterization of Foxp3Cre-/+ IL-4Rα-/lox mice.  
(A) Flow cytometry analysis of IL-4Rα expression by CD19+ B cells, CD4+ Foxp3- and 
CD4+ Foxp3+ T cell from the spleen of naïve IL-4Rα-/lox, Foxp3cre IL-4Rα-/lox, and IL-4Rα-
/- mice. (B) Flow cytometry analysis of IL-4Rα expression by CD19+ B cells, CD4+ Foxp3- 
and CD4+ Foxp3+ T cell from the MLN of naïve mice. (C) Formula for calculating the 
efficiency of deletion of IL-4Rα. A level of 100% is defined here as the difference between 
the average IL-4Rα GMFI on cells from control mice (IL-4Rα-/lox) and that of the average 
IL-4Rα GMFI on cells from IL-4Rα deficient mice (IL-4Rα-/-). (D) Efficiency of IL-4Rα 
deletion in CD4+ Foxp3+ T cells in the MLN of naïve males and females Foxp3cre IL-4Rα-
/lox mice. 
Results are representative of three independent experiments with 3-9 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 




3.1.2.4 Functional evaluation of  IL-4Rα deletion on Foxp3+ Treg cells 
To assess the functional impairment of IL-4Rα mediated-signaling on CD4+ Foxp3+ 
Treg cell, pooled spleen and MLN cells of naïve Foxp3cre IL-4Rα-/lox mice and their 
littermate control were cultured with 0 or 1 ng rIL-4 for 40 hr and then IL-4Rα surface 
expression was measured by flow cytometry. CD19+ B cells and CD4+ Foxp3- T cells from 
Foxp3cre IL-4Rα-/lox mice and their littermate control had a comparable level of IL-4Rα 
expression after the addition of rIL-4 (Fig. 14 A). In contrast, a proportion of rIL-4 
stimulated CD4+ Foxp3+ Treg cells derived from Foxp3cre IL-4Rα-/lox mice were 
significantly impaired in their ability to upregulate IL-4Rα expression in response to IL-4 
stimulation when compared to IL-4Rα expression by CD4+ Foxp3+ Treg cells derived from 
their littermate control (Fig. 14 A). This observation was substantiated by quantitative 
measurement of the increment of IL-4Rα expression in presence and absence of IL-4. 
CD19+ B cells and CD4+ Foxp3- T cells in Foxp3cre IL-4Rα-/lox mice and their littermate 
had a comparable level of IL-4Rα expression (Figure 14 B). In contrast, the increment of 
IL-4Rα expression by CD4+ Foxp3+ Treg cells derived from Foxp3cre IL-4Rα-/lox mice was 




Figure 14. Functional characterization of Foxp3Cre-/+ IL-4Rα-/lox mice.  
(A) Representative histograms of IL-4Rα expression before and after rIL-4 stimulation. 
Cells pooled from spleen and MLN from naïve IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox mice 
were cultured for 40 hr in medium with 0 or 1 ng/ml of rIL-4. (B) Flow cytometry analysis 
of IL-4Rα expression from (A). 
Results are representative of three independent experiments with 6-8 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05 by two-tailed 
unpaired Student’s t-test. 
 
Collectively, our results reveal that IL-4Rα is specifically deleted on Foxp3+ Treg cells 
in Foxp3cre IL-4Rα-/lox mice either partially (~40% in females) or quasi completely (~90% 
in males), resulting - in both cases - in a significant impairment of IL-4Rα-mediated 


















































































































































































3.1.3 The role of IL-4Rα signaling on Foxp3+ Treg cells under steady-state in vivo 
3.1.3.1 Deletion of IL-4Rα specifically within Foxp3+ Treg population does 
neither alter body weight, organs weight, nor tissue cellularities 
Equipped with the aforementioned murine model, the present thesis first interrogated 
the need for Foxp3+ Treg cells to express IL-4Rα expression under steady state. Naïve 
Foxp3cre IL-4Rα-/lox mice and littermate control, sex and age-matched, were examined for 
the alteration of overall tissue pathologies and tissue cellularities. No aberrant changes in 
body weight (Fig. 15 A), vital organs weight (Fig. 15 B), and organs cellularities (Fig. 15 
C) were noted in young mice (8-10 weeks old).  In-depth analyses were further conducted 
to assess the effect of deletion of IL-4Rα specifically on Foxp3+ Treg population on 
lymphocytes distribution in primary lymphoid organs, secondary lymphoid organs and 
peripheral tissues under steady-state. 
 
 
Figure 15. Deletion of IL-4Rα on Foxp3+ Treg cells does not have a major effect on 
body weight, organs weight, nor organs cellularities in young mice. 
(A) Body weight of naïve IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox males and females mice. (B) 
Organs weight of naïve mice. (C) Total cell number of spleen, liver, lung, MLN, and 
thymus of naïve mice. 
Results are representative of two independent experiments with 7-9 mice/group. Data are 






































































































































3.1.3.2 Deletion of IL-4Rα specifically on Foxp3+ Treg population does not 
alter Tregs or other lymphocyte-compartments in primary lymphoid 
organ 
To interrogate the effect of deletion of IL-4Rα specifically on Foxp3+ Treg population 
on Treg cells compartment and T cell ontogeny in the primary lymphoid organ, thymus 
from naïve Foxp3cre IL-4Rα-/lox mice and their littermate control was collected and checked 
for the Foxp3+ Treg compartment as well as the other T cell subsets by flow cytometry. 
Similar to littermate control, Foxp3cre IL-4Rα-/lox mice displayed normal Foxp3+ Treg 
compartment (Fig. 16, A and B) and normal distribution of double negative (DN), double 
positive (DP), single positive 4 (SP4), and SP8 (Fig. 16, C-E) cells in the thymus. These 
data suggest that deletion of IL-4Rα specifically on Foxp3+ Treg population does not affect 
Treg compartment or T cell ontogeny in the thymus.  
 
Figure 16. Deletion of IL-4Rα on Foxp3+ Treg cells does not alter T cell ontogeny. 
(A) Representative flow cytometry analysis of CD4+ Foxp3+ cells among CD3+ cells from 
the thymus of naïve IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox males and females mice. (B) 
Frequency of CD4+ Foxp3+ T cells from (A). (C) Gating strategy for identifying DN, DP, 
SP4, and SP8 populations in the thymus. (D) Representative flow cytometry analysis of 
DN, DP, SP4, and SP8 populations in the thymus of naïve mice. (E) Frequency of cell 
populations from (D). Results are representative of two independent experiments with 7-9 
mice/group. Data are expressed as mean ± S.E.M. NS, not significant (P > 0.05) by two-






































































































3.1.3.3 Deletion of IL-4Rα specifically on Foxp3+ Treg population does not 
alter Tregs or other lymphocyte-compartments in secondary lymphoid 
organs 
To dissect the effect of deletion of IL-4Rα specifically on CD4+ Foxp3+ Treg 
population on Treg cells compartment and other T cell subsets in the secondary lymphoid 
organs, spleen and MLN from naïve Foxp3cre IL-4Rα-/lox mice and their littermate control 
were collected and checked for Foxp3+ Treg compartment, CD3+, CD4+, as well as CD8+ 
T cells by flow cytometry. Similar to littermate control, Foxp3cre IL-4Rα-/lox mice displayed 
normal Foxp3+ Treg compartment (Fig. 17, A and B) and normal distribution of CD3+ (Fig. 
17, C and D), CD4+ (Fig. 17, C and E), and CD8+ (Fig. 17, C and F) T cells in spleen and 
MLN, suggesting that deletion of IL-4Rα specifically on Foxp3+ Treg population does not 
affect either Treg compartment or other T-cell subsets in secondary lymphoid organs. 
 
Figure 17. Deletion of IL-4Rα on Foxp3+ Treg cells does not alter cells distribution in 
secondary lymphoid organs. 
(A) Representative flow cytometry analysis of CD4+ Foxp3+ cells among CD3+ cells from 
spleen and MLN of naïve IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox males and females mice.  (B) 
Frequency of CD4+ Foxp3+ T cells from (A). (C) Gating strategy for identifying CD3, CD4, 
and CD8 populations in spleen and MLN. (D) Frequency of CD3+, (E) CD3+ CD4+, and 
(F) CD3+ CD8+ cells from organs of mice as in (A). Results are representative of two 
independent experiments with 7-9 mice/group. Data are expressed as mean ± S.E.M. NS, 































































































































































3.1.3.4 Deletion of IL-4Rα specifically on Foxp3+ Treg population does not 
alter Tregs or other lymphocyte-compartments in peripheral tissues 
Next, the present work sought to interrogate the effect of deletion of IL-4Rα on Foxp3+ 
Treg population on Treg cells compartment and other T cell subsets in peripheral tissues. 
To do so, lung and liver from naïve Foxp3cre IL-4Rα-/lox mice and their littermate control 
were collected and checked for Foxp3+ Treg compartment, CD3+, CD4+, as well as CD8+ 
T cells by flow cytometry. Similar to littermate control, Foxp3cre IL-4Rα-/lox mice displayed 
normal Foxp3+ Treg compartment (Fig. 18, A and B) and normal distribution of CD3+ (Fig. 
18 C), CD4+ (Fig. 18 D), and CD8+ (Fig. 18 E) T cells in lung and liver, suggesting that 
deletion of IL-4Rα specifically on Foxp3+ Treg population does not affect either Treg 
compartment or other T-cell subsets in peripheral tissues.  
 
Figure 18. Deletion of IL-4Rα on Foxp3+ Treg cells does not alter cells distribution or 
frequency in peripheral tissues. 
(A) Representative flow cytometry analysis of CD4+ Foxp3+ cells among CD3+ cells from 
lung and liver lymphocytes of naïve IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox males and females 
mice. (B) Frequency of CD4+ Foxp3+ T cells from (A). (C) Frequency of CD3+, (D) CD3+ 
CD4+, and (E) CD3+ CD8+ cells from organs of mice as in (A).  
Results are representative of two independent experiments with 7-9 mice/group. Data are 
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3.1.3.5 Deletion of IL-4Rα specifically on Foxp3+ Treg population does not lead 
to spontaneous inflammatory disorder in young mice 
Mice with a Treg cell-specific deletion of GATA3, a transcription factor closely 
associated with IL-4Rα mediated signaling (Zheng and Flavell, 1997), have been shown to 
develop, at old age, a spontaneous inflammatory disorder with an increased release of 
inflammatory soluble mediators (Wang et al., 2011). To address whether the deletion of IL-
4Rα on Foxp3+ Tregs would also instruct a spontaneous and perhaps more subtle 
inflammatory response in Foxp3cre IL-4Rα-/lox mice, serum levels of soluble inflammatory 
mediators, serum enzymes, cytokine production in liver and gut as well as cytokine 
production by CD4+ T cells were analysed. Serum levels of interleukin IL-4, TNF-α, 
Immunoglobulin E (IgE) (Fig. 19 A), and liver enzyme aspartate transaminase (AST) (Fig. 
19 B) in Foxp3cre IL-4Rα-/lox mice were similar to those of littermate controls. Furthermore, 
naïve young Foxp3cre IL-4Rα-/lox mice had a comparable level of type 1 (IFNγ), type 2 (IL-
4, IL-5, IL-10, IL-13), and type 17 (IL-17) cytokine production in the liver (Fig. 19 C) and 
the gut (Fig. 19 D), when compared to their littermate controls. All CD4+ T cell-derived 
cytokines tested (IFN-γ, IL-4, IL-10, and IL-13) were also similar between Foxp3cre IL-
4Rα-/lox mice and littermate controls (Fig. 19, E and F). 
Together, our findings suggest that no major physical alteration are consequent to the 
impairment of IL-4Rα-mediated signaling within the Foxp3+ T cell compartment in our 
Foxp3cre IL-4Rα-/lox mouse model under steady-state. Moreover, impairment of IL-4Rα-
mediated signaling within the Foxp3+ T cell compartment does neither alter Foxp3+ Treg 
tissue compartments nor result in spontaneous inflammatory disorder in young (6-8 weeks 





Figure 19. Deletion of IL-4Rα on Foxp3+ Treg cells does not result in a spontaneous 
inflammatory response in young mice. 
(A) Serum analysis of naïve IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox mice. (B) Analysis of liver 
function in naïve mice. (C) Liver cytokine production in naïve males and females mice. 
Livers from naïve mice were homogenized and the levels of the indicated cytokines were 
detected by ELISA and normalized to mg of liver tissue. (D) Gut cytokine production in 
naïve mice. Small intestines from naïve mice were homogenized and the levels of the 
indicated cytokines were detected by ELISA and normalized to mg of small intestine tissue. 
(E) Gating strategy for identifying cytokine-producing CD4+ T cells. (F) Frequency of IFN-
γ, IL-4, IL-10, and IL-13-expressing CD4+ T cells. MLN cells from naïve mice were 
restimulated with PMA/Ionomycin in the presence of Monensin, after which CD4+ T cells 
stained intracellularly for indicated cytokines. 
Results are representative of two independent experiments with 7-9 mice/group. Data are 
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3.1.4 The role of IL-4Rα signaling on Foxp3+ Treg cells in vitro 
To further address the molecular basis of Foxp3+ Tregs need to express IL-4Rα 
signaling, the present study assessed the in vitro Foxp3 Treg conversion and/or expansion 
capacity of CD4+ CD25-/CD4+ CD25+ cells from Foxp3cre IL-4Rα-/lox mice, respectively, in 
comparison with CD4+ CD25-/CD4+ CD25+ cells from IL-4Rα-/lox littermate controls. 
 
3.1.4.1 IL-4Rα signaling inhibits Treg conversion in vitro 
CD4+ CD25- T cells were sorted with 99.8 % purity (Fig. 20 A) from naïve Foxp3creIL-
4Rα-/lox mice and their IL-4Rα-/lox littermate controls. Sorted cells were cultured in the 
presence of gradient concentration (0, 1, and 2 ng) of TGF-β1 in combination with T cell 
receptor stimulation using anti-CD3 and anti-CD28 for 72 hr (Fig. 20, B and C), which are 
known to induce conversion from CD25 negative to CD25 positive CD4+ T cells (Fantini 
et al., 2007).  As expected and in line with the previously published reports (Noval Rivas 
et al., 2015; Massoud et al., 2016), CD4+ CD25- T cells converted to CD4+ CD25+ Foxp3+ 
T cells (iTreg cells) with the highest rate of conversion recorded from CD4+ CD25- T cell 
cultures derived from Foxp3cre IL-4Rα-/lox mice (Fig. 20, B and C). This suggests that IL-
4Rα signaling in CD4+ CD25- T cells might interfere with their ability to convert but is 










































































Figure 20. IL-4Rα signaling is dispensable for Foxp3 Treg conversion in vitro. 
(A) Representative flow cytometry analysis of the CD4+ CD25- cell populations before and 
after FACS sorting of pooled cells from spleen and MLN of naïve IL-4Rα-/lox and Foxp3cre 
IL-4Rα-/lox mice. (B) Representative flow cytometry of converted CD4+ CD25+ Foxp3+ 
Treg cells from CD4+ CD25- T cells cultured with gradient concentration of TGFβ for 72 
hr. (C) Frequency of iTreg generated in vitro from (B). 
Results are representative of four independent experiments with 5-7 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001 by 
two-tailed unpaired Student’s t-test. 
 
3.1.4.2 IL-4Rα signaling promotes the survival of CD4+ CD25+ Tregs and 
enhances their Foxp3 expression 
Next, the effect of IL-4 stimulation on Tregs was evaluated. To do so, CD4+ CD25+ T 
cells, sorted from naïve Foxp3cre IL-4Rα-/lox mice and their littermate control (Fig. 21 A), 
were cultured in the presence or absence of rIL-4 for 18 or 36 hr. IL-4 treatment enhanced 
the survival of CD4+ CD25+ T cells from control mice, whereas the survival of CD4+ CD25+ 
T cells from Foxp3cre IL-4Rα-/lox mice remained unaltered (Fig. 21 B). These results suggest 
that IL-4/IL-4Rα signaling promotes CD25+ Treg survival in vitro. Furthermore, IL-4 
treatment of CD4+ CD25+ Treg cells derived from IL-4Rα-/lox mice considerably expanded 
Foxp3+ Treg cells frequency (Fig. 21 C) and Foxp3 expression level (Fig. 21, D and E) in 
response to in vitro stimulation with rIL-4 whereas IL-4 treated CD4+ CD25+ Treg cells 
derived from Foxp3cre IL-4Rα-/lox mice failed to do so.  
Taken together, these data indicate that even though IL-4Rα-mediated signaling 
negatively influences the ability of naive CD4+ CD25- Foxp3- T cells to convert into Foxp3+ 
Tregs, this receptor, later on, promotes the survival and enhances the Foxp3 expression of 





Figure 21. IL-4Rα signaling promotes the survival and enhances Foxp3 expression in 
CD4+ CD25+ T cell. 
(A) Representative flow cytometry analysis of the CD4+ CD25+ cell populations before and 
after FACS sorting of pooled cells from spleen and MLN of naïve IL-4Rα-/lox and Foxp3cre 
IL-4Rα-/lox mice. (B) CD4+ CD25+ T cells survival in presence and absence or rIL-4. Sorted 
CD4+ CD25+ T cells from naïve IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice were cultured for 
18 or 36 hr with 0 or 10 ng/ml rIL-4. (C) Frequency of CD25+ Foxp3+ T cells and (D) 
representative histograms of Foxp3 expression by CD25+ Foxp3+ T cells 36 hr post rIL-4 
stimulation with the mean GMFI values summarized in (E). 
Results are representative of four independent experiments with 5-7 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05), *** P < 0.0001 by two-tailed 














































































































































By using a newly generated mouse model, termed Foxp3cre IL-4Rα-/lox mice, various 
levels of knockdown of IL-4Rα specifically on Foxp3+ Tregs were achieved by using Cre-
loxP technology. The present thesis showed that partial or quasi-complete deletion of IL-
4Rα specifically on Foxp3+ Treg cells does neither alter Foxp3 compartment nor break 
tolerance under steady-state in young mice (8-12 weeks old). Moreover, deletion of IL-4Rα 
specifically on Foxp3+ Tregs did not affect, but rather enhance, the ability of CD4+ CD25- 
cells to convert into CD4+ CD25+ Treg cells in vitro. Interestingly, however, under in vitro 
polarized conditions, i.e. IL-4 conditioned environment, IL-4Rα-mediated signaling on 
Foxp3+ Tregs had a crucial role in enhancing the survival, expanding the Foxp3+ Treg 
population, and potentiating the expression of Treg suppressive marker, Foxp3, in CD4+ 
CD25+ Treg cells. 
 
3.2.1 Foxp3+ Treg cells might need IL-4Rα signaling to potentiate their 
suppressive function 
Micro-environmental cues play a crucial role in determining the fate of Treg cells. 
Foxp3+ Tregs pay close attention to the immune environment and alter their phenotype, 
migration, and function in response to specific cues that they encounter in the periphery. In 
this context, cytokines have been shown to have both phenotypical and functional 
influences on Foxp3+ Tregs (Campbell and Koch, 2011). Even though IL-4 is an important 
anti-inflammatory cytokine, the influence of IL-4/IL-4Rα-mediated signaling on Foxp3+ 
Treg cells suppressive activity is not yet clearly understood. Recently published reports 
have shown that augmentation of IL-4Rα-mediated signaling on Foxp3+ Treg cells leads to 
an impaired suppressive activity of those Treg cells with subsequent re-programming into 
ex-Foxp3 Th2 or Th17 cells (Noval Rivas et al., 2015; Massoud et al., 2016; Pelly et al., 
2017). An elegant study by Noval Rivas and colleagues (2016) showed that gain of function 
mutation in IL4RαF709, single amino acid substitution of tyrosine (Y)709-to-phenylalanine 
(F) in the ITIM motif (Tachdjian et al., 2010), leads to significant reduction and impaired 
suppressive function of allergen-specific Foxp3+ Treg population as a result of their re-
programming, in IL4Rα-dependent manner, towards Th2 cells (ex-Foxp3 Th2 cell) (Noval 
Rivas et al., 2015). Another study from the same group showed that another polymorphism 
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in IL4Rα, single amino acid substitution of glutamine (Q)507-to-arginine (R), known as 
IL4RαQ507R, augments allergic airway inflammation by a mechanism involving the IL-4-
induced conversion of Foxp3+ Treg cells into ex-Foxp3 Th17 cell (Massoud et al., 2016). 
In support, Pelly et al. (2017) has reported recently that chronic Heligmosomoides 
polygyrus infection leads to transdifferentiation of Foxp3+ Treg cells to ex-Foxp3 Th2 
effector cells, in IL-4/IL-4Rα-dependent manner, as an attempt to contribute to the overall 
anti-parasitic Th2 response (Pelly et al., 2017). Although these observations would suggest 
that IL-4Rα signaling might not favour Treg activity, our present analyses revealed that 
Foxp3+ Treg cells have a basal expression level of IL-4Rα under steady-state, pointing at a 
possible requirement for this receptor in Treg biology. Our assumption is in accordance 
with other investigators that have reported the potency of IL-4 to prevent spontaneous 
apoptosis and reduction of Foxp3 expression in the cultures of isolated Tregs (Maerten et 
al., 2005). In fact, IL-4 stimulation of isolated cultures of CD4+ CD25+ Tregs in our study 
recapitulated such a need for IL-4Rα mediated signaling to prevent cell death and to 
maintain/enhance Foxp3 expression indicating a hitherto unappreciated need for IL-4Rα 
mediated signaling in Treg biology and arguing for a positive impact of IL-4/IL-4Rα-
mediating signaling on Foxp3+ Treg cells. Such a case is not uncommon as it has been 
shown that many cytokines can have both positive and negative impact on Treg suppressive 
capacity based on the magnitude of the immune response and the context in which the 
signal is perceived (Campbell and Koch, 2011). For instance, whereas IFN-γ, the principle 
effector cytokine produced by Th1 cells to control intracellular pathogens, can inhibit the 
generation of peripheral Foxp3+ Treg cells from naïve CD4+ T cells (Murphy et al., 1999; 
Caretto et al., 2010), under certain conditions, IFN-γ mediated signaling can induce as well 
the expression of T-bet, through STAT1 activation, within Foxp3+ Treg compartment to 
generate/expand a functionally specialized Treg cells subset, T-bet+ Foxp3+ Treg cells, that 
is responsible for efficient control of Th1 cells (Koch et al., 2009; Levine et al., 2017). 
Another example is IL-6. Although IL-6 can induce the expression of STAT3 within 
Foxp3+ Treg cells to endow them with molecular machineries to regulate Th17 immune 
response (Chaudhry et al., 2009; Campbell and Koch, 2011), IL-6 can as well inhibit TGFβ-
mediated development of peripherally-induced Treg cells (Bettelli et al., 2006; Xu et al., 
2007; Zheng et al., 2008).  In addition to IFN-γ and IL-6, many other cytokines, i.e type I 
IFN, TNF, and IL-1, do have double-edged sword type of effect on Treg cells development 
and activity (Reviewed in Campbell and Koch, 2011). Hence, IL-4Rα-mediated signaling 
could also have a positive and a negative impact on Treg suppressive function. 
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3.2.2 IL-4Rα-mediated signaling on Foxp3+ Treg cells is dispensable in young 
mice to maintain immune homeostasis 
IL-4Rα removal specifically from Foxp3 Treg was achieved by intercrossing well-
established BALB/c murine models; IL-4Rα-/- (Mohrs et al., 1999), IL-4Rα-/lox (Herbert et 
al., 2004), and Foxp3-IRES-Cre (Wing et al., 2008) mice. A murine model, Foxp3cre IL-
4Rα-/lox, was obtained where IL-4Rα was deleted specifically within the Foxp3+ Treg 
compartment in a dosage-dependent manner whereby IL-4Rα was partially deleted in 
females and quasi completely deleted in males. The more efficient Cre-mediated IL-4Rα 
deletion achieved in male when compared with female Foxp3cre IL-4Rα-/lox mice strongly 
fits the phenomenon of random inactivation of the X-chromosome that can take place in 
females (Lyon, 1961). Random inactivation of the X-chromosome is a phenomenon 
whereby the maternally derived X or the paternally derived X-chromosome is randomly 
inactive in the mammalian females (Lyon, 1961; Lyon, 1972). The presence of foxp3 gene 
on the X chromosome and the hemizygosity of Cre gene in our mouse model can, therefore, 
explain the differential efficiency of Cre-mediated il4ra deletion in males and females. Of 
importance, our approach herein described could, therefore, set a precedent for the 
generation of transgenic mouse models with various levels of knockdown of a target gene. 
Of note, minimal difference in the efficiency of Cre-mediated IL-4Rα deletion between 
different organs (i.e. more efficiency in MLN compared to spleen, Fig. 8) was observed. 
Although Cre-loxP system is one of the most powerful tools and one of the most widely 
used genetic approaches to generate genetically engineered mice, Cre-mediated loxP 
deletion efficiency is always a major concern in conditional knock-out mice (Schmidt-
Supprian and Rajewsky, 2007; Sharma and Zhu, 2014). Previous reports have extensively 
demonstrated the differences in recombination efficiency among tissue types (Schmidt-
Supprian and Rajewsky, 2007; Heffner et al., 2012; Liu et al., 2013; Nono et al., 2017b). 
Nevertheless, in our mouse model Foxp3cre IL-4Rα-/lox, a high degree of fidelity was 
achieved in the Cre-mediated targeting of IL-4Rα on Foxp3+ Tregs specifically, as neither 
IL-4Rα expression on B-cells nor that of Foxp3- T cells was affected in our Foxp3cre IL-
4Rα-/lox model.  
Partial or quasi-complete deletion of IL-4Rα from the Foxp3+ Treg population did 
neither affect the Foxp3+ Treg compartment ontogeny in the primary lymphoid organ, 
thymus, nor their recruitment/distribution/maintenance in either the secondary lymphoid 
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organs, MLN and spleen, or the peripheral tissues, lung and liver, under steady state. 
Furthermore, all the T cell subsets, CD3+, CD4+, and CD8+ T cell compartments, were not 
affected in primary and secondary lymphoid organs as well as peripheral tissues, as the 
naïve Foxp3cre IL-4Rα-/lox mice and their littermate controls had a similar frequency of the 
indicated T cell populations. Analyses of serum immune response, liver homogenate, gut 
homogenate and cytokines production by CD4+ T cells showed that either partial or quasi-
complete removal of IL-4Rα specifically from Foxp3+ Treg population did not result in 
spontaneous inflammatory disorder in Foxp3cre IL-4Rα-/lox young mice (8-10 weeks old) 
under steady state. A possible explanation could be that the remnant IL-4Rα+ Foxp3 Tregs 
in our Foxp3cre IL-4Rα-/lox model is sufficient to preserve the Foxp3 Treg compartment and 
thus tolerance during steady state. This is consistent with previous studies that have 
attempted to define the physiological importance of factors expressed by Foxp3+ Treg cells. 
Foxp3 specific GATA3 or T-bet deficient mice were clinically indistinguishable from their 
littermate controls and showed no defect in the function of Foxp3+ Treg under steady-state 
in young mice (Koch et al., 2009; Wohlfert et al., 2011; Yu et al., 2015). In older mice (6 
months upwards), however, the targeting of GATA3 within the Foxp3+ Treg population led 
to spontaneous autoimmunity (Wang et al., 2011). It is therefore feasible that specific 
deletion of IL-4Rα from the Foxp3+ Treg compartment would also lead to apparent 
physiological defects only in old mice but this is still to be addressed experimentally. 
 
3.2.3 IL-4Rα-mediated signaling on Treg cells in vitro 
In vitro, it was noted that the ability of CD4+ CD25- T cells to convert into CD4+ CD25+ 
Treg cells was enhanced in the absence of IL-4Rα-mediated signaling on Foxp3+ Treg cells. 
Our observation is in full accordance with previously published reports as it has been shown 
that gain of function mutation specifically on Foxp3+ Treg cells results in decreased iTreg 
conversion capacity in vivo and in vitro (Noval Rivas et al., 2015; Massoud et al., 2016). 
In contrast, consistent with the literature (Maerten et al., 2005), isolated cultures of CD25+ 
Tregs tightly depend on IL-4Rα-mediated signaling for survival, expansion of Foxp3+ Treg 
population and maintenance/enhancement of Foxp3 expression. Altogether, our in vitro 
data indicated clearly that even though IL-4Rα-mediated signaling negatively influences 
the ability of naive CD4+ CD25- Foxp3- T cells to convert into Foxp3+ Tregs, this receptor, 
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later on, promotes the survival and enhances the Foxp3 expression of CD4+ CD25+ Treg 
cells. 
 
In conclusion, the present study demonstrated that under steady-state IL-4Rα-mediated 
signaling on Foxp3+ Treg cells might not be necessary for Treg compartment 
ontogeny/maintenance/distribution or maintenance of immune homeostasis in vivo or in 
inducible Treg conversion in vitro but definitely crucial under more polarized condition 
(i.e. IL-4 rich environment) for preventing spontaneous apoptosis of CD4+ CD25+ Treg 









Chapter 4:  
The Role of IL-4Rα-mediated 
Signaling on Foxp3+ Treg Cells 




Chapter 4: The role of IL-4Rα-mediated signaling on Foxp3+ Treg cells under 
inflammatory conditions 
4.1 Results 
4.1.1 Foxp3+ Treg cells upregulate IL-4Rα expression upon S. mansoni 
infection 
The inability to unveil the role of a biological molecule (i.e. receptor or transcription 
factor) on Foxp3+ Treg cells under steady state is not uncommon. It has been shown that 
conditional ablation of either Tbx21 (gene-encoding T-bet) or gata3 specifically from 
Foxp3+ Treg cells does not result in any apparent defects in those mice under steady state 
(Koch et al., 2009; Wohlfert et al., 2011; Yu et al., 2015). Interestingly, however, the 
strategy of probing subtle immune impairments, non-apparent during steady state, through 
more inflammatory settings has previously proven to be efficient in unveiling hidden 
immune defects (Koch et al., 2009; Yu et al., 2015). Analysis of IL-4Rα expression on 
Foxp3+ Treg cells in spleen and MLN of 8 weeks (8 wk) Schistosoma mansoni (S. mansoni) 
infected BALB/c mice demonstrated that CD4+ Foxp3+ Treg cells upregulated their IL-4Rα 
expression upon S. mansoni infection when compared to naïve mice (Fig. 22, A-C). The 
strikingly higher expression of IL-4Rα by Foxp3+ Treg cells observed during infection 
warranted us to further address the possible higher need for this receptor by Foxp3+ Tregs 
during inflammatory disease conditions. 
 
Figure 22. Foxp3+ Treg cells upregulate IL-4Rα expression upon infection.  
(A) Gating strategy for identifying CD4+ Foxp3+ Treg cell population.  (B) Representative 
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(gray tinted) mice, naïve (solid line), and S. mansoni infected (dashed line) IL-4Rα-/lox mice 
with the mean of Δ GMFI IL-4Rα (GMFI IL-4Rα-/lox-GMFI IL-4Rα-/-) ± S.E.M 
summarized in (C). Data are from two independent experiments. n= 6-8 mice/group. * P < 
0.05, *** P < 0.0001 by two-tailed unpaired Student’s t-test.  
 
4.1.2 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required to control egg-
driven fibrogranulomatous inflammation during schistosomiasis 
Since, adult S. mansoni worms reside in the portal and mesenteric vasculatures, where 
they copulate and the females start to release eggs that subsequently trapped within the 
hepatic sinusoids and the mesenteric vasculature (Pearce and MacDonald, 2002; Elbaz and 
Esmat, 2013), liver and small intestine of S. mansoni infected Foxp3cre IL-4Rα-/lox and IL-
4Rα-/lox were investigated in depth in order to dissect the role of IL-4Rα-mediated signaling 
on Foxp3+ Treg cells under highly polarized, Th2-dominated, condition. 
 
4.1.2.1 Evaluation of efficiency and specificity of IL-4Rα deletion 
Initially, the present study sought to confirm that IL-4Rα-mediated signaling on 
Foxp3+ Treg cells was impaired during the infection, deletion of IL-4Rα in S. mansoni 
infected (Sm-infected) Foxp3cre IL-4Rα-/lox mice, at the genomic level and at the protein 
level, was evaluated in comparison to their littermate controls, Sm-infected IL-4Rα-/lox, and 
Sm-infected IL-4Rα-/-mice. Partial deletion of il-4rα within the Foxp3+ Treg cell population 
in Sm-infected Foxp3cre IL-4Rα-/lox mice was confirmed at the genomic level by qPCR (Fig. 
23 A), and at the protein level by flow cytometry (Fig. 23 C), where specific deletion of 
IL-4Rα on Foxp3+ Treg cells, more efficient in males when compared to females (Fig. 23 
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Figure 23. Efficiency of IL-4Rα deletion on Foxp3+ Treg cells in S. mansoni infected 
Foxp3cre IL-4Rα-/lox mice. 
IL-4Rα-/lox, Foxp3cre IL-4Rα-/lox, and IL-4Rα-/- mice were infected with S. mansoni cercariae 
and euthanized 8 wk post-infection. (A) Efficiency of IL-4Rα deletion by quantitative real-
time PCR. CD4+ Foxp3+ T cells were sorted 8 wk post-infection from pooled cells of spleen 
and MLN, genomic DNA was extracted, and the ratio of Exon8/Exon 5 was calculated. (B) 
Flow cytometry analysis of IL-4Rα expression by CD19+ B cell and (C) CD4+ Foxp3+ T 
cell in pooled cells from spleen and MLN 8 wk post-infection. 
Results are representative of two independent experiments with 4-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05), *** P < 0.0001 by one-way 
ANOVA with Bonferroni post-test analysis. 
 
4.1.2.2 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required for Treg 
cells accumulation and maintenance/upregulation of suppressive markers 
to suppress overshooting inflammation in the liver during S. mansoni 
infection  
4.1.2.2.1 IL-4Rα-mediated signaling on Foxp3+ Treg cells is crucial for 
Treg accumulation 
Next, the present work sought to investigate the effect of IL-4Rα deletion on Foxp3+ 
Treg cells accumulation in the liver of S. mansoni infected mice. To do so, Foxp3cre IL-
4Rα-/lox and IL-4Rα-/lox mice were infected with 100 S. mansoni cercariae, euthanized 8 wk 
post-infection, and Treg cells accumulation in the liver was assessed. At the transcriptional 
level, the Foxp3 expression level by real-time reverse transcription-PCR (qRT-PCR) 
relative to the expression level of hypoxanthine-guanine phosphoribosyl-transferase 
(HPRT, housekeeping gene) was quantified. The livers of Sm-infected Foxp3cre IL-4Rα-/lox 
mice showed a significant reduction in Foxp3 expression level relative to HPRT when 
compared to the expression level of Foxp3 in the livers of Sm-infected IL-4Rα-/lox mice 
(Fig. 24 A). In support, at the translational level, flow cytometry analysis showed a drastic 
reduction in Foxp3+ Treg cell population in the liver of Sm-infected Foxp3cre IL-4Rα-/lox 
mice (Fig. 24, B and C), indicating that  Foxp3+ Treg cells do require IL-4Rα-mediated 




Figure 24. IL-4Rα mediated signaling on Foxp3+ Treg is required for Treg 
accumulation in the liver during S. mansoni infection. 
(A) qRT-PCR analysis of relative expression of Foxp3 to HPRT in the liver of 8 wk S. 
mansoni infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. (B) Representative flow 
cytometry of CD4+ Foxp3+ T cells from the liver of 8 wk S. mansoni infected mice. (C) 
Frequency of CD4+ Foxp3+ T cells from (B).  
Results are representative of two independent experiments with 8-10 mice/group. Data are 
expressed as mean ± S.E.M. ** P < 0.001 by two-tailed unpaired Student’s t-test. 
 
4.1.2.2.2 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required for 
maintenance/upregulation of suppressive markers 
The present thesis next investigated the role of IL-4Rα-mediate signaling on Foxp3+ 
Treg cell proliferation and expression of suppressive markers in the liver during S. mansoni 
infection. Rigorous analyses of Treg cells profile by flow cytometry demonstrated that 
Foxp3+ Treg cells in the liver of Sm-infected Foxp3cre IL-4Rα-/lox mice had a significant 
reduction in the expression levels of Foxp3 (Fig. 25, A and B), IRF4 (Fig. 25, C and D), 
Helios (Fig. 25, E and F), as well as GATA3 (Fig. 25, G and H) on a per cell basis, when 
compared to their infected littermate controls. In contrast, the expression level of CD25 
(Fig. 25, I and J) as well as the proliferation capacity, as indicated by Ki-67 expression 
level, (Fig. 25, K and L) of Foxp3+ Treg cells in the liver were comparable between Sm-
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IL-4Rα-mediated signaling seems to be necessary for the Foxp3+ Treg cells to maintain 
and/or upregulate the expression of certain Treg suppressive markers (such as IRF4, Helios, 
and GATA3), but not CD25 expression nor Treg proliferation, in vivo during inflammation.  
 
Figure 25. Foxp3+ Treg cell profile in the liver of S. mansoni infected IL-4Rα-/Lox and 
Foxp3Cre IL-4Rα-/Lox mice. 
Foxp3+ Treg cells from the liver of IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice were analyzed 
8 wk post S. mansoni infection for the expression of Treg suppresive and proliferation 
markers. (A) Representative histogram of Foxp3 expression by CD4+ Foxp3+ T cells. (B) 
Foxp3 GMFI in CD4+ Foxp3+ T cells from (A). (C) Representative histogram of IRF4 
expression by CD4+ Foxp3+ T cells. (D) IRF4 GMFI in CD4+ Foxp3+ T cells from (C). (E) 
Representative histogram of Helios expression by CD4+ Foxp3+ T cells. (F) Helios GMFI 
in CD4+ Foxp3+ T cells from (E). (G) Representative histogram of GATA3 expression by 
CD4+ Foxp3+ T cells. (H) GATA3 GMFI in CD4+ Foxp3+ T cells from (G). (I) 
Representative histogram of CD25 expression by CD4+ Foxp3+ T cells. (J) CD25 GMFI in 
CD4+ Foxp3+ T cells from (I). (K) Representative histogram of Ki-67 expression by CD4+ 
Foxp3+ T cells. (L) Ki-67 GMFI in CD4+ Foxp3+ T cells from (K). 
Results are representative of two independent experiments with 8-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 
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4.1.2.2.3 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required to 
control cytokines production 
Given the drastic reduction in the Foxp3+ Treg population and the significant drop in 
their expression level of certain Treg suppressive markers, in the liver of Sm-infected 
Foxp3cre IL-4Rα-/lox mice, we, therefore, asked whether such effect will have a consequence 
on the cytokines production in the Sm-diseased livers. To address that, livers of Sm-infected 
Foxp3cre IL-4Rα-/lox mice and their littermate controls were collected 8 wk post-infection, 
homogenized, and level of cytokines was evaluated by ELISA. Deletion of IL-4Rα on 
Foxp3+ Treg cells resulted in a cytokine storm, including Type 1 (IFNγ), Type 17 (IL-17), 
and Type 2 (IL-4, IL-5, IL-10, IL-13) cytokines, in the liver of both male and female of 
Sm-infected Foxp3cre IL-4Rα-/lox mice (Fig. 26), when compared to their littermate control. 
Of note, cytokine production was more pronounced in the females Sm-infected Foxp3cre 
IL-4Rα-/lox mice than the males. Altogether, these data indicate that Foxp3+ Treg cells do 
require IL-4/IL-4Rα-mediated signaling to accumulate in the liver tissue and to 
maintain/enhance their suppressive marker in order to suppress overshooting cytokines-
mediated inflammation during S. mansoni infection.  
 
Figure 26. Deletion of IL-4Rα on Foxp3+ Treg cells results in heightened cytokine 
production in the liver during S. mansoni infection.  
Liver cytokine production 8 wk post-infection of IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. 
Livers from infected mice were homogenized and the levels of the indicated cytokines were 
detected by ELISA and normalized to mg of liver tissue. 
Results are representative of two independent experiments with 8-10 mice/group. Data are 
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4.1.2.3 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required for Treg 
cells maintenance/upregulation of suppressive markers to control T cell 
proliferation and effector functions in the hLN during S. mansoni infection  
4.1.2.3.1 Deletion of IL-4Rα on Foxp3+ Treg cells impairs their ability to 
maintain/upregulate the expression of Treg suppressive markers 
The analyses of the hepatic lymph nodes (hLN) supported our observations in the liver. 
Even though, the frequency of Foxp3+ Treg cells (Fig. 27, A and B) within the hLN of 8 
wk Sm-infected Foxp3cre IL-4Rα-/lox mice were slightly declined compared to the littermate 
controls, Foxp3 (Fig. 27, C and D) and IRF4 (Fig. 27, E and F) expression level on a per-
cell basis were however dramatically reduced in Foxp3+ Treg cells in the hLN of Sm-
infected Foxp3cre IL-4Rα-/lox mice, when compared to infected littermate controls. Foxp3+ 
Treg cells in the hLN of Sm-infected Foxp3cre IL-4Rα-/lox and IL-4Rα-/lox mice had similar 
expression level of Helios (Fig. 27, G and H) and GATA3 (Fig. 27, I and J). Deletion of 
IL-4Rα on Foxp3+ Treg cells resulted in a modest reduction in their proliferation in the 
hLN during S. mansoni infection (Fig. 27, K and L). Together, these findings suggest that 
Foxp3+ Treg cells do require IL-4Rα signaling to potentiate the expression of suppressive 
factors, in particular, Foxp3 and IRF4, but neither Helios expression nor GATA3 







Figure 27. Foxp3+ Treg cell profile in the hLN of S. mansoni infected IL-4Rα-/Lox and 
Foxp3Cre IL-4Rα-/Lox mice. 
Foxp3+ Treg cells from the hLN of IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice were analyzed 
8 wk post S. mansoni infection for the expression of Treg suppressive and proliferation 
markers. (A) Representative flow cytometry of CD4+ Foxp3+ T cells. (B) Frequency of 
CD4+ Foxp3+ T cells from (A). (C) Representative histogram of Foxp3 expression by CD4+ 
Foxp3+ T cells. (D) Foxp3 GMFI in CD4+ Foxp3+ T cells from (C). (E) Representative 
histogram of IRF4 expression by CD4+ Foxp3+ T cells. (F) IRF4 GMFI in CD4+ Foxp3+ T 
cells from (E). (G) Representative histogram of Helios expression by CD4+ Foxp3+ T cells. 
(H) Helios GMFI in CD4+ Foxp3+ T cells from (G). (I) Representative histogram of 
GATA3 expression by CD4+ Foxp3+ T cells. (J) GATA3 GMFI in CD4+ Foxp3+ T cells 
from (I). (K) Representative flow cytometry of Ki-67 expression by CD4+ Foxp3+ T cells. 
(L) Frequency of CD4+ Foxp3- Ki-67+ T cells from (K). 
Results are representative of two independent experiments with 8-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 
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4.1.2.3.2  IL-4Rα-mediated signaling on Foxp3+ Treg cells is required to 
control T cell proliferation and effector function 
Since it has been shown that Foxp3 expression within the Foxp3+ Treg compartment 
can be used as one of the quality control indictors of Foxp3+ Treg cell suppressive capacity 
potential and hence, its attenuation might abolish their ability to control the immune 
response (Wan and Flavell, 2007; Williams and Rudensky, 2007), the present study 
investigated the effect of the reduction of Foxp3 expression on Foxp3+ Treg compartment, 
upon IL-4Rα deletion, on the CD4+ Foxp3- T cell proliferation in the hLN during S. 
mansoni infection. It was noted that CD4+ Foxp3- T cell in Sm-infected Foxp3cre IL-4Rα-
/lox mice had a higher proliferation capacity when compared to CD4+ Foxp3- T cell 
proliferation in Sm-infected IL-4Rα-/lox mice (Fig. 29, A and B). This data arguing that 
Foxp3+ Treg cells do require IL-4Rα signaling to control T cell proliferation in vivo under 
inflammatory condition.  
Because schistosomiasis is a Th2-dominated disease (Pearce and MacDonald, 2002) 
and deletion of IL-4Rα specifically on Foxp3+ Treg compartment led to a significant 
reduction in the expression level of IRF4, the transcription factor essential for the 
development of Th2 (Lohoff et al., 2002; Rengarajan et al., 2002) and crucial for Foxp3+ 
Treg cells to endow themselves with the molecular machinery required to control Th2 
immune response (Zheng et al., 2009), the present study therefore questioned whether the 
reduction of IRF4 expression on Foxp3+ Treg compartment in the hLN of Sm-infected 
Foxp3cre IL-4Rα-/lox mice will lead to heightened Th2 immune response. To address this, 
the present study investigated the expression level of GATA3 by CD4+ T cells and the type 
2 cytokines (IL-4 and IL-13) production by CD4+ GATA3+ T cells (Fig. 28). Consistently, 
a significant increase in the CD4+ GATA3+ T cells was noted in the hLN of Sm-infected 
Foxp3cre IL-4Rα-/lox mice, when compared to Sm-infected IL-4Rα-/lox mice (Fig. 29, C and 
D). In line with that, CD4+ GATA3+ T cells in the hLN of Sm-infected Foxp3cre IL-4Rα-/lox 
mice showed a significant increase in intracellular type 2 cytokines (IL-4 and IL-13, Fig. 
30 A).  
To further appraise the likelihood of cytokine production by newly formed ex-Foxp3+ 
T cells dually expressing GATA3, Foxp3, and releasing cytokines following deletion of IL-
4Rα (Noval Rivas et al., 2015; Massoud et al., 2016; Pelly et al., 2017), the source of the 
produced cytokines during S. mansoni infection was traced back by co-staining of 
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intracellular cytokines and Foxp3 in CD4+ T cells. It was noted that CD4+ Foxp3+ T cells 
did not produce more cytokines in the hLN of Sm-infected Foxp3cre IL-4Rα-/lox mice (Fig. 
30, B), ruling out their role in the heightened cytokine production observed in Sm-infected 
Foxp3cre IL-4Rα-/lox mice, but in contrast CD4+ GATA3+ T cells were the major producers 
of the upregulated cytokines observed in the hLN of Sm-infected Foxp3cre IL-4Rα-/lox mice 
(Fig. 30, A and B). Collectively, the present study concludes that the heightened immune 
response observed due to impairment of IL-4Rα-mediated signaling within the Foxp3+ T 
cell compartment in Sm-infected Foxp3cre IL-4Rα-/lox mice is driven, at least in part, by 
CD4+ GATA3+ Foxp3- but not Foxp3+ T-cells. 
 
Figure 28. Gating strategies. 
(A) Transcription factors-expressing CD4+ T cells. (B) Cytokine-producing CD4+ GATA3+ and 


















































































Figure 29. IL-4Rα mediated signaling on Foxp3+ Treg is required for controlling T cell 
proliferation and GATA3 expression in hLN during S. mansoni infection. 
(A) Representative flow cytometry of CD4+ Ki-67+ cells within CD4+ Foxp3- T cell 
population in hLN of 8 wk S. mansoni infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. 
(B) Frequency of CD4+ Foxp3- Ki-67+ cells from (A). (C) Representative flow cytometry 
of CD4+ GATA3+ T cells within CD4+ T cell population in hLN 8 wk post-infection. (D) 
Frequency of CD4+ GATA3+ T cells from (C). Results are representative of two 
independent experiments with 8-10 mice/group. Data are expressed as mean ± S.E.M. * P 
< 0.05, ** P < 0.001 by two-tailed unpaired Student’s t-test. 
 
Figure 30. Deletion of IL-4Rα on Foxp3+ Treg cells results in heightened Th2 cytokine 
production by CD4+ GATA3+ but not CD4+ Foxp3+ T cells in the hLN during S. 
mansoni infection. 
hLN of 8 wk S. mansoni infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice were stimulated 
with PMA/Ionomycin in the presence of Monensin and intracellular cytokines were 
measured by flow cytometry. (A) Frequency of cytokine-producing CD4+ GATA3+ T cells. 
(B) Frequency of cytokine-producing CD4+ Foxp3+ T cells. Results are representative of 
two independent experiments with 8-10 mice/group. Data are expressed as mean ± S.E.M. 
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4.1.2.4 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required for Treg 
accumulation in the gut during S. mansoni infection 
Since the second major site of parasitism during S. mansoni infection is the mesenteric 
vasculature (Pearce and MacDonald, 2002; Elbaz and Esmat, 2013), the present study 
sought to address the effect of IL-4Rα deletion on Foxp3+ Treg cells recruitment in the 
small intestine during S. mansoni infection. To do so, Foxp3+ Treg population in the small 
intestine of 8 wk Sm-infected Foxp3cre IL-4Rα-/lox and IL-4Rα-/lox mice was examined. 
Deletion of IL-4Rα specifically on Foxp3+ Treg cells impaired their infiltration to the gut 
during S. mansoni infection (Fig. 31, A and B). Thus, and consistent with the liver data, IL-
4Rα-mediated signaling on Foxp3+ Treg cells is crucial for their infiltration in the inflamed 




Figure 31. IL-4Rα mediated signaling on Foxp3+ Treg is required for Treg 
accumulation in the gut during S. mansoni infection. 
(A) Representative flow cytometry of CD4+ Foxp3+ T cells from the gut of 8 wk S. mansoni 
infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. (B) Frequency of CD4+ Foxp3+ T cells 
from (A).  
Results are representative of two independent experiments with 8-10 mice/group. Data are 
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4.1.2.5 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required for the 
maintenance/upregulation of Foxp3 expression in Tregs and the control of 
T cell proliferation and effector function in the MLN during S. mansoni 
infection 
4.1.2.5.1 Deletion of IL-4Rα on Foxp3+ Treg cells impairs their ability to 
maintain Foxp3 expression 
Next, the present thesis sought to dissect the effect of IL-4Rα deletion on Foxp3+ Treg 
cells on the expression level of suppressive markers and the proliferation capacity in the 
MLN during S. mansoni infection. To address this, MLN of 8 wk Sm-infected Foxp3cre IL-
4Rα-/lox and IL-4Rα-/lox mice were collected and Foxp3+ Treg cells profile was investigated 
by flow cytometry. Although, the frequency of Foxp3+ Treg cells (Fig. 32, A and B) within 
the MLN of Sm-infected Foxp3cre IL-4Rα-/lox mice were similar to the littermate controls, 
Foxp3 expression level on a per-cell basis (Fig. 32, C and D) were however drastically 
reduced in Foxp3+ Treg cells in the MLN of Sm-infected Foxp3cre IL-4Rα-/lox mice, when 
compared to the infected littermate controls. In contrast, the expression level of IRF4 (32, 
E and F), Helios (Fig. 32, G and H), GATA3 (Fig. 32, I and J), and CD25 (Fig. 32, K and 
L) of Foxp3+ Treg cells in the MLN of Sm-infected Foxp3cre IL-4Rα-/lox controls were not 
affected, when compared to their infected littermate controls. Deletion of IL-4Rα on 
Foxp3+ Treg cells resulted in a reduction in their proliferation in the MLN during S. 
mansoni infection (Fig. 32, M and N).  
Together, these findings suggest that Foxp3+ Treg cells do require IL-4Rα signaling to 
potentiate the expression of a suppressive factor, in particular, Foxp3, but neither IRF4 
expression, Helios expression, GATA3 expression, nor CD25 expression, as well as to 





Figure 32. Foxp3+ Treg cell profile in the MLN of S. mansoni infected IL-4Rα-/Lox and 
Foxp3Cre IL-4Rα-/Lox mice. 
Foxp3+ Treg cells from the MLN of IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice were analyzed 
8 wk post S. mansoni infection for the expression of Treg suppresive and proliferation 
markers. (A) Representative flow cytometry of CD4+ Foxp3+ T cells. (B) Frequency of 
CD4+ Foxp3+ T cells from (A). (C) Representative histogram of Foxp3 expression by CD4+ 
Foxp3+ T cells. (D) Foxp3 GMFI in CD4+ Foxp3+ T cells from (C). (E) Representative 
histogram of IRF4 expression by CD4+ Foxp3+ T cells. (F) IRF4 GMFI in CD4+ Foxp3+ T 
cells from (E). (G) Representative histogram of Helios expression by CD4+ Foxp3+ T cells. 
(H) Helios GMFI in CD4+ Foxp3+ T cells from (G). (I) Representative histogram of 
GATA3 expression by CD4+ Foxp3+ T cells. (J) GATA3 GMFI in CD4+ Foxp3+ T cells 
from (I). (K) Representative histogram of CD25 expression by CD4+ Foxp3+ T cells. (L) 
CD25 GMFI in CD4+ Foxp3- Ki-67+ T cells from (K). (M) Representative flow cytometry 
of Ki-67 expression by CD4+ Foxp3+ T cells. (N) Frequency of CD4+ Foxp3- Ki-67+ T cells 
from (M). 
Results are representative of two independent experiments with 6-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 
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4.1.2.5.2 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required to 
control T cell proliferation and effector function 
The analyses within the MLN supported our previous observations in the hLN of Sm-
infected Foxp3cre IL-4Rα-/lox mice. Reduced suppressive capacity potential of Foxp3+ Treg 
cells, as indicated by the significant reduction of Foxp3 expression (Fig. 31, C and D), was 
combined with increased frequency of proliferating (CD4+ Foxp3- ki67+; Fig. 33, A and B) 
and effector (CD4+ CD44+; Fig. 33, C and D) T cells within the MLN of Sm-infected 
Foxp3cre IL-4Rα-/lox mice. To examine the effect of the uncontrolled T cell proliferation and 
effector function on cytokines production, cytokine production in the supernatant of SEA-
stimulated MLN cells from Sm-infected Foxp3cre IL-4Rα-/lox mice and their infected 
littermate controls was assessed by using ELISA. SEA-stimulated MLN cells from Sm-
infected Foxp3cre IL-4Rα-/lox mice showed a significant increase in IL-4, IL-5, and IL-10, 
amid a reduction of IFN-γ production (Fig. 33 E). In support, ex vivo stimulation of MLN 
cells with a cocktail of PMA/Ionomycin/Monensin and subsequent intracellular FACS 
analyses, induced a significant increase in IL-4, IL-10 and IL-13 production by CD4+ T 
cells from Sm-infected Foxp3cre IL-4Rα-/lox mice, when compared to infected littermate 
controls (Fig. 33 F). Together, these findings strongly suggest that the impairment of IL-
4/IL-4Rα-mediated signaling within the Foxp3+ T cell compartment impair Treg ability to 
upregulate suppressive factors, culminating into a heightened immune activation. 
The present study next questioned the nature of the heightened immune response 
observed during inflammation in Foxp3cre IL-4Rα-/lox mice. To do so, MLN cells from Sm-
infected Foxp3cre IL-4Rα-/lox mice and littermate controls were probed for CD4+ T cell 
expressing GATA3, as a marker of Th2 responses (Zheng and Flavell, 1997), T-bet as a 
marker of Th1 responses (Szabo et al., 2000), RORγt, as a marker of Th17 responses 
(Ivanov et al., 2006), and Bcl-6 as a marker of T follicular responses (Nurieva et al., 2009; 
Yu et al., 2009). Consistent with the Th2 hegemony that is characteristic of S. mansoni 
infection (Pearce and MacDonald, 2002) and our hLN data, MLN CD4+ T cells from Sm-
infected Foxp3cre IL-4Rα-/lox mice over-expressed GATA3 (Fig. 34), however, all other T 
cell polarization markers remained unaltered compared to littermate control (Fig. 34 and 
Fig. 28). Of importance, and consistently, CD4+ GATA3+ cells from Sm-infected Foxp3cre 
IL-4Rα-/lox mice produced more IL-4, IL-10, and IL-13 compared to littermate controls (Fig. 
35 A and Fig. 28). Together, these suggest that CD4+ GATA3+ responses likely drive the 
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heightened immune response and the cytokine storm observed in Foxp3cre IL-4Rα-/lox mice 
during inflammation. Nevertheless, with the recent description of ex-Foxp3 T cells (Noval 
Rivas et al., 2015; Massoud et al., 2016; Pelly et al., 2017), this observation could be 
confounded by the likelihood of cytokine production by newly formed ex-Foxp3+ T cells 
dually expressing GATA3, Foxp3, and releasing cytokines following deletion of IL-4Rα. 
To examine that, the source of the produced cytokines during S. mansoni infection was 
traced back by co-staining of intracellular cytokines and Foxp3 in CD4+ T cells. It was 
observed that CD4+ Foxp3+ T cells did not produce more cytokines in the MLN of Sm-
infected Foxp3cre IL-4Rα-/lox mice (Fig. 35 B and; Fig. 28), ruling out a role for Foxp3+ T 
cells in the heightened cytokine production observed in Sm-infected Foxp3cre IL-4Rα-/lox 
mice. Collectively, the present study concludes that the heightened immune response 
observed due to impairment of IL-4Rα-mediated signaling within the Foxp3+ T cell 
compartment in Sm-infected Foxp3cre IL-4Rα-/lox mice is driven, at least in part, by CD4+ 





Figure 33. IL-4Rα mediated signaling on Foxp3+ Treg is required for controlling T cell 
proliferation and effector function in MLN during S. mansoni infection. 
(A) Representative flow cytometry of CD4+ Ki-67+ cells within CD4+ Foxp3- T cell 
population in MLN of 8 wk S. mansoni infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. 
(B) Frequency of CD4+ Foxp3- Ki-67+ cells from (A). (C) Representative flow cytometry 
of CD3+ CD4+ CD44+ effector T cells within CD4+ Foxp3- T cell population in MLN 8 wk 
post-infection. (D) Frequency of CD3+ CD4+ CD44+ effector T cells from (C). (E) Cytokine 
release detected by ELISA in the supernatant of SEA stimulated MLN cells of 8 wk S. 
mansoni infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. (F) Frequency of cytokine-
producing CD3+ CD4+ T cells from MLN of 8 wk S. mansoni infected mice. MLN of 
infected mice was stimulated with PMA/Ionomycin in the presence of Monensin and 
intracellular cytokines were measured by flow cytometry.  
Results are representative of two independent experiments with 8-10 mice/group. Data are 
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Figure 34. Deletion of IL-4Rα on Foxp3+ Treg cells results in heightened CD4+ 
GATA3+ T cells in the MLN during S. mansoni infection. 
Frequency of indicated transcription factors-expressing CD4+ T cells in the MLN of 8 wk 
S. mansoni infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. 
Results are representative of two independent experiments with 6-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); ** P < 0.001 by two-tailed 
unpaired Student’s t-test. 
 
 
Figure 35. Deletion of IL-4Rα on Foxp3+ Treg cells results in heightened Th2 cytokine 
production by CD4+ GATA3+ but not CD4+ Foxp3+ T cells in the MLN during S. 
mansoni infection. 
MLN of 8 wk S. mansoni infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice were stimulated 
with PMA/Ionomycin in the presence of Monensin and intracellular cytokines were 
measured by flow cytometry. (A) Frequency of cytokine-producing CD4+ GATA3+ T cells. 
(B) Frequency of cytokine-producing CD4+ Foxp3+ T cells. 
Results are representative of two independent experiments with 8-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001 by 
two-tailed unpaired Student’s t-test. 


































































































































4.1.2.6 Deletion of IL-4Rα on Foxp3+ Treg cells impairs their ability to control 
egg-driven fibrogranulomatous inflammation during S. mansoni infection 
To further appraise the consequences of the heightened immune responses observed in 
diseased Sm-infected Foxp3cre IL-4Rα-/lox mice, egg-driven fibro-granulomatous 
inflammation, as well as Foxp3+ Treg cells infiltration in the liver of Sm-infected Foxp3cre 
IL-4Rα-/lox mice, were microscopically assessed in comparison to that of Sm-infected 
littermate controls. It was noted that S. mansoni infection resulted in enlarged egg-driven 
granulomas in the liver of Foxp3cre IL-4Rα-/lox mice when compared to granulomas in the 
liver of their littermate control (Fig. 36, A and B). In agreement with this observation, the 
average number of Foxp3+ Treg cells within egg-driven granulomas in Foxp3cre IL-4Rα-/lox 
mice was significantly reduced when compared with the amount of Foxp3+ Tregs recruited 
to the liver of littermate controls (Fig. 36, C and D). Furthermore, collagen levels, attesting 
the degree of tissue fibrosis, were considerably higher in the livers of Sm-infected Foxp3cre 
IL-4Rα-/lox mice when compared to the levels reported in Sm-infected littermate controls 
(Fig. 36 E). Indeed, colorimetric measurement of 4-hydroxyproline, a direct product of acid 
hydrolysis of collagen, confirmed our observed increased level of collagen in the liver of 
Sm-infected Foxp3cre IL-4Rα-/lox mice (Fig. 36 F). In fact, with similar egg burdens in the 
guts and livers of Foxp3cre IL-4Rα-/lox mice and their littermate control (Fig. 36 G), Sm-
infected Foxp3cre IL-4Rα-/lox mice still displayed much larger coalescing granulomas (Fig. 
36 H) as indicated by hematoxylin and eosin (H&E) (Fig. 36 A) and chromotrope aniline 
blue (CAB) staining (Fig. 36 E). Similar to the liver, gut tissues of Sm-infected Foxp3cre 
IL-4Rα-/lox mice revealed elevated levels of cellular recruitment around trapped parasite 
eggs (Fig. 36 I), that associated with a more pronounced deposition of collagen (Fig. 36 J), 
as confirmed by gut hydroxyproline content (Fig. 36 K) indicating a heightened fibro-
granulomatous inflammation around Sm-trapped eggs in Foxp3cre IL-4Rα-/lox mice when 
compared to littermate controls.  
Taken together, these observations indicate that the impairment of IL-4Rα-mediated 
signaling within the Foxp3+ Treg cells compartment during experimental schistosomiasis 
drives a poor accumulation of Foxp3+ T cells in the inflamed tissues and consequently 
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Figure 36. Deletion of IL-4Rα on Foxp3+ Treg cells impairs the control of fibro-
granulomatous inflammation in the liver during experimental S. mansoni infection. 
(A) Representative H&E staining of liver sections from 8 wk S. mansoni infected IL-4Rα-
/lox and Foxp3Cre IL-4Rα-/lox mice (original magnification 100X). (B) Liver granuloma size. 
Granuloma size was determined from (A) by using a computerized morphometric analysis 
program (NIS elements by NIKON) by measuring 100 granulomas/group. (C) 
Representative Foxp3 Tregs infiltration within liver granuloma 8 wk post S. mansoni 
infection (original magnification 100X) of IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. Thin 
arrows point to Foxp3+ cells. (D) Quantification of the number of Foxp3+ cells per each 
granuloma from (C). (E) Representative CAB-stained liver sections from S. mansoni 
infected mice (original magnification 40X). (F) Liver hydroxyproline content measured by 
colorimetry 8 wk post-infection. (G) Liver and gut egg burden 8 wk post-infection. (H) Bar 
graphs showing the number of coalescent granulomas. (I) Representative H&E staining of 
gut sections from 8 wk S. mansoni infected mice (original magnification 100X). (J) 
Representative CAB-stained gut sections 8 wk post-infection (original magnification 
200X). (K) Gut hydroxyproline content 8 wk post-infection.  
Results are representative of two independent experiments with 8-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 
P < 0.0001 by two-tailed unpaired Student’s t-test. 
 
Because Cre expression can generate a phenotype of its own (Loonstra et al., 2001; 
Pomplun et al., 2007; Schmidt-Supprian and Rajewsky, 2007; Huh et al., 2010; Heffner et 
al., 2012; Qureshi et al., 2014; Carow et al., 2016), the present study sought to address 
whether the uncontrolled immune responses and the exaggerated fibrogranulomatous 
inflammation noted in the S. mansoni-infected Foxp3cre IL-4Rα-/lox mice were due to the 
deletion of IL-4Rα specifically on the Foxp3+ Treg cells or that was artefact effects from 
the Cre transgene alone. To test that, IL-4Rα+/+ and Foxp3cre IL-4Rα+/+ mice were infected 
with 100 S. mansoni cercariae and then Foxp3+ Treg compartments and fibrogranulomatous 
inflammation were investigated 8 wk post-infection. IL-4Rα expression on either CD19+ B 
cells or Foxp3+ Treg compartment (Fig. 37 A) in Sm-infected Foxp3cre IL-4Rα+/+ mice was 
similar to their littermate controls. Furthermore, in liver, frequency of Foxp3+ Treg 
population (Fig. 37, B and C) and level of Foxp3 (Fig. 37, D and E) as well as GATA3 
(Fig. 37, F and G) expression within the Foxp3+ Treg compartment in Sm-infected Foxp3cre 
IL-4Rα+/+ mice were similar/slightly affected compared to their infected littermate controls. 
The similar frequency of Foxp3+ Treg population (Fig. 37, H and I), as well as the 
comparable level of Foxp3 expression (Fig. 37, J and K) were also noted in the MLN of 
Sm-diseased mice. In fact, Cre transgene expression in Foxp3cre IL-4Rα+/+ mice did neither 
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lead to expansion of CD4+ GATA3+ T cell population (Fig. 37 L) nor uncontrolled Type 1 
(IFNγ), Type 17 (IL-17), or Type 2 (IL-4, IL-5, IL-10, IL-13) cytokine production (Fig. 37 
M). Thus, these data indicate that Cre-expression in our mouse model does not have any 
influences on either Foxp3+ Treg compartment, their expression of the suppressive marker, 
or immune response-driven by the infection. In agreement of these observations, Cre 
expression did not affect either liver granuloma size (Fig. 38, A and B) or hepatic fibrosis 
as indicated by CAB staining (Fig. 38 C) and colourimetric measurement of 4-
hydroxyproline (Fig. 38 D). Similar to the liver, gut tissues of Sm-infected Foxp3cre IL-
4Rα+/+ mice had a comparable granuloma size (Fig. 38 E), similar collagen deposition (Fig. 
38 F), as well as similar level of 4-hydroxyproline content (Fig. 38 G), when compared to 
their infected littermate controls. 
Taken together, Cre transgene, in our mouse model, does not have effects on either 
the immune response or tissue inflammation but rather the specific deletion of IL-4Rα on 
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Figure 37. Cre expression does neither alter Foxp3+ Treg phenotype nor infection-
driven immune responses during experimental schistosomiasis. 
IL-4Rα+/+ and Foxp3Cre IL-4Rα+/+ mice were infected with 100 S. mansoni cercariae, 
euthanized 8 weeks after, and Foxp3+ Treg compartment was analysed in liver and MLN. 
(A) Flow cytometry analysis of IL-4Rα expression by CD19+ B cell and CD4+ Foxp3+ T 
cell in pooled spleen and MLN cells 8 wk post-infection. (B) Representative flow 
cytometry of CD4+ Foxp3+ T cells in the liver. (C) Frequency of CD4+ Foxp3+ T cells from 
(A). (D) Representative histogram of Foxp3 expression by CD4+ Foxp3+ T cells in the liver. 
(E) Foxp3 GMFI in CD4+ Foxp3+ T cells from (D). (F) Representative histogram of 
GATA-3 expression by CD4+ Foxp3+ T cells in the liver 8 wk post-infection with the mean 
values summarized in (G). (H) Representative flow cytometry of CD4+ Foxp3+ T cells in 
the MLN. (I) Frequency of CD4+ Foxp3+ T cells from (H). (J) Representative histogram 
of Foxp3 expression by CD4+ Foxp3+ T cells in MLN. (K) Foxp3 GMFI in CD4+ Foxp3+ 
T cells from (J). (L) Frequency of CD4+ GATA3+ T cells in MLN 8 wk post-infection. (M) 
Liver cytokine production 8 wk post-infection. Livers from infected mice were 
homogenized and the levels of the indicated cytokines were detected by ELISA and 
normalized to mg of liver tissue.  
Results are representative of two independent experiments with 6-8 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 




Figure 38. Cre expression does not induce exaggerated fibrogranulomatous 
inflammation during experimental S. mansoni infection.  
A) Representative H&E staining of liver sections from 8 wk S. mansoni infected IL-4Rα+/+ 
and Foxp3Cre IL-4Rα+/+ mice (original magnification 100X). (B) Liver granuloma size. 
Granuloma size was determined from (A) by using a computerized morphometric analysis 
program (NIS elements by NIKON) by measuring 100 granulomas/group. (C) 
Representative CAB-stained liver sections from S. mansoni infected mice (original 
magnification 100X). (D) Liver hydroxyproline content measured by colorimetry 8 wk 
post-infection. (E) Representative H&E staining of gut sections from 8 wk S. mansoni 
infected mice (original magnification 100X). (F) Representative CAB-stained gut sections 
8 wk post-infection (original magnification 100X). (G) Gut hydroxyproline content 8 wk 
post-infection.  
Results are representative of two independent experiments with 6-8 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 
P < 0.0001 by two-tailed unpaired Student’s t-test. 


























































































































4.1.2.7 Humoral immune response in Foxp3cre IL-4Rα-/lox mice S. mansoni 
infection 
Since it has been previously shown that Treg cells play a crucial role in the control of 
humoral immunity (Chung et al., 2011; Linterman et al., 2011; Wing and Sakaguchi, 2014), 
the present study questioned whether the deletion of IL-4Rα specifically on Foxp3+ Treg 
cells might have any impact on the humoral immune response during S. mansoni infection. 
To address that, blood from 8 wk S. mansoni infected Foxp3cre IL-4Rα-/lox and IL-4Rα-/lox 
mice were collected, serum separated and, the humoral immune response was investigated. 
It was noted that despite a maintained level of total IgE (Fig. 39 A) and SEA-specific IgG2b 
( Fig. 39 D), a slight increase in SEA-specific IgG1 (Fig. 39 B) and a reduction in SEA-
specific IgG2a (Fig. 39 C), were noted in the serum of Sm-infected Foxp3cre IL-4Rα-/lox 
mice, when compared to their infected littermate controls, suggesting that IL-4Rα-mediated 
signaling on Foxp3+ Treg cells might play a minimal role, possibly indirect, in regulating 
the humoral immune response during S. mansoni infection. 
 
Figure 39. Humoral immune response of 8 wk S. mansoni infected IL-4Rα-/lox and 
Foxp3Cre IL-4Rα-/Lox mice. 
IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox mice were infected with 100 S. mansoni cercariae and 
euthanized 8 wk post-infection. Sera were collected and analysed by using ELISA for 
humoral immune response. (A) Total seric IgE in S. mansoni infected mice. (B) SEA-
specific IgG1, (C) IgG2a, and (D) IgG2b isotype antibodies. 
Results are representative of two independent experiments with 8-10 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001 by 






















































































4.1.2.8 IL-4Rα-mediated signaling on Foxp3+ Treg cells is dispensable for host 
survival during S. mansoni infection 
Next, the present study asked whether the heightened immune activation observed in 
Sm-infected Foxp3cre IL-4Rα-/lox mice might have any impact on gross pathology during 
schistosomiasis. To address that, the gross pathology of 8 wk Sm-infected Foxp3cre IL-4Rα-
/lox and IL-4Rα-/lox mice was investigated by evaluating body weight and organs (liver and 
spleen) weight as well as comparing autopsy images. No significant difference was noted 
between Sm-infected Foxp3cre IL-4Rα-/lox mice and their littermate control in terms of final 
body weight (Fig. 40 A), livers weight (Fig. 40 B), spleens weight (Fig. 40 C), or autopsy 
images (Fig. 40 D). To further appraise the effect of deletion of IL-4Rα specifically within 
Foxp3+ Treg cells on the host susceptibility to S. mansoni infection, Foxp3cre IL-4Rα-/lox 
mice and their littermate control were infected with a dose of 80 viable S. mansoni cercariae 
and monitored until the attainment of an pre-defined humane endpoint (persistent bloody 
diarrhoea, severe lethargy, and weight loss of 20% or more). No difference either in the 
pattern of the body weight changes (Fig. 41 A) or the survival rate (Fig. 41 B) was noted 
between Sm-infected Foxp3cre IL-4Rα-/lox mice and their littermate controls. Together, these 
data suggest that IL-4Rα-mediated signaling on Foxp3+ Treg cells might be dispensable for 























































































Figure 40. Deletion of IL-4Rα on Foxp3+ Treg cells does not alter gross pathology 
during acute schistosomiasis. 
(A) Body weight of IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox mice 8 wk post S. mansoni 
infection. (B) Liver weight, (C) Spleen weight, and (D) Gross pathology of 8 wk S. mansoni 
infected mice.  
Results are representative of two independent experiments with 8-10 mice/group. Data are 






Figure 41. Intact IL-4Rα-mediated signaling on Foxp3+ Treg cells is not critical for 
mice survival during schistosomiasis.  
IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox mice were infected with 80 S. mansoni cercariae and 
host survival was recorded. (A) Body weight measured weekly during the onset of 
infection. (B) Survival curve of S. mansoni infected IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox 
mice. 
Results are representative of two independent experiments with 8-10 mice/group.  
  













































4.1.3 IL-4Rα-mediated signaling on Foxp3+ Treg cells is required for Treg 
accumulation and control of inflammation in the lung during primary 
Nippostrongylus brasiliensis infection 
4.1.3.1 Deletion of IL-4Rα on Foxp3+ Treg cells does not alter worm expulsion 
ability of the host 
The present study next aimed to appraise whether the heightened inflammatory 
response in Sm-infected Foxp3cre IL-4Rα-/lox mice is specific to S. mansoni infection, sub-
cutaneous infection of Foxp3cre IL-4Rα-/lox and the littermate control mice was performed 
with 500 L3 Nippostrongylus brasiliensis larvae. Worm count, MLN immune response, gut 
pathology, and lung pathology were assessed 9 days post-infection. Similar to Nb-infected 
IL-4Rα-/lox mice, Nb-infected Foxp3cre IL-4Rα-/lox were able to clear the worms by day 9 
post-infection (Fig. 42, A and B), suggesting that IL-4Rα-mediated signaling on Foxp3+ 




Figure 42. Deletion of IL-4Rα on Foxp3+ Treg cells does not alter worm expulsion 
capacity of the host. 
(A) Experimental design. (B)Worm count. IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox mice were 
infected with 500 L3 larvae of N. brasiliensis, euthanized 9 days after, and worms in the 
gut were counted. 
Results are representative of two independent experiments with 6 mice/group. Data are 


























































4.1.3.2 IL-4Rα-mediated signaling is required to maintain/enhance Foxp3 
expression on Foxp3+ Treg cells in the MLN during primary N. brasiliensis 
infection 
To examine the effect of IL-4Rα deletion on Foxp3+ Treg cells on the Foxp3+ Treg 
cells and their expression level of the suppressive marker, Foxp3, in the MLN during N. 
brasiliensis infection, MLNs of Nb-infected Foxp3cre IL-4Rα-/lox and IL-4Rα-/lox mice were 
collected 9 days post-infection and Foxp3+ Treg cells profile was investigated by flow 
cytometry. Although, the frequency of Foxp3+ Treg cells (Fig. 43, A and B) within the 
MLN of Nb-infected Foxp3cre IL-4Rα-/lox mice was significantly higher compared to the 
littermate controls, Foxp3 expression level on a per-cell basis (Fig. 43, C and D) were 
however drastically reduced in Foxp3+ Treg cells in the MLN of Nb-infected Foxp3cre IL-
4Rα-/lox mice, when compared to the infected littermate controls, suggesting that, 
consistently in vitro and in vivo under inflammatory conditions, Foxp3+ Treg cells do 
require IL-4Rα-signaling to potentiate Foxp3 expression. Although, however, T cell 
polarization markers (Fig. 43 E), as well as cytokines production (IL-4, IL-10, IL-13, and 
IFN-γ) by CD4+ T (Fig. 43 F) cells in the MLN of Nb-infected Foxp3cre IL-4Rα-/lox mice, 
were similar to those of infected littermate control. In support, no significant difference in 
the number of mucus-producing goblet cells in the gut of Nb-infected Foxp3cre IL-4Rα-/lox 




Figure 43. Deletion of IL-4Rα on Foxp3+ Treg cells does not alter gut pathology during 
primary N. brasiliensis infection. 
(A) Representative flow cytometry of CD4+ Foxp3+ T cells from the MLN of N. brasiliensis 
infected IL-4Rα-/lox and Foxp3Cre IL-4Rα-/lox mice. (B) Frequency of CD4+ Foxp3+ T cells 
from (A). (C) Representative histogram of Foxp3 expression by CD4+ Foxp3+ T cells in 
the MLN of N. brasiliensis infected mice. (D) Foxp3 GMFI in CD4+ Foxp3+ T cells from 
(C). (E) Frequency of indicated transcription factors-expressing CD4+ T cells in the MLN 
N. brasiliensis infected mice. (F) Frequency of cytokine-producing CD3+ CD4+ T cells 
from MLN of N. brasiliensis infected mice. MLN of infected mice was stimulated with 
PMA/Ionomycin in the presence of Monensin and intracellular cytokines were measured 
by flow cytometry. (G) Representative PAS staining of mucus-producing goblet cells 
(original magnification 100X) in the gut tissues 9-days post-infection. (H) Quantification 
of PAS+ goblet cells/villus/mouse from (G). 
Results are representative of two independent experiments with 6 mice/group. Data are 
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4.1.3.3 IL-4Rα-mediated signaling on Foxp3+ Treg is required for Treg 
accumulation and the control of worm-driven emphysematous 
inflammation in the lung during primary N. brasiliensis infection 
Since N. brasiliensis larvae migration through the lung to the bronchi causes a 
dilatation of distal airway spaces and a significant reduction in lung function, a 
phenomenon known as emphysema, and it was previously published that IL-4Rα signaling 
plays a crucial role in mediating acute wound healing (Chen et al., 2012), the present study 
asked whether IL-4Rα signaling, particularly on Foxp3+ Treg cell, plays a role in the 
regulation of worm-driven lung emphysema. To address this hypothesis, emphysema in the 
lung of Nb-infected Foxp3cre IL-4Rα-/lox and IL-4Rα-/lox mice was measured using mean 
linear intercept method (MLI) (Brandsma et al., 2008; Knudsen et al., 2010; Cremona et 
al., 2013; Bouchery et al., 2017) 9 days post-infection. Deletion of IL-4Rα specifically on 
Foxp3+ Treg cell resulted in worsened emphysema in the lung of Nb-infected Foxp3cre IL-
4Rα-/lox, when compared to infected littermate controls (Fig 44, A and B), indicating that 
IL-4Rα-mediated signaling on Foxp3+ Treg cells is critical in controlling parasite-induced 
emphysema. 
Moreover, the airways of Nb-infected Foxp3cre IL-4Rα-/lox mice showed much heavier 
mucus production 9 days post-infection (Fig. 45, A and B). Furthermore, it was noted that 
Foxp3+ Treg cells recruitment to the inner layer of the alveoli of the lungs of Nb-infected 
Foxp3cre IL-4Rα-/lox mice (Fig. 45, C and D) was diminished, indicating that in this model 
as well the impairment of IL-4Rα-mediated signaling within the Foxp3+ Treg cell 
compartment impair their ability to accumulate at the inflamed tissue and to control local 
tissue inflammation. Collectively, these results clearly suggest, in two different and major 
inflammatory helminth models that impairment of IL-4Rα-mediated signaling within the 
Foxp3+ T cell compartment leads to uncontrolled immune responses and exacerbated 
tissue(s) inflammation, underscoring a hitherto unappreciated role of IL-4Rα mediated 




Figure 44. Deletion of IL-4Rα on Foxp3+ Treg cells impairs the control of emphysema 
during primary N. brasiliensis infection. 
(A) Representative H&E staining of lung section (original magnification 4X) from N. 
brasiliensis infected IL-4Rα-/lox and Foxp3cre IL-4Rα-/lox mice. H&E lung sections were 
used to measure emphysema by drawing horizontal lines across the section and then count 
the number of intercepts between the line and the lung septa to measure MLI. (B) 
Measurement of MLI from (A). 
Results are representative of two independent experiments with 6 mice/group. Data are 
















































Figure 45. IL-4Rα signaling on Foxp3+ Treg cells is required to control worm-driven 
lung inflammation during N. brasiliensis infection.  
(A) Representative PAS staining of mucus-producing goblet cells, with lower (20X, top) 
and higher (200X) magnifications, in the lung tissues 9-days post-infection of IL-4Rα-/lox 
and Foxp3cre IL-4Rα-/lox mice with 500 L3 larvae of N. brasiliensis. (B) Quantification of 
PAS+ bronchi/lung/mouse. (C) Representative of Foxp3+ Treg cells infiltration within the 
lung alveoli 9-days post-N. brasiliensis infection (original magnification 200X). Thin 
arrows point to inner and outer Foxp3+ cells. (D) Ratio of inner to outer Foxp3+ Treg cells 
per alveoli from (C).  
Results are representative of two independent experiments with 6 mice/group. Data are 
expressed as mean ± S.E.M. NS, not significant (P > 0.05); * P < 0.05, ** P < 0.001, *** 





















































































Even though naïve Foxp3cre IL-4Rα-/lox mice were indistinguishable from their 
littermate controls, by using two different models of tissue-dwelling helminth infections, 
Schistosoma mansoni and Nippostrongylus brasiliensis, the present thesis showed that 
Foxp3+ Treg cells do require an intact IL-4Rα signaling to maintain/potentiate Foxp3+ 
Tregs. The present thesis does show that Foxp3+ Treg cells require an intact IL-4Rα to 
maintain/upregulate Foxp3 expression, and other suppressive markers based on the 
anatomical location, to control T cell proliferation as well as effector functions, as 
evidenced by overshooting cytokine production and exacerbated parasite-driven tissue 
inflammation. Mechanistically, IL-4Rα-mediated signaling on Foxp3+ Treg cells is crucial 
for their infiltration /accumulation at the inflamed tissues. Our data reveal for the first time, 
the host requirement for an intact, rather than a threshold, level of expression of IL-4Rα 
mediated signaling on Foxp3+ Treg cells to optimally control inflammation during helminth 
infections, describing a positive regulation of Foxp3+ Tregs function by IL-4Rα in vivo.  
 
4.2.1 Upregulation of IL-4Rα expression by Foxp3+ Treg cell in vivo under 
inflammatory conditions  
Similar to mice with specific deletion of either GATA3 or T-bet on Foxp3+ Treg cells 
(Koch et al., 2009; Yu et al., 2015), deletion of IL-4Rα specifically on Foxp3+ Treg cells 
did not show any physical alteration or spontaneous inflammatory disorders under steady-
state in naïve young mice and hence, induction of inflammatory conditions, i.e. by infecting 
the mice with tissue-dwelling helminth, was crucial in dissecting the role of IL-4Rα-
mediated signaling on Foxp3+ Treg cells. It was first noted that Foxp3+ Treg cells do 
upregulate the expression of IL-4Rα during acute experimental schistosomiasis. The IL-
4Rα upregulation on the Foxp3+ Treg compartment during acute experimental 
schistosomiasis led to two opposing but not mutually exclusive hypotheses; i) the first 
hypothesis is that IL-4Rα is a critical receptor in conferring to Foxp3+ Treg cells the 
necessary potency to control inflammatory immune responses in disease and/or ii) the 
second hypothesis is that the need for this IL-4Rα receptor to foster Foxp3+ Treg 





4.2.2 Foxp3+ Treg cells do require IL-4Rα signaling to control inflammatory 
immune responses in disease 
4.2.2.1 IL-4Rα signaling on Foxp3+ Treg is crucial in maintaining/promoting 
their Foxp3 expression in vivo 
The first hypothesis does find support in our observations. Deletion of IL-4Rα 
specifically on Foxp3+ Treg resulted in a significant reduction of Foxp3+ Treg population 
in the liver and the gut during S. mansoni infection, arguing for the need of that receptor by 
Foxp3+ Treg to maintain/enforce their pool in the infected tissues. In fact, and despite the 
effect of different anatomical locations on Foxp3+ Treg cells phenotypical and functional 
characteristics, conditional ablation of IL-4Rα specifically on Foxp3+ Treg cells led to a 
drastic reduction in Foxp3 expression in Foxp3+ Treg population in the liver, hLN, and 
MLN of S. mansoni infected Foxp3cre IL-4Rα-/lox mice. The pattern that was reproducible 
in another helminth infection, N. brasiliensis. Even though, the mechanism in N. 
brasiliensis might be slightly different as Foxp3+ Treg population was higher in N. 
brasiliensis infected Foxp3cre IL-4Rα-/lox mice compared to their littermate controls, Foxp3 
expression on a per cell basis were significantly reduced in those Foxp3+ Treg population 
in the N. brasiliensis infected Foxp3cre IL-4Rα-/lox mice. One possible explanation could be 
that the host was trying to compensate for the reduction of Treg cells suppressive capacity, 
as indicated by the reduction of the Foxp3 expression, by increasing the number of the 
available Foxp3+ Treg population. Foxp3 is the canonical transcription factor of Foxp3+ 
Treg cells. Its expression is crucial in endowing Treg cells with their suppressive ability 
(Fontenot et al., 2003; Hori et al., 2003; Wan and Flavell, 2007; Williams and Rudensky, 
2007). Most importantly, sustained and continuous expression of Foxp3 in Treg cells is 
required to maintain the transcriptional and functional programs in developmentally 
established Treg cells. Foxp3 expression level within the Foxp3+ Treg population has been 
considered to be a quality control indicator for the Foxp3 suppressive functional capacity 
(Wan and Flavell, 2007; Williams and Rudensky, 2007). Although the frequency of Foxp3+ 
Treg compartment could be possibly comparable, reduction in Foxp3 expression within 
Treg cells can cause auto-immune diseases under steady-state and failure to control 
immune responses under inflammatory conditions (Wan and Flavell, 2007; Kitoh et al., 
2009; Wohlfert et al., 2011). Consequently, our observation of a reduced Foxp3 expression 
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during inflammation following IL-4Rα removal on Foxp3+ Treg cells define, rather 
remarkably, a need for this receptor in stabilizing/promoting Foxp3 expression by Foxp3+ 
Treg cells in vivo under inflammatory conditions. 
 
4.2.2.2 Differential regulation of Foxp3+ Treg population by IL-4Rα signaling 
Unlike the marked reduction in Foxp3 expression observed, the expression level of 
CD25, a consensus receptor expressed by Treg cells (Zemmour et al., 2018), on Foxp3+ 
Treg cells was not affected in the liver, hLN, and MLN of S. mansoni infected Foxp3cre IL-
4Rα-/lox mice, suggesting that IL-4Rα signaling on Foxp3+ Treg cells is dispensable for 
CD25 expression by Foxp3+ Treg cells. Of importance, differential regulation of IL-4Rα 
signaling on Foxp3+ Treg cells in different anatomical location was noted. Such a case is 
not uncommon. The Foxp3+ Treg population is one of the most heterogeneous T cell 
population. Its phenotypical heterogeneity reflects the diverse environment and the 
different cell types these cells do regulate (Zhou et al., 2015; Zemmour et al., 2018). With 
recently available high throughput technologies, i.e. single-cell RNA sequencing, it has 
been shown that transcriptional profile of lymphoid and non-lymphoid Treg cells are quite 
distinct (Zhou et al., 2015), which might partially explain why in our case the specific 
deletion of IL-4Rα on Foxp3+ Treg cells affected their proliferation only in the lymph nodes 
(MLN and hLN) but not in the tissue (the liver) during S. mansoni infection. Similarly, 
single-cell transcriptomic analyses showed that non-lymphoid Treg cells present in 
different non-lymphoid tissues/lymphoid Treg cells present in different LNs do have 
similar but not identical transcriptional profile, indicating Treg cells adaptation to support 
a particular tissue/LN specific function (Miragaia et al., unpublished data). Hence, it is not 
surprising that IL-4Rα signaling could present with different impacts on the expression 
level of different suppressive molecules by Foxp3+ Treg cells from different anatomical 
locations.  
The reduction of Foxp3 expression by Foxp3+ Treg population noted in the MLN and 
hLN of S. mansoni infected male and female Foxp3cre IL-4Rα-/lox mice can very well 
explain the uncontrolled T cell proliferation and effector function observed in both organs. 
Thus, the data are arguing for a need of Foxp3+ Treg to have an intact IL-4Rα signaling to 
potentiate their suppressive function. Even though IRF4 expression, the transcription factor 
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required by Treg cells to control Th2 immune response (Zheng et al., 2009), by Foxp3+ 
Treg compartments was differentially regulated in the MLN and hLN of S. mansoni 
infected Foxp3cre IL-4Rα-/lox mice, the present study noted a consistent increase in CD4+ 
GATA3+ Th2 cell paralleled by an augmentation of type 2 cytokine production, suggesting 
that Treg cells in different lymphoid organs could use different suppressive mechanisms in 
order to maintain homeostasis. One likelihood could be that Foxp3+ Treg population in the 
MLN controls Th2 immune response in IRF4-independent manner. The uncontrolled T cell 
proliferation, T cell effector function and type 2 cytokines production in the MLN, as well 
as the reduction in Foxp3+ Treg population in the gut, observed in S. mansoni infected 
Foxp3cre IL-4Rα-/lox mice can, therefore, explain the exacerbated egg-driven 
fibrogranulomatous inflammation in the gut accompanied by high level of fibrosis as 
indicated by histology and hydroxy-proline content. 
In the liver, the present study noted that partial or quasi-complete deletion of IL-4Rα 
specifically on Foxp3+ Treg cells results in significant reduction in IRF4 and Helios 
expression by Foxp3+ Treg cells during S. mansoni infection, suggesting that IL-4Rα-
mediated signaling on Foxp3+ Treg cells is crucial for maintaining/enhancing IRF4 and 
Helios expression by Foxp3+ Treg cells present in the liver. Helios and IRF4 expression by 
Foxp3+ Treg cells are crucial in maintaining and stabilizing Tregs suppressive capacity 
potential in the face of the inflammatory immune response (Zheng et al., 2009; Kim et al., 
2015; Nakagawa et al., 2016). It has been shown that Foxp3+ Treg cells do require the 
expression of IRF4 to endow themselves with molecular machineries required to control 
Th2 immune response (Zheng et al., 2009). A study by Kim and colleagues (2015) showed 
that conditional ablation of helios specifically on Foxp3+ Treg cells results in a reduction 
in Foxp3 expression as well as uncontrolled cytokine production (Kim et al., 2015). In fact, 
a recently published report demonstrated that effector Treg cells, Treg cells that populate 
the non-lymphoid tissues (Smigiel et al., 2014), have a higher need for Helios expression 
to maintain their fitness (Sebastian et al., 2016). Therefore, the heterogeneous effect of IL-
4Rα deletion specifically on Foxp3+ Treg cells on Helios expression by Foxp3 Treg 
population present in the liver and those present in the MLN and hLN of S. mansoni 
infected Foxp3cre IL-4Rα-/lox mice could be that Helios expression by Foxp3+ Treg cells is 
independent of IL-4Rα signaling but once in the tissues where the peak of inflammation is 
present, IL-4Rα could be possibly playing a role in boosting Helios expression on Foxp3+ 
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Treg cells in order to stabilize Foxp3 expression and survival of Treg cells in the face of 
the heightened immune response.  
Consequently, our observation of the marked reduction in the expression of Treg 
suppressive markers, Foxp3, Helios, and IRF4, in Foxp3+ Treg cells in the S. mansoni 
infected Foxp3cre IL-4Rα-/lox mice could give an explanation for the significant increase in 
type 1 (IFN-γ), type 2 (IL-4, IL-5, IL-10, and IL-13), and type 17 (IL-17) cytokine 
production, exaggerated egg-driven fibro-granulomatous inflammation, and large 
coalescing granuloma, accompanied by dramatic increase in the level of tissue fibrosis. It 
is also important to point out that similarly heightened cytokine release and inflammation 
were noted in diseased female Foxp3cre IL-4Rα-/lox mice, where the less efficient deletion 
of IL-4Rα was observed when compared to Sm-infected male Foxp3cre IL-4Rα-/lox mice. 
Even though the effect of IL-4Rα deletion on Foxp3+ Treg cell on S. mansoni-induced 
immunopathology at different time points is yet to be experimentally validated, the present 
study, as it stands, convincingly argues for a requirement of IL-4Rα in full, i.e. intact, on 
Foxp3+ Tregs, rather than beyond a threshold level, to enable Foxp3+ Treg-mediated control 
of inflammatory responses in diseases. 
 
4.2.2.3 IL-4Rα signaling on Foxp3+ Treg is required to control hookworm-
induced emphysematous lung pathology 
Deletion of IL-4Rα on Foxp3+ Treg cells did not alter the host ability to expel the 
worms during N. brasiliensis infection. Even though this finding argues for a dispensable 
role of IL-4Rα signaling on Foxp3+ Treg cell in the worm expulsion capacity of the host, it 
does not rule out the possibility that Foxp3cre IL-4Rα-/lox mice might have cleared the worms 
before IL-4Rα-/lox mice. Hence, checking worm counts, cytokines production, and gut 
pathology at earlier time points (i.e. 6-7 days) might help in dissecting the role of IL-4Rα 
signaling on Foxp3+ Treg cell in gut pathology and worm clearance during primary N. 
brasiliensis infection. Interestingly, however, in the lung, the present study found that 
conditional ablation of IL-4Rα specifically within Foxp3+ Treg cells results in higher 
mucus production and exacerbated emphysema. Emphysema is a devastating pathology, 
which can be replicated by N. brasiliensis infection and migration of the parasite through 
the lungs where a reduction in lung function and a difficulty in breathing arise. Emphysema 
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gets worse over time and continues even after the parasite has left the lung (Marsland et al., 
2008; Heitmann et al., 2012; Bouchery et al., 2017). The mechanism(s) underlying the host 
protection or susceptibility to emphysema is (are) yet to be defined (Brandsma et al., 2008; 
Knudsen et al., 2010; Cremona et al., 2013; Bouchery et al., 2017). Previously published 
reports showed that IL-4Rα signaling plays a crucial in mediating acute wound healing in 
the lung during helminth infection (Chen et al., 2012) making it desirable to specifically 
pinpoint the IL-4Rα responsive cell type(s) involved in this repair process for a role was 
previously suggested for alternatively activated macrophages (Marsland et al., 2008). The 
present study now shows for the first time that IL-4Rα-mediated signaling on Foxp3+ Treg 
cells, in particular, is crucial in protecting the host against helminth-induced lung 
emphysematous pathology. 
 
4.2.2.4 IL-4Rα signaling mediates Foxp3+ Treg cells accumulation within 
inflamed tissues 
Partial or quasi-complete removal of IL-4Rα within the Foxp3+ Treg compartment of 
Foxp3cre IL-4Rα-/lox diseased mice led to an impaired accumulation of Tregs to the site of 
inflammation. The impaired accumulation of Foxp3+ Treg population was recorded in two 
different models; i) in the liver and the gut of S. mansoni diseased Foxp3cre IL-4Rα-/lox mice 
and ii) in the inner layer of the alveoli of the lungs during N. brasiliensis infection. In-depth 
investigations showed that Foxp3+ Tregs that failed to accumulate in the liver of our S. 
mansoni diseased Foxp3cre IL-4Rα-/lox mice had a significant reduction in their expression 
levels of GATA3. In fact, this is consistent with previous report showing that GATA3 
deficient Foxp3+ Tregs fail to efficiently accumulate in inflamed tissues, that report can as 
well explain the comparable expression level of GATA3 by Foxp3+ Treg cells in the MLN 
and hLN of S. mansoni diseased Foxp3cre IL-4Rα-/lox mice compared to their littermate 
controls (Wohlfert et al., 2011). Thus our data argue for the need of an intact IL-4Rα within 
the Foxp3+ Treg compartment to maintain/enhance GATA3 expression for endowing 
Foxp3+ Treg cells with the ability to accumulate at the inflamed tissues and to be able to 
protect the host against exacerbated tissue inflammation. Mechanistically, various 
processes can mediate such an impaired accumulation of Foxp3cre IL-4Rα-/lox Tregs 
observed in our infectious settings including  
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a) defects in extra-thymic Treg conversion,  
b) reduced Treg proliferation, and/or 
c) increased Treg apoptosis  
With regard to the hypothesis a), it was noted that no obvious defect of CD25- CD4+ cell 
precursors from Foxp3cre IL-4Rα-/lox mice in converting into Foxp3+ Treg in vitro arguing 
against a defect in extra-thymic Treg conversion.  
For b), ex-vivo analyses of Foxp3+ Tregs from diseased Foxp3cre IL-4Rα-/lox mice 
showed no signs of impaired proliferation, as indicated by the comparable expression level 
of Ki-67 by Foxp3+ Treg cells in the liver of Sm-infected Foxp3cre IL-4Rα-/lox and their 
littermate controls, dismissing Foxp3+ Treg defective proliferation as a possible cause of 
the poor accumulation reported.  
Interestingly, however, with regards to the option c), CD25+ Tregs survival and 
stability (as judged by cell viability staining and Foxp3 expression) were compromised in 
the absence of IL-4 in vitro supporting Foxp3+ Treg impaired survival and disturbed 
stability as likely mediating the poor accumulation of Tregs to inflamed sites shown in the 
diseased- Foxp3cre IL-4Rα-/lox mice.  
It should be also noted that defective Treg migration to the inflamed tissues could 
further explain the observed reduction of Tregs in the livers of S. mansoni-infected or the 
lungs of N. brasiliensis-infected Foxp3cre IL-4Rα-/lox mice. In as much as our present study 
does not provide an experimental appraisal of this possibility, a follow-up approach would 
be to test for the frequencies of CCR7 low, CD44 high effector Tregs –usual tissue recruited 
Tregs- within the Foxp3 Treg compartment. 
As of yet, however, our present data support an impaired survival and a disturbed 
stability of Foxp3 Tregs in our Foxp3cre IL-4Rα-/lox mice as likely the driving causes of the 





4.2.3 Exaggerated immune response and tissue inflammation following deletion 
of IL-4Rα specifically on Foxp3+ Treg cells 
The reduction in Foxp3+ Treg population, as well as Treg suppressive capacity that 
resulted in uncontrolled immune response and exaggerated tissue inflammation in diseased 
Foxp3cre IL-4Rα-/lox mice, were due to the deletion of IL-4Rα specifically on Foxp3+ Treg 
cells rather than a bystander effect from the Cre-expression. Plethora of reports have shown 
that Cre alone can produce a phenotype as they can excise genomic DNA sequences flanked 
by loxP-like sites or possibly because the expression level of Cre could be high to an extent 
that affects the physiology of the cells (Loonstra et al., 2001; Pomplun et al., 2007; 
Schmidt-Supprian and Rajewsky, 2007; Huh et al., 2010; Heffner et al., 2012; Qureshi et 
al., 2014; Carow et al., 2016). The similar Foxp3+ Treg cell frequency, Foxp3 expression 
by Foxp3+ Tregs, as well as the comparable level of fibrogranulomatous inflammation in 
the liver and the gut of S. mansoni infected IL-4Rα+/+ and Foxp3cre IL-4Rα+/+ were 
sufficiently dismissive of the potential unspecific effects of Cre-expression and were 
further proving that our phenotype was specifically due to the deletion of IL-4Rα on Foxp3+ 
Treg cells. 
 
4.2.4 Deletion of IL-4Rα specifically on Foxp3+ Treg cells does not induce Foxp3+ 
Treg cells transdifferentiation to ex-Foxp3-Th2 
The second hypothesis that Foxp3+ Treg cells need IL-4Rα receptor to foster their 
transdifferentiation into effector T cells is less supported and even dismissed by some of 
our present observations: i) Should ex-Foxp3 Th2 effector cells be mounted during 
experimental acute schistosomiasis from IL-4Rα responsive Foxp3+ Treg cells, the absence 
of these cells from the pool of the Th2 effector population – that is widely reported to ensure 
survival during acute schistosomiasis (Pelly et al., 2017) -  did not affect the host survival, 
arguing either against the need for IL-4Rα to mount the pool of the required Foxp3-derived 
protective Th2 cells in our system or denotes a lack of ex-Foxp3 Th2 requirement by the 
host to survive acute schistosomiasis. Secondly, the present study noted that ii) the T-cells 
responsible for the increased cytokine production reported in Foxp3cre IL-4Rα-/lox diseased 
mice did not express Foxp3 but rather GATA3 in both MLN and hLN, a profile inconsistent 
with recently reported ex-Foxp3 T cells during helminth infections (Pelly et al., 2017). 
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Even though a clear-cut can only be established by using FATE-mapping mice, our present 
data argue against Foxp3 Treg transdifferentiation into cytokine-producing effector T cells 
as mediating the heightened inflammation observed in diseased Foxp3cre IL-4Rα-/lox mice. 
Overall, our results support the idea that an intact, rather than a potentiated/diminished, IL-
4Rα-mediated signaling is optimal to endow Foxp3+ Treg cells with their most efficient 
ability to control inflammation in disease as illustrated here in helminthiases. As per our 
current findings, such an optimal response is most likely achieved by preventing Foxp3+ 
Treg death and stabilizing the expression of canonical Treg suppressive and associated 
markers such as Foxp3, IRF4, GATA3, and Helios (Fig. 46).  
 
 
Figure 46. IL-4Rα is required by Foxp3+ Treg cells to control inflammation in disease. 
Schematic diagram showing that either partial or complete deletion of IL-4Rα from Foxp3+ 
Treg cells lead to aggravated pathology and uncontrolled inflammation, but rather Foxp3+ 




This study further highlights the fact that a cytokine can have both a positive and 
negative effects on Treg cell activity and reinstates the notion that balance is key. 
Promoting or impairing IL-4Rα mediated signaling yielded a similar impairment of Foxp3+ 
Treg cell, therefore, strongly arguing against the benefits of uninformedly modulating this 
cytokine receptor on Foxp3+ Tregs to ameliorate/break tolerance, particularly in the current 
global context where helminthiases are rampant. This is, therefore, particularly important 
in the light of recent therapeutic advances against non-communicable diseases such as 
asthma or atopic dermatitis, where IL-4Rα targeting is being introduced and is attracting 
considerable interest and funding (Noval Rivas et al., 2015; Massoud et al., 2016). 
Although potentially disease-specific, thus not applicable to the above-mentioned diseases, 
the observations reported in the present work remain alarming and warrant more caution 
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